TWI594739B - Absorbent article - Google Patents

Absorbent article Download PDF

Info

Publication number
TWI594739B
TWI594739B TW102135077A TW102135077A TWI594739B TW I594739 B TWI594739 B TW I594739B TW 102135077 A TW102135077 A TW 102135077A TW 102135077 A TW102135077 A TW 102135077A TW I594739 B TWI594739 B TW I594739B
Authority
TW
Taiwan
Prior art keywords
acid
blood
chain hydrocarbon
imparting agent
group
Prior art date
Application number
TW102135077A
Other languages
Chinese (zh)
Other versions
TW201436776A (en
Inventor
中下將志
Original Assignee
優你 嬌美股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 優你 嬌美股份有限公司 filed Critical 優你 嬌美股份有限公司
Publication of TW201436776A publication Critical patent/TW201436776A/en
Application granted granted Critical
Publication of TWI594739B publication Critical patent/TWI594739B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/45Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the shape
    • A61F13/47Sanitary towels, incontinence pads or napkins
    • A61F13/476Sanitary towels, incontinence pads or napkins characterised by encircling the crotch region of the undergarment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/51Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the outer layers
    • A61F13/511Topsheet, i.e. the permeable cover or layer facing the skin
    • A61F13/51113Topsheet, i.e. the permeable cover or layer facing the skin comprising an additive, e.g. lotion or odour control

Description

吸收性物品 Absorbent article

本發明關於一種吸收性物品。 The present invention relates to an absorbent article.

吸收性物品,例如生理用衛生棉、內褲護墊等,藉由長年累積下來的技術開發使得基本的性能提升,與以前相比,在吸收經血等排泄物後,外漏等發生漸漸減少,現在更為高機能化,例如,進行關於具有與貼身衣物相近之著用感、或即使在吸收經血等排泄物後頂部薄片亦有乾爽感之研究。 Absorbent articles, such as sanitary napkins, panty liners, etc., have been improved by the development of technology accumulated over the years. Compared with before, after leaking excretions such as menstrual blood, leakage has gradually decreased. It is more highly functional, for example, a study has a feeling of being similar to that of the close-fitting clothing, or a feeling of dryness of the top sheet even after absorbing excrement such as menstrual blood.

尤其是,月經時之經血有時候會包含子宮內膜等成分,雖然其黏度高,但吸收該高黏度之經血後,在頂部薄片亦無沾黏感,並有乾爽感較佳。且,黏度高之經血在頂部薄片上,較多以塊狀狀態殘留,使用者較多感受到視覺上的不快感,由此觀點來看,不使黏度高的經血在頂部薄片上殘留較佳。 In particular, the menstrual blood during menstruation sometimes contains components such as the endometrium. Although the viscosity is high, after absorbing the high-viscosity menstrual blood, the top sheet is also non-sticky and has a good dry feeling. Moreover, the menstrual blood with high viscosity is mostly in the form of a block on the top sheet, and the user feels a sense of visual discomfort. From this point of view, it is better not to leave the menstrual blood with high viscosity on the top sheet. .

該技術領域中,已熟知經乳液組成物塗佈之吸收性物品。 Absorbent articles coated with emulsion compositions are well known in the art.

例如,專利文獻1中發明一種吸收性物品,其係將包 含聚丙二醇材料之乳液組成物配置於頂部薄片之內表面(著衣側之面)、後部薄片之內表面(身體側之面)、頂部薄片之內表面及後部薄片之內表面之間之基材等。 For example, Patent Document 1 discloses an absorbent article which is a package The emulsion composition containing the polypropylene glycol material is disposed on the inner surface of the top sheet (the side on the garment side), the inner surface of the rear sheet (the side on the body side), the inner surface of the top sheet, and the inner surface of the rear sheet. Materials and so on.

且,專利文獻2中揭示一種吸收性物品,其係將包含聚丙二醇材料之乳液組成物適用於頂部薄片之外表面(身體側之面)。 Further, Patent Document 2 discloses an absorbent article in which an emulsion composition containing a polypropylene glycol material is applied to the outer surface of the top sheet (the side on the body side).

[先前技術文獻] [Previous Technical Literature] [專利文獻] [Patent Literature]

[專利文獻1]日本特表2010-518918號公報 [Patent Document 1] Japanese Patent Publication No. 2010-518918

[專利文獻2]日本特表2011-510801號公報 [Patent Document 2] Japanese Patent Publication No. 2011-510801

然而,專利文獻1及2記載之吸收性物品並沒有提及,為了在吸收經血之後,使頂部薄片不易沾黏且有乾爽感,應將頂部薄片作成哪一種形狀。 However, the absorbent articles described in Patent Documents 1 and 2 do not mention which shape the top sheet should be formed in order to make the top sheet less likely to be sticky and have a dry feeling after absorbing menstrual blood.

因此,本發明之目的為提供一種吸收性物品,其頂部薄片之排泄口接觸區域在吸收經血後不易沾黏,且有乾爽感。 Accordingly, it is an object of the present invention to provide an absorbent article in which the exudation port contact area of the top sheet is less likely to stick after absorption of menstrual blood and has a dry feeling.

本發明者們,為了解決上述問題進行嚴密之探討,發現一種吸收性物品,其係具有液體可透性之頂部 薄片、與液體不可透性之後部薄片、與上述頂部薄片及後部薄片之間之吸收體之吸收性物品,其特徵為上述液體可透性頂部薄片在排泄口接觸區域中具有複數突狀部,上述突狀部相對於上述吸收性物品之平面方向,具有36~80°角度,且上述液體可透性之頂部薄片在排泄口接觸區域之至少上述突狀部中具有含有血液滑性賦予劑之區域,其含有血液滑性賦予劑之區域包含具有於40℃下為0.01~80mm2/s之動力黏度、0.01~4.0質量%之抱水率、未滿1,000之重量平均分子量之血液滑性賦予劑。 The inventors of the present invention have conducted intensive studies to solve the above problems, and have found an absorbent article having a liquid permeable top sheet, a liquid impermeable back sheet, and the top sheet and the back sheet. The absorbent article of the absorbent body, characterized in that the liquid permeable top sheet has a plurality of protruding portions in the discharge port contact region, and the protruding portion has an angle of 36 to 80° with respect to a plane direction of the absorbent article. And the liquid permeable top sheet has a region containing a blood slip imparting agent in at least the protruding portion of the excretory opening contact region, and the region containing the blood slip imparting agent comprises 0.01 to 80 mm at 40 ° C. 2 / s dynamic viscosity, 0.01 to 4.0% by mass of water holding capacity, less than 1,000 weight average molecular weight of the blood slip property imparting agent.

本發明之吸收性物品之頂部薄片之排泄口接觸區域在吸收經血後,不易沾黏,且有乾爽感。 The excretory opening contact area of the top sheet of the absorbent article of the present invention is not easily adhered after absorption of menstrual blood, and has a dry feeling.

1‧‧‧吸收性物品 1‧‧‧Absorbables

2‧‧‧頂部薄片 2‧‧‧Top sheet

3‧‧‧吸收體 3‧‧‧ absorber

4‧‧‧側翼 4‧‧‧Flanking

5‧‧‧側邊薄片 5‧‧‧Side sheet

6‧‧‧壓印 6‧‧‧ Imprint

7‧‧‧含有血液滑性賦予劑之區域 7‧‧‧A zone containing a blood slip agent

8‧‧‧後部薄片 8‧‧‧ rear sheet

9‧‧‧突狀部 9‧‧‧ 突部

11‧‧‧凸部 11‧‧‧ convex

12‧‧‧凹部 12‧‧‧ recess

13‧‧‧接觸肌膚面 13‧‧‧Contact skin surface

14‧‧‧血液滑性賦予劑 14‧‧‧ Blood slip agent

15、15’、15”‧‧‧經血 15, 15', 15" ‧ ‧ menstrual blood

[圖1]圖1為依照本發明之1個實施形態之吸收性物品之正面圖。 Fig. 1 is a front elevational view showing an absorbent article according to an embodiment of the present invention.

[圖2]圖2為圖1所示之吸收性物品1之剖面圖。 Fig. 2 is a cross-sectional view of the absorbent article 1 shown in Fig. 1.

[圖3]圖3為相當於圖1所示之吸收性物品1之含有血液滑性賦予劑之區域7之X-X剖面之剖面圖,是為了將血液滑性賦予劑所造成之經血之往吸收體之移行進行模式的說明之圖。 Fig. 3 is a cross-sectional view taken along the line XX of the region 7 containing the blood slidability imparting agent of the absorbent article 1 shown in Fig. 1 for absorbing the menstrual blood caused by the blood slidability-imparting agent. A diagram illustrating the mode of movement of the body.

[圖4]圖4為頂部薄片包含三C2L油脂肪酸甘油酯之 生理用衛生棉中,頂部薄片之接觸肌膚面之電子顯微鏡照片。 [Fig. 4] Fig. 4 is a top sheet containing three C2L oil fatty acid glycerides In the sanitary napkin, the top sheet is in contact with the electron micrograph of the skin surface.

[圖5]圖5為包含或不包含血液滑性賦予劑之經血顯微鏡照片。 Fig. 5 is a photomicrograph of a menstrual blood with or without a blood slip imparting agent.

[圖6]圖6為說明表面張力測定方法之圖。 Fig. 6 is a view for explaining a method of measuring surface tension.

[定義] [definition]

定義一部份本說明書中所使用之用語。 Define some of the terms used in this manual.

.「突狀部之角度」 . "angle of the bulge"

本說明書中,「突狀部之角度」(以下,亦稱為「角度θ」、「θ」等)意指,通過突狀部之頂部與突狀部之底部之直線,與吸收性物品之平面方向之面所成之角度。 In the present specification, the "angle of the protrusion" (hereinafter also referred to as "angle θ", "θ", etc.) means a line passing through the top of the protrusion and the bottom of the protrusion, and the absorbent article. The angle formed by the plane in the plane direction.

具體的測定方法如後述。 The specific measurement method will be described later.

.「排泄口接觸區域」 . "Drainage contact area"

本說明書中,頂部薄片之「排泄口接觸區域」意指,在頂部薄片中,接觸著用者之排泄口(小陰唇等)之區域。上述排泄口接觸區域雖然會因為吸收性物品之大小等其位置會相異,具有側翼之吸收性物品時,一般來說,經連續或非連續配置成包圍通過吸收性物品之寬方向的中心之縱向線、與通過兩翅翼部之縱向中心之寬方向線之交點之壓印所劃分之區域的內側為排泄口接觸區域。且,不具 有側翼之吸收性物品時,一般來說,藉由經連續或非連續之配置成包圍吸收性物品之寬方向中心部且縱向中心部之壓印之劃分為排泄口接觸區域。 In the present specification, the "excretion port contact area" of the top sheet means an area in the top sheet which is in contact with the user's excretory opening (small labia, etc.). The above-mentioned excretory opening contact area may have a different position depending on the size of the absorbent article, and when it has a flanked absorbent article, it is generally arranged continuously or discontinuously to surround the center of the width direction of the absorbent article. The inner side of the region defined by the embossing of the longitudinal line and the intersection of the broad direction lines passing through the longitudinal centers of the two wing portions is the drain port contact area. And not In the case of a flanked absorbent article, in general, the embossing is defined as a venting contact area by a continuous or discontinuous configuration that surrounds the central portion of the absorbent article in the width direction and the longitudinal center portion.

.「前方」 . "Front"

本說明書中,「前方」意指以著用者為基準,著用者之前方。 In the present specification, "forward" means that the user is used as the reference on the basis of the user.

.「含有血液滑性賦予劑之區域」 . "A zone containing a blood slip agent"

本說明書中,頂部薄片內相關之「含有血液滑性賦予劑之區域」意指,頂部薄片在排泄口接觸區域中包含血液滑性賦予劑之區域。頂部薄片在排泄口接觸區域之一部份中亦可具有含有血液滑性賦予劑之區域,且排泄口接觸區域之全體中亦可具有含有血液滑性賦予劑之區域。且,頂部薄片在超過排泄口接觸區域之排泄口非接觸區域中,也可具有含有血液滑性賦予劑之區域。 In the present specification, the "region containing the blood slip imparting agent" in the top sheet means that the top sheet contains the region of the blood slip imparting agent in the excretory opening contact region. The top sheet may have a region containing the blood slip imparting agent in a portion of the excretory opening contact region, and the entire expulsion port contact region may have a region containing the blood slip imparting agent. Further, the top sheet may have a region containing the blood slip imparting agent in the non-contact region of the excretion port exceeding the excretion port contact region.

針對本發明之吸收性物品,以下進行詳細地說明。 The absorbent article of the present invention will be described in detail below.

圖1為依照本發明之一個實施形態之吸收性物品正面圖,更具體來說,為生理用衛生棉之正面圖。圖1為由頂部薄片2之接觸肌膚面觀察之圖。圖1所示之吸收性物品1具有液體可透性之頂部薄片2、液體不可透性之後部薄片(無圖示)、與頂部薄片2及後部薄片之間之吸收體3。圖1所示之吸收性物品1中,在吸收性物品1之縱向 的兩側部分具備為了將吸收性物品1固定於著用者的衣服,例如內褲上之一對側翼4。 BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 is a front elevational view of an absorbent article according to an embodiment of the present invention, and more particularly, a front view of a sanitary napkin. Fig. 1 is a view of the top sheet 2 as it contacts the skin surface. The absorbent article 1 shown in Fig. 1 has a liquid permeable top sheet 2, a liquid impermeable back sheet (not shown), and an absorbent body 3 between the top sheet 2 and the back sheet. In the absorbent article 1 shown in Fig. 1, in the longitudinal direction of the absorbent article 1 The both side portions are provided with clothes for fixing the absorbent article 1 to the user, for example, one pair of the side flaps 4 on the underwear.

且,圖1所示之吸收性物品1,朝向左側為前方。 Further, the absorbent article 1 shown in Fig. 1 is forward toward the left side.

且,圖1所示之吸收性物品1中,排泄口接觸區域為,經含有血液滑性賦予劑之區域7內的4個壓印6’而被劃分之區域,頂部薄片2之排泄口接觸區域全部具有含有血液滑性賦予劑之區域7。 Further, in the absorbent article 1 shown in Fig. 1, the excretory opening contact area is an area partitioned by the four imprints 6' in the area 7 containing the blood slip imparting agent, and the excretory opening of the top sheet 2 is in contact. The regions all have a region 7 containing a blood slip imparting agent.

且,圖1所示之吸收性物品1雖然具有側邊薄片5、複數之壓印6,但依照本發明之其他實施形態之吸收性物品不具有側邊薄片及/或壓印。 Further, the absorbent article 1 shown in Fig. 1 has a side sheet 5 and a plurality of embossments 6, but the absorbent article according to another embodiment of the present invention does not have side sheets and/or embossing.

圖1所示之吸收性物品中,頂部薄片2雖然是由不織布所形成,但根據本發明之其他實施形態之吸收性物品中,頂部薄片是由織布或孔洞薄膜所形成。 In the absorbent article shown in Fig. 1, the top sheet 2 is formed of a nonwoven fabric, but in the absorbent article according to another embodiment of the present invention, the top sheet is formed of a woven fabric or a film of a hole.

圖1所示之吸收性物品1中,頂部薄片2在排泄口接觸區域中具有複數突狀部(無圖示)。圖1所示之吸收性物品1中,頂部薄片2在排泄口接觸區域之至少上述突狀部中,具有含有血液滑性賦予劑之區域7,其含有血液滑性賦予劑之區域7包含具有於40℃下為0.01~80mm2/s之動力黏度、0.01~4.0質量%之抱水率、與未滿1,000之重量平均分子量之血液滑性賦予劑。 In the absorbent article 1 shown in Fig. 1, the top sheet 2 has a plurality of projections (not shown) in the discharge port contact area. In the absorbent article 1 shown in Fig. 1, the top sheet 2 has at least the above-mentioned projecting portion of the excretory opening contact region, and has a region 7 containing a blood slip imparting agent, and the region 7 containing the blood slip imparting agent contains It is a dynamic viscosity of 0.01 to 80 mm 2 /s at 40 ° C, a water holding ratio of 0.01 to 4.0% by mass, and a blood slip property imparting agent having a weight average molecular weight of less than 1,000.

圖2為圖1所示之吸收性物品1之剖面圖,相當於圖1之X-X剖面。圖2所示之吸收性物品1具有液體可透性之頂部薄片2、液體不可透性之後部薄片8、 頂部薄片2及後部薄片8之間之吸收體3。 Fig. 2 is a cross-sectional view of the absorbent article 1 shown in Fig. 1, which corresponds to the X-X cross section of Fig. 1. The absorbent article 1 shown in Fig. 2 has a liquid permeable top sheet 2, a liquid impermeable back sheet 8, The absorber 3 between the top sheet 2 and the back sheet 8.

於圖2所示之吸收性物品1中,頂部薄片2在排泄口接觸區域中具有複數之突狀部9,突狀部9相對於吸收性物品1之平面方向的面S1,具有角度θ。 In the absorbent article 1 shown in Fig. 2, the top sheet 2 has a plurality of projections 9 in the discharge port contact area, and the projections 9 have an angle θ with respect to the plane S 1 of the absorbent article 1 in the plane direction. .

將突狀部之角度θ的測定方法使用圖2說明。 The method of measuring the angle θ of the protruding portion will be described with reference to Fig. 2 .

突狀部之角度θ意指,通過突狀部之頂部9’、與突狀部之底部9”之直線L1,與吸收性物品1之平面方向的面S1所成之角度。角度θ之測定方法如以下所述。 The angle θ of the protruding portion means a straight line passing through the top of the protruding portion 9 ', with the bottom of the protruding portion 9 "of 1, and the planar direction of the absorbent article 1 to the surface S of L 1 angle θ angle The measurement method is as follows.

由突狀部9之頂部9’之高度與突狀部9之底部9”之高度之差,求出突狀部9之高度H。 The height H of the projection 9 is obtained from the difference between the height of the top portion 9' of the projection 9 and the height of the bottom portion 9" of the projection 9.

接著,求出突狀部9之頂部9’與突狀部9之底部9”之吸收性物品之平面方向距離,求出突狀部9之1/2寬度W。 Next, the distance between the top 9' of the projecting portion 9 and the bottom portion 9' of the projecting portion 9 in the plane direction is obtained, and the 1/2 width W of the projecting portion 9 is obtained.

將角度θ(°)根據以下之式算出:θ(°)=(360/2π)×tan-1(H/W) The angle θ(°) is calculated according to the following equation: θ (°) = (360/2π) × tan -1 (H/W)

且,作為角度θ,至少採用50點的數據平均值。 Further, as the angle θ, at least a data average of 50 points is employed.

高度H及寬度W可藉由同技術領域中公知的方法來測定,例如藉由雷射變位計,例如,Keyence股份有限公司製之高精度2次元雷射變位計LJ-G系列(型式:LJ-G030)等來測定。 The height H and the width W can be determined by a method known in the art, for example, by a laser displacement gauge, for example, a high-precision 2-dimensional laser displacement gauge LJ-G series manufactured by Keyence Corporation (type :LJ-G030), etc. to measure.

且,高度H及寬度W,可由例如,將需測定之樣本浸漬於液態氮30秒,浸漬於液態氮之樣本分成2個,將其剖面以電子顯微鏡攝影、成相來計算。 Further, for the height H and the width W, for example, the sample to be measured may be immersed in liquid nitrogen for 30 seconds, and the sample immersed in liquid nitrogen may be divided into two, and the cross section thereof may be calculated by electron microscopy and phase formation.

本發明之吸收性物品中,突狀部具有約36~約80°,較佳為約37~約70°,且更佳為約38~約60°之角度。若上述角度低於約36°後,突狀部較難具有對經血之高滑落能。且,若上述角度超過約80°後,突狀部之強度容易變得較弱,著用時突狀部會因為體壓而被壓壞。 In the absorbent article of the present invention, the projections have an angle of from about 36 to about 80, preferably from about 37 to about 70, and more preferably from about 38 to about 60. If the angle is less than about 36°, the protrusion is more difficult to have a high sliding energy to the menstrual blood. Further, when the angle exceeds about 80°, the strength of the protruding portion tends to be weak, and when used, the protruding portion is crushed by the body pressure.

本發明之吸收性物品中,頂部薄片在突狀部之頂部之處,較佳為具有約0.2~約15.0mm,更佳為約0.5~約5.0mm,且最佳為約0.5~約2.0mm之厚度。因為突狀部具有上述角度θ,故,即使頂部薄片厚,微少量之經血也能滑落至其內部。 In the absorbent article of the present invention, the top sheet preferably has a top portion of the projections of from about 0.2 to about 15.0 mm, more preferably from about 0.5 to about 5.0 mm, and most preferably from about 0.5 to about 2.0 mm. The thickness. Since the protrusion has the above-described angle θ, even if the top sheet is thick, a small amount of menstrual blood can slide down to the inside thereof.

且,若上述厚度超過約15.0mm後,會有著用感差之傾向。 Further, if the thickness exceeds about 15.0 mm, there is a tendency to feel bad.

依照本發明之一實施形態之吸收性物品中,複數之突狀部為複數之脊部,且在2個脊部之間有形成溝部,亦即,依照本發明之一實施形態之吸收性物品中,頂部薄片在排泄口接觸區域具有複數之脊部、與複數之溝部。 In an absorbent article according to an embodiment of the present invention, the plurality of protruding portions are a plurality of ridge portions, and a groove portion is formed between the two ridge portions, that is, an absorbent article according to an embodiment of the present invention. The top sheet has a plurality of ridges and a plurality of grooves at the discharge port contact area.

本發明之吸收性物品中,突狀部之高度較佳為約0.1mm以上且小於約15.0mm,更佳為約0.4mm以上且小於約5.0mm,且最佳為約0.4mm以上且小於約2.0mm。若上述高度小於約0.1mm,難以形成上述角度。 In the absorbent article of the present invention, the height of the protruding portion is preferably about 0.1 mm or more and less than about 15.0 mm, more preferably about 0.4 mm or more and less than about 5.0 mm, and most preferably about 0.4 mm or more and less than about 2.0mm. If the height is less than about 0.1 mm, it is difficult to form the above angle.

作為具有突狀部之頂部薄片之例,例如,液體可透性之頂部薄片在接觸肌膚面具有包含複數之脊部、與複數之溝部之脊溝構造者,可舉例如,日本特公平7- 84697號、日本特開平2-229255號、日本特開2001-328191號、日本特開2008-002034號、同第2008-023311號、同第2008-025078號~同第2008-025085號、同第2008-307179號、同第2009-030218號、同第2010-285735號、同第2011-038211號、同第2011-074515號、同第2011-080178號等記載之不織布、以及日本特開昭64-34365、日本特公昭57-17081等記載之孔洞薄膜。 As an example of the top sheet having the protruding portion, for example, the liquid permeable top sheet has a ridge groove structure including a plurality of ridges and a plurality of grooves at the skin contact surface, and for example, Japanese special fair 7- No. 84,697, Japanese Patent Laid-Open No. Hei 2-229255, Japanese Patent Laid-Open No. 2001-328191, Japanese Patent Laid-Open No. 2008-002034, and No. 2008-023311, the same as No. 2008-025078 No. 2008-025085, the same Non-woven fabrics such as No. 2008-307179, the same as No. 2009-030218, the same as No. 2010-285735, the same as No. 2011-038211, the same as No. 2011-074515, the same as No. 2011-080178, and the Japanese special opening 64 -34365, a hole film described in Japanese Patent Publication No. 57-17081.

頂部薄片具有脊部及溝部之實施形態中,脊部之高度較佳為約0.1mm以上且小於約15.0mm,更佳為約0.4mm以上且小於約5.0mm,最佳為約0.4mm以上且小於約2.0mm。是為了要將經血由脊部滑落至溝部,接著迅速移行至吸收體。 In the embodiment in which the top sheet has a ridge portion and a groove portion, the height of the ridge portion is preferably about 0.1 mm or more and less than about 15.0 mm, more preferably about 0.4 mm or more and less than about 5.0 mm, and most preferably about 0.4 mm or more. Less than about 2.0 mm. It is to slide the menstrual blood from the ridge to the groove, and then move quickly to the absorber.

依照本發明之一實施形態之吸收性物品中,液體可透性之頂部薄片至少具有藉由壓榨上述液體可透性之頂部薄片所形成之壓印。例如,上述液體可透性之頂部薄片具有藉由壓榨液體可透性之頂部薄片、與吸收體所形成之壓印。且,依照本發明其他實施形態之吸收性物品包含第2薄片,且上述液體可透性之頂部薄片具有壓榨液體可透性頂部薄片、第2薄片、吸收體所形成之壓印。由於頂部薄片具有上述壓印,在頂部薄片可形成突狀部。 In the absorbent article according to an embodiment of the present invention, the liquid permeable top sheet has at least an embossing formed by pressing the liquid permeable top sheet. For example, the liquid permeable topsheet has an embossing formed by the wicking topsheet and the absorbent body. Further, an absorbent article according to another embodiment of the present invention includes a second sheet, and the liquid permeable top sheet has a embossing formed by pressing a liquid permeable top sheet, a second sheet, and an absorbent body. Since the top sheet has the above embossing, a protrusion can be formed at the top sheet.

本發明之吸收性物品中,頂部薄片在含有血液滑性賦予劑之區域中,包含上述血液滑性賦予劑之範圍較佳為約1~約30g/m2,更佳為約2~約20g/m2,最佳為約3~約10g/m2之基重。雖然針對血液滑性賦予劑之作用為 後述,但上述基重若低於約1g/m2後,到達頂部薄片之排泄口接觸區域之經血無法迅速地移動至吸收體,並有殘留於原處之傾向,且若上述基重超過約30g/m2後,會有增加著用中之濕黏感之傾向。 In the absorbent article of the present invention, the top sheet contains the blood slip imparting agent in the region containing the blood slip imparting agent, preferably in the range of from about 1 to about 30 g/m 2 , more preferably from about 2 to about 20 g. /m 2 is preferably a basis weight of from about 3 to about 10 g/m 2 . Although the effect of the blood-slip imparting agent is described later, if the basis weight is less than about 1 g/m 2 , the menstrual blood reaching the excretory contact region of the top sheet cannot be rapidly moved to the absorbent body, and remains in the original place. However, if the basis weight exceeds about 30 g/m 2 , the wet sticky feeling in use tends to increase.

在本說明書中,頂部薄片所包含之血液滑性賦予劑之基重如以下來測定。 In the present specification, the basis weight of the blood slip property imparting agent contained in the top sheet is measured as follows.

(1)將頂部薄片之應測定的範圍,使用銳利的刀刃,例如,刀片之可替換刀刃,以不改變其厚度之下切出,而得到樣本。 (1) The range of the top sheet to be measured is obtained by using a sharp blade, for example, a replaceable blade of the blade, to cut out without changing its thickness.

(2)樣本之面積:測定SA(m2)及質量:SM0(g)。 (2) Area of sample: Determination of SA (m 2 ) and mass: SM 0 (g).

(3)將樣本,以可溶於血液滑性賦予劑之溶媒,例如,醇、丙酮等中,至少攪拌3分鐘,將血液滑性賦予劑溶解於溶媒中。 (3) The sample is dissolved in a solvent in a solvent soluble in a blood slip imparting agent, for example, an alcohol, acetone, or the like, at least for 3 minutes.

(4)將樣本於測量質量之濾紙上過濾,在濾紙上,將樣本以溶媒充分洗淨。將濾紙上之樣本於60℃之烤箱內乾燥。 (4) The sample is filtered on the filter paper of the measurement quality, and the sample is thoroughly washed with the solvent on the filter paper. The sample on the filter paper was dried in an oven at 60 °C.

(5)測定濾紙及樣本之質量,之後藉由減去濾紙之質量,算出乾燥後之樣本之質量:SM1(g)。 (5) Measure the quality of the filter paper and the sample, and then calculate the mass of the dried sample by subtracting the mass of the filter paper: SM 1 (g).

(6)將血液滑性賦予劑之基重BS(g/m2)由以下之式算出:BS(g/m2)=[SM0(g)-SM1(g)]/SA(m2)且,為了減少誤差,從複數之吸收性物品中採取複數 樣本,至樣本之總面積超過100cm2,重覆進行複數次實驗,採用此等之平均值。 (6) The basis weight BS (g/m 2 ) of the blood slip imparting agent is calculated by the following formula: BS (g/m 2 ) = [SM 0 (g) - SM 1 (g)] / SA (m 2 ) Moreover, in order to reduce the error, a plurality of samples are taken from a plurality of absorbent articles, and the total area of the samples exceeds 100 cm 2 , and a plurality of experiments are repeated, and the average value is used.

[血液滑性賦予劑] [blood slippery agent]

本發明之吸收性物品中,液體可透性之頂部薄片至少在突狀部中具有含有血液滑性賦予劑之區域,其含有血液滑性賦予劑之區域中包含於40℃下為約0.01~約80mm2/s之動力黏度、約0.05~約4.0質量%之抱水率、與未滿約1,000之重量平均分子量之血液滑性賦予劑。 In the absorbent article of the present invention, the liquid permeable top sheet has a region containing the blood slip imparting agent at least in the protruding portion, and the region containing the blood slip imparting agent is contained in the region of about 0.01 at 40 ° C. A viscous viscosity of about 80 mm 2 /s, a water holding ratio of about 0.05 to about 4.0% by mass, and a blood slip property imparting agent having a weight average molecular weight of less than about 1,000.

上述血液滑性賦予劑在40℃下,具有約0~約80mm2/s之動力黏度,較佳為具有約1~約70mm2/s之動力黏度,更佳為具有約3~約60mm2/s之動力黏度,最佳為具有約5~約50mm2/s之動力黏度,且極佳為具有約7~約45mm2/s之動力黏度。 The blood slip imparting agent has a dynamic viscosity of from about 0 to about 80 mm 2 /s at 40 ° C, preferably a dynamic viscosity of from about 1 to about 70 mm 2 /s, more preferably from about 3 to about 60 mm 2 . The dynamic viscosity of /s is preferably a dynamic viscosity of from about 5 to about 50 mm 2 /s, and is preferably a dynamic viscosity of from about 7 to about 45 mm 2 /s.

上述動力黏度隨著,a)血液滑性賦予劑之分子量越大,b)極性基,例如,羰基鍵結(-CO-)、醚鍵結(-O-)、羧基(-COOH)、羥基(-OH)等之比率越高,且c)IOB越大,有變高之傾向。 The above dynamic viscosity is a) the greater the molecular weight of the blood slip imparting agent, b) the polar group, for example, a carbonyl bond (-CO-), an ether bond (-O-), a carboxyl group (-COOH), a hydroxyl group. The higher the ratio of (-OH) and the like, and the greater the c) IOB, the tendency to become higher.

且,為了於40℃中具有約0~約80mm2/s之動力黏度,血液滑性賦予劑之熔點較佳為45℃以下。是因為若血液滑性賦予劑於40℃下含有結晶,其動力黏度會有變高之傾向。 Further, in order to have a dynamic viscosity of from about 0 to about 80 mm 2 /s at 40 ° C, the melting point of the blood slip imparting agent is preferably 45 ° C or less. This is because if the blood slip imparting agent contains crystals at 40 ° C, the dynamic viscosity tends to be high.

且,本說明書中有時會將於40℃下之動力黏度單純稱作「動力黏度」。 Further, in the present specification, the dynamic viscosity at 40 ° C is simply referred to as "dynamic viscosity".

雖然關於血液滑性賦予劑中之動力黏度之意義如後述,但若上述動力黏度超過約80mm2/s後,血液滑性賦予劑之黏性變高,血液滑性賦予劑會有與到達頂部薄片之接觸肌膚面之經血難以滑落至吸收性物品之內部之傾向。 Although the meaning of the dynamic viscosity in the blood slip imparting agent is as follows, if the dynamic viscosity exceeds about 80 mm 2 /s, the viscosity of the blood slip imparting agent becomes high, and the blood slip imparting agent reaches and reaches the top. The tendency of the thin film to contact the skin surface is difficult to slip into the interior of the absorbent article.

上述動力黏度為根據JIS K 2283:2000之「5.動力黏度試驗方法」,使用Cannon-Fenslce逆流形黏度計,於40℃試驗溫度下測定。 The above dynamic viscosity is measured according to "5. Dynamic viscosity test method" of JIS K 2283:2000, using a Cannon-Fenslce counter-flow viscosity meter at a test temperature of 40 °C.

上述血液滑性賦予劑具有約0.01~約4.0質量%之抱水率,較佳為具有約0.02~約3.5質量%之抱水率,更佳為具有約0.03~約3.0質量%之抱水率,最佳為具有約0.04~約2.5質量%之抱水率,且最佳為具有約0.05~約2.0質量%之抱水率。 The blood slip imparting agent has a water holding ratio of about 0.01 to about 4.0% by mass, preferably a water holding ratio of about 0.02 to about 3.5% by mass, more preferably a water holding ratio of about 0.03 to about 3.0% by mass. Preferably, it has a water holding ratio of from about 0.04 to about 2.5% by mass, and most preferably has a water holding ratio of from about 0.05 to about 2.0% by mass.

本說明書中,「抱水率」意指,物質能夠保持之水之比率(質量),如以下所述來測定。 In the present specification, the "water holding ratio" means the ratio (mass) of water that the substance can hold, and is measured as described below.

(1)於40℃之恆溫室中,將20mL之試驗管、橡膠栓、應測定之物質及去離子水靜置一整夜。 (1) In a thermostatic chamber at 40 ° C, 20 mL of test tube, rubber stopper, substance to be measured, and deionized water were allowed to stand overnight.

(2)上述恆溫室中,於試驗管內加入應測定之物質5.0g、與去離子水5.0g。 (2) In the above-mentioned constant temperature chamber, 5.0 g of the substance to be measured and 5.0 g of deionized water were placed in the test tube.

(3)上述恆溫室中,將試驗管口以橡膠栓栓緊,將試驗管轉動一次,靜置5分鐘。 (3) In the above-mentioned constant temperature chamber, the test nozzle is fastened with a rubber bolt, and the test tube is rotated once and allowed to stand for 5 minutes.

(4)於上述恆溫室中,採取應測定之物質之層(通常是,上層)3.0g至直徑90mm之質量:W0(g)之玻璃 製培養皿中。 (4) In the above-mentioned thermostatic chamber, a layer of a substance to be measured (usually, an upper layer) of 3.0 g to a mass of 90 mm in diameter: W 0 (g) in a glass culture dish is used.

(5)將上述培養皿於烤箱內以105℃加熱3小時,將水分蒸發,測量每培養皿之質量:W1(g)。 (5) The above culture dish was heated in an oven at 105 ° C for 3 hours to evaporate water, and the mass per dish was measured: W 1 (g).

(6)將抱水率根據以下之式算出。 (6) The water holding ratio is calculated according to the following formula.

抱水率(質量%)=100×[W0(g)-W1(g)]/3.0(g) Water holding capacity (% by mass) = 100 × [W 0 (g) - W 1 (g)] / 3.0 (g)

測定為實施3次,並採用平均值。 The measurement was carried out 3 times, and the average value was used.

雖然針對血液滑性賦予劑中之抱水率的意義如後述,但是若上述抱水率變低,血液滑性賦予劑與經血的親和性會降低,會有到達頂部薄片之接觸肌膚面之經血難以滑落至吸收性物品內部之傾向。 The significance of the water absorbing rate in the blood slidability imparting agent will be described later. However, if the water absorbing ratio is lowered, the affinity of the blood slidability imparting agent and menstrual blood is lowered, and there is a menstrual blood that reaches the top sheet and contacts the skin surface. The tendency to slip down into the interior of an absorbent article.

另一方面,若上述抱水率變高,同樣地界面活性劑與經血之親和性也會變的非常高,於頂部薄片之接觸肌膚面會殘留吸收後的經血,頂部薄片之接觸肌膚面會有容易著色成紅色之傾向。 On the other hand, if the water holding ratio is high, the affinity between the surfactant and the menstrual blood will be extremely high, and the absorbed menstrual blood will remain on the skin contacting the top sheet, and the top sheet will contact the skin surface. There is a tendency to be easily colored in red.

上述抱水率會隨著a)血液滑性賦予劑之分子量越小,且b)極性基,例如,羰基鍵結(-CO-)、醚鍵結(-O-)、羧基(-COOH)、羥基(-OH)等之比率越高,抱水率的值有越大之傾向。是因為血液滑性賦予劑更具有親水性。且,上述抱水率會隨著後述之IOB越大,亦即,隨著無機性值越高,且有機性值越小,抱水率的值有越大之傾向。是因為血液滑性賦予劑更具有親水性。 The above water holding rate will be smaller with a) the molecular weight of the blood slip imparting agent, and b) a polar group, for example, a carbonyl bond (-CO-), an ether bond (-O-), or a carboxyl group (-COOH). The higher the ratio of hydroxyl groups (-OH), the greater the tendency of the water retention rate. This is because the blood slip imparting agent is more hydrophilic. Further, the water absorbing rate tends to increase as the IOB described later increases, that is, as the inorganic value increases and the organic value decreases, the value of the water absorbing ratio tends to increase. This is because the blood slip imparting agent is more hydrophilic.

針對上述血液滑性賦予劑中之動力黏度、與抱水率之意義進行說明。 The meaning of the dynamic viscosity and the water holding ratio in the blood slip imparting agent will be described.

圖3為相當於圖1所示之吸收性物品1之含有血液滑 性賦予劑之區域7之X-X剖面之剖面圖,是用來說明由於血液滑性賦予劑所造成之經血往吸收體之移行模式的圖。圖3所示之吸收性物品1具有液體可透性之頂部薄片2、液體不可透性之後部薄片8、與液體可透性之頂部薄片2及液體不可透性之後部薄片8之間之吸收體3。 Figure 3 is a blood-sliding equivalent of the absorbent article 1 shown in Figure 1. The cross-sectional view of the X-X cross section of the region 7 of the sex-imparting agent is used to explain the migration pattern of the menstrual blood to the absorbent body due to the blood slip imparting agent. The absorbent article 1 shown in Fig. 3 has an absorption between a liquid permeable top sheet 2, a liquid impermeable back sheet 8, a liquid permeable top sheet 2, and a liquid impermeable back sheet 8. Body 3.

圖3中,頂部薄片2是由不織布所形成,於接觸肌膚面13上具有複數之凸部11、與複數之凹部12,於頂部薄片2之接觸肌膚面13上有塗布血液滑性賦予劑14。且,圖3中,在方便上,雖然血液滑性賦予劑14在頂部薄片2之接觸肌膚面13上有顯示作為液滴(或粒子),但本發明之吸收性物品中,血液滑性賦予劑之形狀及分布並不限定於該圖示所表示者。 In Fig. 3, the top sheet 2 is formed of a non-woven fabric, and has a plurality of convex portions 11 and a plurality of concave portions 12 on the contact skin surface 13, and a blood-slip imparting agent 14 is applied to the contact skin surface 13 of the top sheet 2. . Further, in FIG. 3, although the blood slip property imparting agent 14 is displayed as a liquid droplet (or particle) on the contact skin surface 13 of the top sheet 2, the blood slip property is imparted to the absorbent article of the present invention. The shape and distribution of the agent are not limited to those shown in the drawings.

如圖3所示,到達頂部薄片2之凸部11的經血15,會與存在於凸部11之血液滑性賦予劑14接觸。存在於凸部11之血液滑性賦予劑14的其中一部份會與經血15一起滑落到凹部12(經血15’)。接著經血15’會滑落凹部12之內部,到達吸收體3中(經血15”)。接著,經血15”會被吸收體3所吸收。 As shown in FIG. 3, the menstrual blood 15 reaching the convex portion 11 of the top sheet 2 comes into contact with the blood slip property imparting agent 14 present in the convex portion 11. A part of the blood slip imparting agent 14 present in the convex portion 11 is slid down to the concave portion 12 (menstrual blood 15') together with the menstrual blood 15. Then, the menstrual blood 15' slides down into the inside of the concave portion 12 and reaches the absorbent body 3 (menstrual blood 15"). Then, the menstrual blood 15" is absorbed by the absorbent body 3.

更詳細地說明為,具有約0.01~約4.0質量%之抱水率之血液滑性賦予劑14具有與經血15之一定的親和性。例如,血液滑性賦予劑14之親水性部分(例如,具有親水性之基,例如,極性基,例如,羰基、氧基、羧基、羥基等、及具有親水性之鍵結,例如,具有極性之鍵結,例如,羰基鍵結、酯鍵結、碳酸酯鍵結、醚鍵結等) 與經血15中之親水性成分(血漿等)親和性高,在牽引該親和性成分的同時,血液滑性賦予劑14之疏水性部分(例如,烴部分)與經血15中之親水性成分(血漿等)之親和性低,由於排斥該親水性成分,作為所謂滑劑時有作用,並使經血15朝向吸收體3滑落。 More specifically, the blood slip property imparting agent 14 having a water holding ratio of about 0.01 to about 4.0% by mass has a certain affinity with the menstrual blood 15. For example, the hydrophilic portion of the blood slip property imparting agent 14 (for example, a hydrophilic group such as a polar group such as a carbonyl group, an oxy group, a carboxyl group, a hydroxyl group or the like, and a hydrophilic bond, for example, having a polarity Bonding, for example, carbonyl bonding, ester bonding, carbonate bonding, ether bonding, etc.) The hydrophilic component (plasma, etc.) in the menstrual blood 15 has high affinity, and while the affinity component is pulled, the hydrophobic portion (for example, the hydrocarbon portion) of the blood slip imparting agent 14 and the hydrophilic component in the menstrual blood 15 ( The affinity of plasma or the like is low, and the hydrophilic component is repelled, which acts as a so-called slip agent, and causes the menstrual blood 15 to slide toward the absorber 3.

且,具有於40℃下為約0.01~約80mm2/s之動力黏度之血液滑性賦予劑14,由於在著用者的體溫左右時為非常的低黏度,其一部份會與經血15,從凸部11滑落至凹部12,接著透過凹部12滑落至吸收性物品1之內部。 Further, the blood slip property imparting agent 14 having a dynamic viscosity of about 0.01 to about 80 mm 2 /s at 40 ° C is a very low viscosity at the time of the user's body temperature, and a part thereof is related to menstrual blood 15 The slider 11 is slid down to the recess 12, and then slides down through the recess 12 to the inside of the absorbent article 1.

另外,血液滑性賦予劑14由於具有約0.01~約4.0質量%之抱水率,與經血15中之主要親水性成分(血漿等)的親和性較低,故經血15難以殘留在頂部薄片2上。這是因為經血15中之親水性成分(血漿等)會排斥血液滑性賦予劑14之疏水性部分。 In addition, since the blood slip property imparting agent 14 has a water absorbing ratio of about 0.01 to about 4.0% by mass and has a low affinity with the main hydrophilic component (plasma or the like) in the menstrual blood 15, it is difficult for the menstrual blood 15 to remain in the top sheet 2 on. This is because the hydrophilic component (plasma, etc.) in the menstrual blood 15 repels the hydrophobic portion of the blood slip imparting agent 14.

於圖3中,頂部薄片2之凸部11的高度越高,亦即,凸部11之傾斜越陡,到達凸部11之經血15的滑落速度會變快,往吸收性物品1內部之移行變得容易。尤其是,經血15微量時,其自體重量較輕,雖然會有難以從凸部11滑落之傾向,但是凸部11之傾斜較陡時,凸部11會將微量的經血15迅速的滑落至凹部12。 In Fig. 3, the higher the height of the convex portion 11 of the top sheet 2, that is, the steeper the inclination of the convex portion 11, the faster the sliding speed of the menstrual blood 15 reaching the convex portion 11 is, and the migration to the inside of the absorbent article 1 is made. It's easy. In particular, when the menstrual blood 15 is a small amount, the self-weight is light, and there is a tendency that it is difficult to slide off the convex portion 11. However, when the inclination of the convex portion 11 is steep, the convex portion 11 rapidly slides a small amount of menstrual blood 15 to Concave portion 12.

且,圖3中,雖模式性地說明血液滑性賦予劑所造成之經血往吸收體之移行進行,但為含有血液滑性賦予劑之組成物時,也具有同樣的機能。 In addition, in FIG. 3, although the migration of the menstrual blood to the absorber by the blood-slipness-imparting agent is demonstrated, it is set as the thing which contains the composition of a blood-sliding agent.

上述血液滑性賦予劑具有未滿約1,000之重量平均分子量,且較佳為小於約900之重量平均分子量。是因為上述重量平均分子量若為約1,000以上時,在血液滑性賦予劑上會產生黏性,會有給予著用者不快感之傾向。且,若重量平均分子量變高,由於血液滑性賦予劑之黏度會有變高之傾向,故藉由加溫後,血液滑性賦予劑之黏度會難以降低成適合於塗布之黏度,其結果,即產生不得不將血液滑性賦予劑以溶媒稀釋之狀態。 The above blood slip imparting agent has a weight average molecular weight of less than about 1,000, and preferably a weight average molecular weight of less than about 900. When the weight average molecular weight is about 1,000 or more, viscosity is generated in the blood slip imparting agent, which tends to give the user an unpleasant feeling. Further, when the weight average molecular weight is increased, the viscosity of the blood slip imparting agent tends to be high, so that the viscosity of the blood slip imparting agent is hard to be reduced to a viscosity suitable for coating by heating. That is, a state in which the blood slip imparting agent has to be diluted with a solvent has occurred.

上述血液滑性賦予劑較佳為具有約100以上之重量平均分子量,且更佳為具有約200以上之重量平均分子量。是因為若上述重量平均分子量變得更小後,上述血液滑性賦予劑之蒸氣壓會變高,且於保存中會發生氣化、量的減少、著用時的臭味等問題。 The above blood slip imparting agent preferably has a weight average molecular weight of about 100 or more, and more preferably has a weight average molecular weight of about 200 or more. When the weight average molecular weight is smaller, the vapor pressure of the blood slip imparting agent is increased, and vaporization, amount reduction, and odor during use are caused during storage.

且,本說明書中,「重量平均分子量」包含:藉由多分散系之化合物(例如逐次聚合所製造之化合物、由複數之脂肪酸、與複數之脂肪族1價醇所生成之酯)、與單一化合物(例如,由1種脂肪酸、與1種脂肪族1價醇所生成之酯)之概念,意指在由Ni個之分子量Mi之分子(i=1,或i=1、2···)所構成之系列中,以以下之式求出之Mw:Mw=ΣNiMi 2/ΣNiMiFurther, in the present specification, the "weight average molecular weight" includes a compound obtained by a polydisperse system (for example, a compound produced by sequential polymerization, an ester derived from a plurality of fatty acids, and a plurality of aliphatic monovalent alcohols), and a single The concept of a compound (for example, an ester formed from one fatty acid and one aliphatic monovalent alcohol) means a molecule having a molecular weight M i of N i (i=1, or i=1, 2· In the series composed of ··), M w : M w = Σ N i M i 2 / Σ N i M i obtained by the following equation.

本說明書中,重量平均分子量意指,藉由透膠層析法(GPC)所求出的聚苯乙烯換算的值。 In the present specification, the weight average molecular weight means a value in terms of polystyrene obtained by a gel permeation chromatography (GPC).

作為GPC之測定條件,可舉例如以下。 The measurement conditions of GPC are as follows, for example.

機種:(股份)日立High-Technologies Corporation製之高速液體層析圖Lachrom Elite Model: (share) High-speed liquid chromatogram by Hitachi High-Technologies Corporation Lachrom Elite

管柱:昭和電工(股)製SHODEX KF-801,KF-803及KF-804 Pipe column: SHODEX KF-801, KF-803 and KF-804 made by Showa Denko Co., Ltd.

溶離液:THF Dissolution: THF

流量:1.0mL/分 Flow rate: 1.0mL/min

打入的量:100μL The amount entered: 100μL

檢測:RI(示差折射計) Detection: RI (differential refractometer)

且,本說明書之實施例所記載之重量平均分子量為藉由上述條件所測定。 Further, the weight average molecular weight described in the examples of the present specification is measured by the above conditions.

上述血液滑性賦予劑較佳為具有約0.00~約0.60之IOB。 The above blood slip imparting agent preferably has an IOB of from about 0.00 to about 0.60.

IOB(Inorganic Organic Balance)為表示親水性及親油性之平衡的指標,本說明書中意指藉由小田等所提出之以下之式算出之值:IOB=無機性值/有機性值。 IOB (Inorganic Organic Balance) is an index indicating the balance between hydrophilicity and lipophilicity, and the present specification means a value calculated by the following formula proposed by Oda et al.: IOB = inorganic value / organic value.

上述無機性值、與有機性值為基於藤田穆「有機化合物之預測與有機概念圖」化學之領域Vol.11,No.10(1957)p.719-725)所記載之有機概念圖。 The inorganic value and the organic value are organic concept maps described in the field of "The prediction of organic compounds and the organic concept map" by Fujita Mu, Vol. 11, No. 10 (1957) p. 719-725).

以藤田氏所提出的,將主要之基之有機性值及無機性值整理於下述表1。 According to Fujita's proposal, the organic and inorganic values of the main base are summarized in Table 1 below.

例如,當碳原子數14之十四酸、與碳原子數12之十二基醇之酯時,由於有機性值為520(CH2,20×26個),無機性值為60(-COOR,60×1個),故IOB=0.12。 For example, when an ester of a tetradecanoic acid having 14 carbon atoms and a 12-decyl alcohol having 12 carbon atoms, the inorganic value is 60 (-COOR) because the organic value is 520 (CH 2 , 20 × 26). , 60 × 1), so IOB = 0.12.

在上述血液滑性賦予劑中,IOB較佳為約0.00~約0.60,更佳為約0.00~約0.50,最佳為約0.00~約0.40,極佳為約0.00~約0.30。是因為當IOB在上述之範圍中時,上述抱水力及動力黏度較容易滿足上述之要件。 In the above blood slip imparting agent, IOB is preferably from about 0.00 to about 0.60, more preferably from about 0.00 to about 0.50, most preferably from about 0.00 to about 0.40, and most preferably from about 0.00 to about 0.30. This is because when the IOB is in the above range, the above-mentioned holding power and dynamic viscosity are easier to satisfy the above requirements.

上述血液滑性賦予劑較佳為具有45℃以下之熔點,更佳為具有40℃以下之熔點。是因為由於血液滑性賦予劑具有45℃以下之熔點時,上述血液滑性賦予劑較容易具有上述之範圍的動力黏度。 The blood slip imparting agent preferably has a melting point of 45 ° C or less, more preferably 40 ° C or less. The reason why the blood slip property imparting agent has a melting point of 45 ° C or less is that the above-mentioned blood slip property imparting agent is more likely to have a dynamic viscosity in the above range.

本說明書中,「熔點」意指,在示差掃描測熱法量分析計中,以昇溫速度10℃/分來測定時,由固狀變化成液狀時,吸熱高峰之高峰頂點溫度。作為上述示差 掃描測熱法量分析計,可舉例如,島津製作所公司製的DSC-60型DSC測定裝置。 In the present specification, the term "melting point" means the peak peak temperature of the endothermic peak when the solid state changes to a liquid state when measured at a temperature rising rate of 10 ° C /min in a differential scanning calorimetry analyzer. As the above difference For example, a DSC-60 DSC measuring device manufactured by Shimadzu Corporation can be used as the scanning calorimetry analyzer.

上述血液滑性賦予劑若具有約45℃以下之熔點時,在室溫(約25℃)下為液體、或亦可為固體,亦即,熔點可為約25℃以上、或亦可為小於約25℃,且例如具有約-5℃、約-20℃等熔點。 When the blood slip imparting agent has a melting point of about 45 ° C or lower, it may be liquid at room temperature (about 25 ° C) or may be solid, that is, the melting point may be about 25 ° C or more, or may be less than It is about 25 ° C and has, for example, a melting point of about -5 ° C, about -20 ° C, and the like.

上述血液滑性賦予劑雖然在熔點中不存在下限,但蒸氣壓較佳為低。上述血液滑性賦予劑之蒸氣壓較佳為在25℃(1氣壓)下約0~約200Pa,更佳為約0~約100Pa,最佳為約0~約10Pa,極佳為約0~約1Pa,且超佳為約0.0~約0.1Pa。 The blood slip property imparting agent does not have a lower limit in the melting point, but the vapor pressure is preferably low. The vapor pressure imparting agent has a vapor pressure of preferably from 0 to 200 Pa at 25 ° C (1 atm), more preferably from about 0 to about 100 Pa, most preferably from about 0 to about 10 Pa, and most preferably from about 0 to about 0 It is about 1 Pa, and it is preferably about 0.0 to about 0.1 Pa.

本發明之吸收性物品考慮到是接觸人體使用,上述蒸氣壓較佳為在40℃(1氣壓)下約0~約700Pa,更佳為約0~約100Pa,最佳為約0~約10Pa,極佳為約0~約1Pa,且超佳為約0.0~約0.1Pa。是因為上述血液滑性賦予劑之蒸氣壓若變高,保存中會發生氣化、量之減少、著用時之臭味等問題。 The absorbent article of the present invention is preferably used in contact with a human body, and the vapor pressure is preferably from about 0 to about 700 Pa at 40 ° C (1 atm), more preferably from about 0 to about 100 Pa, most preferably from about 0 to about 10 Pa. It is preferably from about 0 to about 1 Pa, and is preferably from about 0.0 to about 0.1 Pa. This is because if the vapor pressure of the blood slip imparting agent is increased, problems such as vaporization, a decrease in amount, and an odor during use are caused during storage.

且,上述血液滑性賦予劑之熔點能夠依照氣候、著用時間之長短等來選擇。例如,平均氣溫在約10℃以下之地區,藉由採用具有約10℃以下之熔點之血液滑性賦予劑,經血在排泄後,即使有時會因為周圍溫度而冷卻,但血液滑性賦予劑仍有機能。 Further, the melting point of the blood slip imparting agent can be selected in accordance with the weather, the length of time of use, and the like. For example, in an area where the average temperature is below about 10 ° C, a blood slip property imparting agent having a melting point of about 10 ° C or less is used, and after the blood is excreted, even if it is sometimes cooled by the ambient temperature, the blood slip property imparting agent Still organic.

且,在長時間使用吸收性物品時,血液滑性賦予劑之熔點較佳為在約45℃以下之範圍下較高者。是因 為較不易受到出汗、著用時摩擦等影響,長時間著用時,血液滑性賦予劑也較不會偏離。 Further, when the absorbent article is used for a long period of time, the melting point of the blood slip imparting agent is preferably higher in the range of about 45 ° C or lower. because In order to be less susceptible to sweating, friction during use, etc., when used for a long time, the blood slip imparting agent does not deviate.

該技術領域中,將使經血之表面張力等產生變化、迅速吸收經血作為目的,也進行將頂部薄片之接觸肌膚面以界面活性劑包覆。但是,被界面活性劑包覆之頂部薄片與經血中之親水性成分(血漿等)的親和性會變高,牽引此等成分,反而會有將經血殘留於頂部薄片之傾向。上述血液滑性賦予劑與以往熟知的界面活性劑不同,與經血之親和性低,不會使經血殘留於頂部薄片,並迅速地移行至吸收體。 In this technical field, the surface tension of menstrual blood is changed, and the menstrual blood is rapidly absorbed. The skin contact surface of the top sheet is also coated with a surfactant. However, the affinity between the top sheet coated with the surfactant and the hydrophilic component (plasma, etc.) in the menstrual blood becomes high, and the components are pulled, and the menstrual blood tends to remain on the top sheet. Unlike the conventionally known surfactant, the blood slip property-imparting agent has low affinity with menstrual blood, does not leave menstrual blood on the top sheet, and rapidly migrates to the absorber.

上述血液滑性賦予劑較佳為選自以下之(i)~(iii)以及此等之任意組合所構成之群,(i)烴、(ii)具有(ii-1)烴部分、與(ii-2)一個或複數之相同或相異之插入上述烴部分之C-C單鍵間之選自羰基(-CO-)及氧基(-O-)所成之群之基之化合物、及(iii)具有(iii-1)烴部分、(iii-2)一個或複數之相同或相異之插入上述烴部分之C-C單鍵間之選自羰基(-CO-)及氧基(-O-)所構成之群之基、與(iii-3)一個或複數之相同或相異之取代上述烴部分之氫原子之選自羧基(-COOH)及羥基(-OH)所構成之群之基之化合物。 The blood slip property imparting agent is preferably a group consisting of (i) to (iii) and any combination of the following, (i) a hydrocarbon, (ii) having a (ii-1) hydrocarbon moiety, and ( Ii-2) one or more of the same or different compounds inserted between the CC single bonds of the above hydrocarbon moiety selected from the group consisting of a carbonyl group (-CO-) and an oxy group (-O-), and ( Iii) having a carbonyl group (-CO-) and an oxy group (-O-) having (iii-1) a hydrocarbon moiety, (iii-2) one or a plurality of identical or different CC single bonds inserted into the above hydrocarbon moiety. a group consisting of a group consisting of a carboxyl group (-COOH) and a hydroxyl group (-OH), which is the same or different from (iii-3) one or a plurality of hydrogen atoms replacing the hydrocarbon moiety. Compound.

本說明書中,「烴」意指由碳原子與氫原子所成之化合物,鏈狀烴,例如,烴類烴(不包含雙鍵及三 鍵,亦稱烷烴)、烯烴類烴(包含一個雙鍵,亦稱正烯烴)、乙炔類烴(包含一個三鍵,亦稱炔)、及包含選自2個以上由雙鍵及三鍵所成之群之鍵結之烴、及環狀烴,可舉例如,芳香族烴,脂環式烴。 In the present specification, "hydrocarbon" means a compound formed by a carbon atom and a hydrogen atom, a chain hydrocarbon such as a hydrocarbon hydrocarbon (excluding double bonds and three a bond, also known as an alkane), an olefinic hydrocarbon (containing a double bond, also known as a normal olefin), an acetylene hydrocarbon (containing a triple bond, also known as an alkyne), and comprising two or more selected from the group consisting of a double bond and a triple bond. Examples of the hydrocarbons to be bonded and the cyclic hydrocarbons include aromatic hydrocarbons and alicyclic hydrocarbons.

作為上述烴,較佳為鏈狀烴及脂環式烴,更佳為鏈狀烴,最佳為烴類烴、烯烴類烴、及包含2個以上之雙鍵之烴(不包含三鍵),且極佳為烴類烴。 The hydrocarbon is preferably a chain hydrocarbon or an alicyclic hydrocarbon, more preferably a chain hydrocarbon, and most preferably a hydrocarbon hydrocarbon, an olefin hydrocarbon, and a hydrocarbon containing two or more double bonds (excluding a triple bond) And it is excellent as a hydrocarbon hydrocarbon.

上述鏈狀烴中包含直鏈狀烴及分枝狀烴。 The chain hydrocarbons include linear hydrocarbons and branched hydrocarbons.

上述(ii)及(iii)之化合物中,插入2個以上之氧基(-O-)時,各氧基(-O-)不相鄰接。因此,於上述(ii)及(iii)化合物中,不包含氧基為連續之化合物(所謂過氧化物)。 In the compounds of the above (ii) and (iii), when two or more oxy groups (-O-) are inserted, each oxy group (-O-) is not adjacent to each other. Therefore, in the above compounds (ii) and (iii), a compound which is a continuous compound (so-called peroxide) is not contained.

且,上述(iii)之化合物中,相較於烴部分之至少1個氫原子以羧基(-COOH)取代之化合物,烴部分之至少1個氫原子以羥基(-OH)取代之化合物較佳。是因為羧基與經血中之金屬等鍵結後,血液滑性賦予劑之抱水率會變高,有時會超過特定之範圍。此點與IOB之觀點是相同的。如表1所示,由於羧基會與經血中之金屬等鍵結,無機性值會從150大幅上升至400以上,故具有羧基之血液滑性賦予劑在使用時IOB的值有可能會超過約0.60。 Further, in the compound of the above (iii), a compound in which at least one hydrogen atom of the hydrocarbon moiety is substituted with a carboxyl group (-COOH), and a compound in which at least one hydrogen atom of the hydrocarbon moiety is substituted with a hydroxyl group (-OH) is preferred. . Since the carboxyl group is bonded to a metal such as menstrual blood, the water slidability of the blood slip imparting agent becomes high, and sometimes it exceeds a specific range. This point is the same as the IOB. As shown in Table 1, since the carboxyl group is bonded to the metal in the menstrual blood, and the inorganic value is greatly increased from 150 to 400 or more, the value of the IOB may be more than about when the blood slip imparting agent having a carboxyl group is used. 0.60.

上述血液滑性賦予劑更佳為選自以下之(i’)~(iii’)以及此等之任意組合所構成之群,(i’)烴、 (ii’)具有(ii’-1)烴部分、與(ii’-2)一個或複數之相同或相異之插入上述烴部分之C-C單鍵間之選自羰基鍵結(-CO-)、酯鍵結(-COO-)、碳酸酯鍵結(-OCOO-)、及醚鍵結(-O-)所構成之群之鍵結之化合物、及(iii’)具有(iii’-1)烴部分、與(iii’-2)一個或複數之相同或相異之插入上述烴部分之C-C單鍵間之選自羰基鍵結(-CO-)、酯鍵結(-COO-)、碳酸酯鍵結(-OCOO-)、及醚鍵結(-O-)所構成之群之鍵結、與(iii’-3)一個或複數之相同或相異之取代上述烴部分之氫原子之選自羧基(-COOH)及羥基(-OH)所構成之群之基之化合物。 The above-mentioned blood slip property imparting agent is more preferably a group consisting of (i') to (iii') and any combination of the above, (i') hydrocarbon, (ii') a carbonyl bond (-CO-) selected from the CC single bond having the (ii'-1) hydrocarbon moiety, the same or different from (ii'-2) one or more of the above hydrocarbon moiety. a compound of a group consisting of an ester bond (-COO-), a carbonate bond (-OCOO-), and an ether bond (-O-), and (iii') having (iii'-1 a hydrocarbon moiety, which is the same as or different from (iii'-2) one or more of the CC single bonds inserted into the hydrocarbon moiety selected from the group consisting of a carbonyl bond (-CO-), an ester bond (-COO-), a bond of a group consisting of a carbonate bond (-OCOO-) and an ether bond (-O-), and a hydrogen atom replacing the above hydrocarbon moiety with the same or different from (iii'-3) one or plural A compound selected from the group consisting of a carboxyl group (-COOH) and a hydroxyl group (-OH).

上述(ii’)及(iii’)之化合物中,插入2個以上相同或相異之鍵結時,亦即,插入2個以上相同或相異之選自羰基鍵結(-CO-)、酯鍵結(-COO-)、碳酸酯鍵結(-OCOO-)及醚鍵結(-O-)之鍵結時,各鍵結不相鄰接,各鍵結之間至少介著1個碳原子。 In the above compounds (ii') and (iii'), when two or more identical or different linkages are inserted, that is, two or more identical or different ones are selected from a carbonyl bond (-CO-), When an ester bond (-COO-), a carbonate bond (-OCOO-), and an ether bond (-O-) are bonded, each bond is not adjacent, and at least one bond is interposed between each bond. carbon atom.

上述血液滑性賦予劑最佳為,在烴部分中,在每10個碳原子中,具有約1.8個以下之羰基鍵結(-CO-),2個以下之酯鍵結(-COO-),約1.5個以下之碳酸酯鍵結(-OCOO-),約6個以下之醚鍵結(-O-),約0.8個以下之羧基(-COOH),且/或約1.2個以下之羥基(-OH)。 The above-mentioned blood slip imparting agent is preferably such that, in the hydrocarbon portion, there are about 1.8 or less carbonyl bonds (-CO-) and two or less ester bonds (-COO-) per 10 carbon atoms. , about 1.5 or less carbonate linkages (-OCOO-), about 6 or less ether linkages (-O-), about 0.8 or less carboxyl groups (-COOH), and/or about 1.2 or less hydroxyl groups (-OH).

上述血液滑性賦予劑,最佳為,選自以下(A)~(F)以及此等之任意組合所構成之群, (A)(A1)與(A2)之酯,其中(A1)為具有鏈狀烴部分、與取代上述鏈狀烴部分之氫原子之2~4個羥基之化合物,(A2)為具有鏈狀烴部分、與取代上述鏈狀烴部分之氫原子之1個羧基之化合物、(B)(B1)與(B2)之醚,其中(B1)為具有鏈狀烴部分、與取代上述鏈狀烴部分之氫原子之2~4個羥基之化合物,(B2)為具有鏈狀烴部分、與取代上述鏈狀烴部分之氫原子之1個羥基之化合物、(C)(C1)與(C2)之酯,其中(C1)為包含鏈狀烴部分、與取代上述鏈狀烴部分之氫原子之2~4個羧基之羧酸、羥酸、烷氧酸或含氧酸,(C2)為具有鏈狀烴部分、與取代上述鏈狀烴部分之氫原子之1個羥基之化合物、(D)具有鏈狀烴部分、與插入上述鏈狀烴部分之C-C單鍵間之選自醚鍵結(-O-)、羰基鍵結(-CO-)、酯鍵結(-COO-)、及碳酸酯鍵結(-OCOO-)所構成之群之任一個鍵結之化合物、(E)聚氧C3~C6伸烷基二醇、或其之烷基酯或烷基醚、及(F)鏈狀烴。 The above-mentioned blood slip property imparting agent is preferably selected from the group consisting of (A) to (F) and any combination of the above, (A) (A1) and (A2), wherein (A1) is a compound having a chain hydrocarbon moiety and 2 to 4 hydroxyl groups which replace a hydrogen atom of the above-mentioned chain hydrocarbon moiety, and (A2) is a carboxyl group having a chain hydrocarbon moiety and a hydrogen atom replacing the chain hydrocarbon moiety. a compound, (B) (B1) and (B2), wherein (B1) is a compound having a chain hydrocarbon moiety and 2 to 4 hydroxyl groups which replace a hydrogen atom of the above chain hydrocarbon moiety, and (B2) has a chain hydrocarbon moiety, a compound substituted with one hydroxyl group of a hydrogen atom of the above chain hydrocarbon moiety, and an ester of (C) (C1) and (C2), wherein (C1) is a chain hydrocarbon moiety and a substituted chain a carboxylic acid, a hydroxy acid, an alkoxy acid or an oxo acid of 2 to 4 carboxyl groups of a hydrogen atom of a hydrocarbon portion, (C2) being one having a chain hydrocarbon moiety and a hydrogen atom replacing the above chain hydrocarbon moiety a compound of a hydroxyl group, (D) having a chain hydrocarbon moiety, and an ether bond (-O-), a carbonyl bond (-CO-), an ester bond (between a CC single bond inserted into the above-mentioned chain hydrocarbon moiety) -COO-), and carbonate linkage (-OCOO-) Any of a group composed of the bonding compound, (E) polyoxy C 3 ~ C 6 alkylene glycol, or of an alkyl ester or alkyl ether, and (F) a chain hydrocarbon.

以下,針對依照(A)~(F)之血液滑性賦予劑進行詳細說明。 Hereinafter, the blood slip property imparting agent according to (A) to (F) will be described in detail.

[(A)(A1)與(A2)之酯,其中(A1)為具有鏈狀烴 部分、與取代上述鏈狀烴部分之氫原子之2~4個羥基之化合物,(A2)為具有鏈狀烴部分、與取代上述鏈狀烴部分之氫原子之1個羧基之化合物] [(A) (A1) and (A2) esters, wherein (A1) is a chain hydrocarbon a compound partially substituted with 2 to 4 hydroxyl groups of a hydrogen atom of the above-mentioned chain hydrocarbon moiety, and (A2) is a compound having a chain hydrocarbon moiety and a carboxyl group substituted for a hydrogen atom of the above chain hydrocarbon moiety]

(A)(A1)與(A2)之酯,其中(A1)為具有鏈狀烴部分、與取代上述鏈狀烴部分之氫原子之2~4個羥基之化合物,(A2)為具有鏈狀烴部分、與取代上述鏈狀烴部分之氫原子之1個羧基之化合物(以下亦稱作「化合物(A)」),只要具有上述動力黏度、抱水率及重量平均分子量,全部的羥基沒有被酯化亦可。 (A) an ester of (A1) and (A2), wherein (A1) is a compound having a chain hydrocarbon moiety and 2 to 4 hydroxyl groups which replace a hydrogen atom of the above-mentioned chain hydrocarbon moiety, and (A2) has a chain shape. The hydrocarbon moiety and the compound which replaces one carboxyl group of the hydrogen atom of the above-mentioned chain hydrocarbon moiety (hereinafter also referred to as "compound (A)") have all of the hydroxyl groups as long as they have the above-mentioned dynamic viscosity, water retention ratio and weight average molecular weight. It can also be esterified.

作為(A1)具有鏈狀烴部分、與取代上述鏈狀烴部分之氫原子之2~4個羥基之化合物(以下,亦稱「化合物(A1)」),可舉例如,鏈狀烴四元醇,例如,烷烴四元醇,例如,季戊四醇,鏈狀烴三元醇,例如,烷烴三元醇,例如,甘油,及鏈狀烴二元醇,例如,烷烴二元醇,例如,二醇。 (A1) a compound having a chain hydrocarbon moiety and 2 to 4 hydroxyl groups which replace the hydrogen atom of the chain hydrocarbon moiety (hereinafter also referred to as "compound (A1)"), for example, a chain hydrocarbon quaternary An alcohol, for example, an alkane tetraol, for example, pentaerythritol, a chain hydrocarbon triol, for example, an alkane triol, for example, glycerin, and a chain hydrocarbon diol, for example, an alkane diol, for example, a diol .

作為(A2)之具有鏈狀烴部分、與取代上述鏈狀烴部分之氫原子之1個羧基之化合物,可舉例如,烴上之1個氫原子經1個羧基(-COOH)取代置換之化合物,例如,脂肪酸。 The compound having a chain hydrocarbon moiety (A2) and a carboxyl group replacing the hydrogen atom of the chain hydrocarbon moiety, for example, one hydrogen atom on the hydrocarbon is substituted by one carboxyl group (-COOH). Compounds, for example, fatty acids.

作為化合物(A),可舉例如,(a1)鏈狀烴四元醇與至少1個脂肪酸之酯、(a2)鏈狀烴三元醇與至少1個脂肪酸之酯、及(a3)鏈狀烴二元醇與至少1個脂肪酸之酯。 The compound (A) may, for example, be an ester of (a 1 ) a chain hydrocarbon tetraol with at least one fatty acid, an ester of (a 2 ) a chain hydrocarbon triol and at least one fatty acid, and (a 3 ) An ester of a chain hydrocarbon diol with at least one fatty acid.

[(a1)鏈狀烴四元醇與至少1個脂肪酸之酯] [(a 1 ) an ester of a chain hydrocarbon tetraol with at least one fatty acid]

作為上述鏈狀烴四元醇與至少1個脂肪酸之酯,例如,以下之式(1): As the ester of the above chain hydrocarbon tetraol and at least one fatty acid, for example, the following formula (1):

之季戊四醇與脂肪酸之四酯,以下之式(2): a tetraester of pentaerythritol and a fatty acid, the following formula (2):

之季戊四醇與脂肪酸之三酯,以下之式(3): a pentaerythritol and a fatty acid triester, the following formula (3):

之季戊四醇與脂肪酸之二酯,以下之式(4): a diester of pentaerythritol and a fatty acid, the following formula (4):

之季戊四醇與脂肪酸之單酯。 a monoester of pentaerythritol and a fatty acid.

(式中,R1~R4各自為鏈狀烴)。 (wherein R 1 to R 4 are each a chain hydrocarbon).

作為構成上述季戊四醇與脂肪酸之酯之脂肪酸(R1COOH,R2COOH,R3COOH、及R4COOH),季戊四醇與脂肪酸之酯只要滿足上述動力黏度、抱水率及重量平均分子量之要件即可,並無特別限制,例如,飽和脂肪酸,例如,C2~C30之飽和脂肪酸,例如,乙酸(C2)(C2表示碳原子數,相當於R1C、R2C、R3C或R4C之碳原子數,以下相同)、丙酸(C3)、丁酸(C4)及其同分異構物,例如,2-甲基丙酸(C4)、戊酸(C5)及其同分異構物,例如,2-甲基丁酸(C5)、2,2-二甲基丙酸(C5)、己酸(C6)、庚酸(C7)、辛酸(C8)及其同分異構物,例如,2-乙基己酸(C8)、壬酸(C9)、癸酸(C10)、十二酸(C12)、十四酸(C14)、十六酸(C16)、十七酸(C17)、十八酸(C18)、二十酸(C20)、二十二酸(C22)、二十四酸(C24)、二十六酸(C26)、二十八酸(C28)、三十酸(C30)等、以及沒有被列舉之此等同分異構物。 As the fatty acid (R 1 COOH, R 2 COOH, R 3 COOH, and R 4 COOH) constituting the ester of the pentaerythritol and the fatty acid, the ester of the pentaerythritol and the fatty acid satisfies the above-mentioned dynamic viscosity, water retention ratio, and weight average molecular weight. There is no particular limitation, for example, a saturated fatty acid, for example, a C 2 - C 30 saturated fatty acid, for example, acetic acid (C 2 ) (C 2 represents a carbon number, which is equivalent to R 1 C, R 2 C, R 3 C or R 4 C has the same number of carbon atoms, the same), propionic acid (C 3 ), butyric acid (C 4 ) and its isomers, for example, 2-methylpropionic acid (C 4 ), valeric acid (C 5 ) and its isomers, for example, 2-methylbutyric acid (C 5 ), 2,2-dimethylpropionic acid (C 5 ), caproic acid (C 6 ), heptanoic acid (C) 7 ), octanoic acid (C 8 ) and its isomers, for example, 2-ethylhexanoic acid (C 8 ), citric acid (C 9 ), citric acid (C 10 ), dodecanoic acid (C 12 ) , tetradecanoic acid (C 14 ), hexadecanoic acid (C 16 ), heptadecanoic acid (C 17 ), octadecanoic acid (C 18 ), icosonic acid (C 20 ), behenic acid (C 22 ), lignoceric acid (C 24), twenty-six acid (C 26), twenty-eight acid (C 28), thirty acid (C 30), etc., are not enumerated herein and equivalents differentiation Thereof.

且,上述脂肪酸為不飽和脂肪酸亦可。作為上述不飽和脂肪酸,例如,C3~C20之不飽和脂肪酸,例 如,單不飽和脂肪酸,例如,巴豆酸(C4)、9-十四烯酸(C14)、軟脂油酸(C16)、十八烯酸(C18)、反油酸(C18)、反11-十八烯酸(C18)、順9-甘碳烯酸(C20)、二十烯酸(C20)等、二不飽和脂肪酸,例如,亞油酸(C18)、二十碳二烯酸(C20)等、三不飽和脂肪酸,例如,亞麻仁油酸,例如,α-亞麻仁油酸(C18)及γ-亞麻仁油酸(C18)、皮諾斂酸(pinolenic acid)(C18)、桐酸,例如,α-桐酸(C18)及β-桐酸(C18)、Mead acid(C20)、dihomo-γ-亞麻仁油酸(C20)、二十碳四烯酸(C20)等,四不飽和脂肪酸,例如,十八碳四烯酸(C20)、二十碳四烯酸(C20)、花生四烯酸(C20)等、五不飽和脂肪酸,例如,bosseopentaenoic acid(C18)、二十碳五烯酸(C20)等、以及此等之部分氫原子附加物。 Further, the above fatty acid may be an unsaturated fatty acid. As the above unsaturated fatty acid, for example, a C 3 - C 20 unsaturated fatty acid, for example, a monounsaturated fatty acid, for example, crotonic acid (C 4 ), 9-tetradecenoic acid (C 14 ), or palmitic acid (C) 16), oleic acid (C 18 is), elaidic acid (C 18 is), trans vaccenic acid (C 18 is), 9- cis Gan carbon acid (C 20 is), eicosenoic acid (C 20 ) an iso-, di-unsaturated fatty acid, for example, linoleic acid (C 18 ), eicosadienoic acid (C 20 ), etc., a triunsaturated fatty acid, for example, linoleic oleic acid, for example, α-linseed oil Acid (C 18 ) and γ-linolenic acid (C 18 ), pinolenic acid (C 18 ), tung acid, for example, α-tungstic acid (C 18 ) and β-tungstic acid (C) 18 ), Mead acid (C 20 ), dihomo-γ-linolenic acid (C 20 ), arachidonic acid (C 20 ), etc., tetraunsaturated fatty acids, for example, stearidonic acid (C 20 ), arachidonic acid (C 20 ), arachidonic acid (C 20 ), etc., penta-unsaturated fatty acids, for example, bosseopentaenoic acid (C 18 ), eicosapentaenoic acid (C 20 ), etc. And some of these hydrogen atom additions.

作為上述季戊四醇與脂肪酸之酯,若考慮氧化等所造成的改質之可能性,較佳為來自飽和脂肪酸之季戊四醇與脂肪酸之酯,亦即,季戊四醇與飽和脂肪酸之酯。 The ester of the pentaerythritol and the fatty acid is preferably an ester of pentaerythritol and a fatty acid derived from a saturated fatty acid, that is, an ester of pentaerythritol and a saturated fatty acid, in consideration of the possibility of reforming due to oxidation or the like.

且,作為上述季戊四醇與脂肪酸之酯,以將抱水率之值縮小之觀點來看,較佳為二酯、三酯或四酯,更佳為三酯或四酯,最佳為四酯。 Further, as the ester of the pentaerythritol and the fatty acid, a diester, a triester or a tetraester is preferable, and a triester or a tetraester is more preferable from the viewpoint of reducing the value of the water holding ratio, and a tetraester is preferable.

若以考慮將IOB設成約0.00~約0.60之觀點,在上述季戊四醇與脂肪酸之四酯中,合計構成季戊四醇與脂肪酸之四酯之脂肪酸之碳原子數,亦即,在上述式 (1)中,R1C、R2C、R3C及R4C部分之碳原子數的合計,較佳為約15(上述碳原子數之合計為15時,IOB為0.60)。 In view of the fact that the IOB is set to be from about 0.00 to about 0.60, the carbon number of the fatty acid constituting the tetraester of pentaerythritol and a fatty acid is added to the tetraester of the pentaerythritol and the fatty acid, that is, in the above formula (1). The total number of carbon atoms in the R 1 C, R 2 C, R 3 C and R 4 C moieties is preferably about 15 (when the total number of carbon atoms is 15, the IOB is 0.60).

在上述季戊四醇與脂肪酸之四酯中,可舉例例如,季戊四醇與、己酸(C6)、庚酸(C7)、辛酸(C8),例如,2-乙基己酸(C8)、壬酸(C9)、癸酸(C10)及/或十二酸(C12)之四酯。 In the above tetraester of pentaerythritol and a fatty acid, for example, pentaerythritol and hexanoic acid (C 6 ), heptanoic acid (C 7 ), octanoic acid (C 8 ), for example, 2-ethylhexanoic acid (C 8 ), nonanoic acid (C 9), capric acid (C 10) and / or lauric acid (C 12) of the tetraester.

若以考慮將IOB設成約0.00~約0.60之觀點,於上述季戊四醇與脂肪酸之三酯中,合計構成季戊四醇與脂肪酸之三酯之脂肪酸的碳原子數,亦即,在上述式(2)中,R1C、R2C及R3C部分之碳原子數的合計,較佳為約19以上(上述碳原子數之合計為19時,IOB為0.58)。 In view of the fact that the IOB is set to be from about 0.00 to about 0.60, the number of carbon atoms of the fatty acid constituting the triesters of pentaerythritol and a fatty acid is added to the above-mentioned pentaerythritol and a fatty acid triester, that is, in the above formula (2). The total number of carbon atoms in the R 1 C, R 2 C and R 3 C moieties is preferably about 19 or more (when the total number of carbon atoms is 19, IOB is 0.58).

若以考慮將IOB設成約0.00~約0.60之觀點,在上述季戊四醇與脂肪酸之二酯中,合計構成季戊四醇與脂肪酸之二酯之脂肪酸的碳原子數,亦即,於上述式(3)中,R1C及R2C部分之碳原子數的合計,較佳為約22以上(上述碳原子數之合計為22時,IOB為0.59)。 In view of the fact that the IOB is set to be from about 0.00 to about 0.60, the carbon number of the fatty acid constituting the diester of pentaerythritol and a fatty acid is added to the diester of the pentaerythritol and the fatty acid, that is, in the above formula (3). The total number of carbon atoms in the R 1 C and R 2 C moieties is preferably about 22 or more (when the total number of carbon atoms is 22, IOB is 0.59).

若以考慮將IOB設成約0.00~約0.60之觀點,在上述季戊四醇與脂肪酸之單酯中,構成季戊四醇與脂肪酸之單酯之脂肪酸的碳原子數,亦即,於上述式(4)中,R1C部分之碳原子數較佳為約25以上(上述碳原子數為25時,IOB為0.60)。 In view of the fact that the IOB is set to be from about 0.00 to about 0.60, the number of carbon atoms of the fatty acid constituting the monoester of pentaerythritol and a fatty acid in the monoester of the pentaerythritol and the fatty acid, that is, in the above formula (4), The number of carbon atoms in the R 1 C moiety is preferably about 25 or more (when the number of carbon atoms is 25, the IOB is 0.60).

且,在每次的上述IOB之計算中,不考慮雙鍵、三 鍵、iso分枝、及tert分枝的影響(以下,相同)。 Moreover, in each calculation of the above IOB, double keys and three are not considered. The effects of the bond, iso branch, and tert branch (the same applies below).

作為上述季戊四醇與脂肪酸之酯之市販品,有列舉Unister H-408BRS、H-2408BRS-22(混合品)等(以上,日油股份公司製)。 As a commercial product of the above-mentioned ester of pentaerythritol and a fatty acid, there are listed Unister H-408BRS, H-2408BRS-22 (mixed product), etc. (above, manufactured by Nippon Oil Co., Ltd.).

[(a2)鏈狀烴三元醇與至少1個脂肪酸之酯] [(a 2 ) an ester of a chain hydrocarbon triol with at least one fatty acid]

作為上述鏈狀烴三元醇與至少1個脂肪酸之酯,例如,以下之式(5): As the ester of the above chain hydrocarbon triol and at least one fatty acid, for example, the following formula (5):

之甘油與脂肪酸之三酯,以下之式(6): The triglyceride of glycerol and fatty acid, the following formula (6):

之甘油與脂肪酸之二酯,及以下之式(7): The diester of glycerol and fatty acid, and the following formula (7):

(式中,R5~R7分別為鏈狀烴) (wherein, R 5 to R 7 are each a chain hydrocarbon)

之甘油與脂肪酸之單酯。 Monoester of glycerol and fatty acids.

作為構成上述甘油與脂肪酸之酯之脂肪酸(R5COOH,R6COOH及R7COOH),只要甘油與脂肪酸之酯滿足上述動力黏度、抱水率及重量平均分子量之要件即可,並無特別限制,例如,「(a1)鏈狀烴四元醇與至少1個脂肪酸之酯」中所舉例之脂肪酸,亦即,可列舉飽和脂肪酸及不飽和脂肪酸,若考慮氧化等所造成的改質之可能性,較佳為來自飽和脂肪酸之甘油與脂肪酸之酯,亦即,甘油與飽和脂肪酸之酯。 As the fatty acid (R 5 COOH, R 6 COOH and R 7 COOH) constituting the above-mentioned ester of glycerin and a fatty acid, as long as the ester of glycerin and fatty acid satisfies the above-mentioned dynamic viscosity, water retention ratio and weight average molecular weight, there is no particular The fatty acid exemplified in the "(a 1 ) chain hydrocarbon tetraol and at least one fatty acid ester", that is, the saturated fatty acid and the unsaturated fatty acid, for example, is considered to be modified by oxidation or the like. The possibility is preferably an ester of glycerin and a fatty acid derived from a saturated fatty acid, that is, an ester of glycerin and a saturated fatty acid.

且,作為上述甘油與脂肪酸之酯,以將抱水率之值縮小之觀點來看,較佳為二酯或三酯,且更佳為三酯。 Further, as the ester of the glycerin and the fatty acid, a diester or a triester is preferable, and a triester is more preferable from the viewpoint of reducing the value of the water holding ratio.

上述甘油與脂肪酸之三酯亦稱三甘油酯,例如,甘油與辛酸(C8)之三酯、甘油與癸酸(C10)之三酯、甘油與十二酸(C12)之三酯、及甘油與、2種或3種之脂肪酸之三酯、以及此等之混合物。 The above-mentioned triglyceride of glycerin and fatty acid is also called triglyceride, for example, a triester of glycerin and caprylic acid (C 8 ), a triester of glycerin and capric acid (C 10 ), a triester of glycerin and dodecanoic acid (C 12 ). And glycerol and a triester of two or three fatty acids, and mixtures thereof.

作為上述甘油與2種以上之脂肪酸之三酯,例如,甘油與辛酸(C8)及癸酸(C10)之三酯,甘油與辛酸(C8)、癸酸(C10)及十二酸(C12)之三酯,甘油與辛酸(C8)、癸酸(C10)、十二酸(C12)、十四酸(C14)、十六酸(C16)及十八酸(C18)之三酯等。 As the triester of the above glycerin and two or more kinds of fatty acids, for example, a triester of glycerin and caprylic acid (C 8 ) and capric acid (C 10 ), glycerin and caprylic acid (C 8 ), capric acid (C 10 ) and twelve Acid (C 12 ) triester, glycerin and octanoic acid (C 8 ), citric acid (C 10 ), dodecanoic acid (C 12 ), tetradecanoic acid (C 14 ), hexadecanoic acid (C 16 ) and A triester of an acid (C 18 ) or the like.

若考慮將熔點設為約45℃以下之觀點,上述甘油與脂肪酸之三酯,為構成甘油與脂肪酸之三酯之脂肪酸的碳原子數的合計,亦即,於式(5)中,R5C、R6C及 R7C部分之碳原子數的合計,較佳為約40以下。 In view of the fact that the melting point is set to be about 45 ° C or lower, the triglyceride of the glycerin and the fatty acid is a total of the number of carbon atoms of the fatty acid constituting the triester of glycerin and the fatty acid, that is, in the formula (5), R 5 The total number of carbon atoms in the C, R 6 C and R 7 C moieties is preferably about 40 or less.

若以考慮將IOB設成約0.00~約0.60之觀點,在上述甘油與脂肪酸之三酯中,合計構成甘油與脂肪酸之三酯之脂肪酸的碳原子數,亦即,於式(5)中,R5C,R6C及R7C部分之碳原子數的合計,較佳為約12以上(碳原子數之合計為12時,IOB為0.60)。 In view of the fact that the IOB is set to be from about 0.00 to about 0.60, the number of carbon atoms of the fatty acid constituting the triester of glycerin and the fatty acid is totaled in the above-mentioned triglyceride of glycerin and fatty acid, that is, in the formula (5), The total number of carbon atoms in the R 5 C, R 6 C and R 7 C moieties is preferably about 12 or more (when the total number of carbon atoms is 12, the IOB is 0.60).

上述甘油與脂肪酸之三酯為所謂之脂肪,由於是構成人體之成分,以安全性之觀點較佳。 The above-mentioned triglyceride of glycerin and fatty acid is a so-called fat, and is a component constituting a human body, and is preferable from the viewpoint of safety.

作為上述甘油與脂肪酸之三酯之市販品,可舉例如三椰子油脂肪酸甘油酯、NA36、Panacet800、Panacet800B及Panacet810S,及三C2L油脂肪酸甘油酯及三CL油脂肪酸甘油酯(以上,日油股份公司製)等。 As a commercial product of the above-mentioned glycerin and a fatty acid triester, for example, tricocohol fatty acid glyceride, NA36, Panacet 800, Panacet 800B, and Panacet 810S, and three C2L oil fatty acid glycerides and tri-CL oil fatty acid glycerides (above, Nippon Oil Co., Ltd.) Company system) and so on.

上述甘油與脂肪酸之二酯亦稱二甘油酯,例如,甘油與癸酸(C10)之二酯、甘油與十二酸(C12)之二酯、甘油與十六酸(C16)之二酯、及甘油與2種之脂肪酸之二酯、以及此等之混合物。 The above diglyceride of glycerin and fatty acid is also called diglyceride, for example, diester of glycerin and capric acid (C 10 ), diester of glycerin and dodecanoic acid (C 12 ), glycerol and palmitic acid (C 16 ) Diesters, and diesters of glycerol and two fatty acids, and mixtures thereof.

若以考慮將IOB設成約0.00~約0.60之觀點,在上述甘油與脂肪酸之二酯中,合計構成甘油與脂肪酸之二酯之脂肪酸的碳原子數,亦即,於式(6)中,R5C及R6C部分之碳原子數的合計,較佳為約16以上(上述碳原子數之合計為16時,IOB為0.58)。 In view of the fact that the IOB is set to be from about 0.00 to about 0.60, the carbon number of the fatty acid constituting the diester of glycerin and the fatty acid is added to the diester of the glycerin and the fatty acid, that is, in the formula (6), The total number of carbon atoms in the R 5 C and R 6 C moieties is preferably about 16 or more (when the total number of carbon atoms is 16, the IOB is 0.58).

上述甘油與脂肪酸之單酯亦稱作單甘油酯,例如,甘油之十八酸(C18)單酯,甘油之二十二酸(C22)單酯等。 The monoester of the above glycerin and fatty acid is also called a monoglyceride, for example, a monoester of octadecanoic acid (C 18 ) of glycerin, a monoester of phthalic acid (C 22 ), and the like.

若以考慮將IOB設成約0.00~約0.60之觀點,於上述甘油與脂肪酸之單酯中,構成甘油與脂肪酸之單酯之脂肪酸的碳原子數,亦即,式(7)中,R5C部分之碳原子數較佳為約19以上(上述碳原子數為19時,IOB為0.59)。 In view of the fact that the IOB is set to be from about 0.00 to about 0.60, the number of carbon atoms of the fatty acid constituting the monoester of glycerin and the fatty acid in the monoester of the glycerin and the fatty acid, that is, R 5 in the formula (7) The number of carbon atoms in the C moiety is preferably about 19 or more (when the number of carbon atoms is 19, the IOB is 0.59).

[(a3)鏈狀烴二元醇與至少1個脂肪酸之酯] [(a 3 ) an ester of a chain hydrocarbon diol with at least one fatty acid]

作為上述鏈狀烴二元醇與至少1個脂肪酸之酯,例如,C2~C6之鏈狀烴二元醇,例如,C2~C6之二醇,例如,乙二醇、丙二醇、丁二醇、戊二醇或己二醇與脂肪酸之單酯或二酯。 As the ester of the chain hydrocarbon diol and at least one fatty acid, for example, a C 2 -C 6 chain hydrocarbon diol, for example, a C 2 -C 6 diol, for example, ethylene glycol, propylene glycol, A monoester or diester of butanediol, pentanediol or hexanediol with a fatty acid.

具體來說,作為上述鏈狀烴二元醇與至少1個脂肪酸之酯,例如,以下之式(8):R8COOCkH2kOCOR9 (8) Specifically, as the ester of the above chain hydrocarbon diol and at least one fatty acid, for example, the following formula (8): R 8 COOC k H 2k OCOR 9 (8)

(式中,k為2~6之整數,且R8及R9分別為鏈狀烴) (wherein k is an integer from 2 to 6, and R 8 and R 9 are each a chain hydrocarbon)

之C2~C6二醇與脂肪酸之二酯,及以下之式(9):R8COOCkH2kOH (9) a diester of a C 2 -C 6 diol and a fatty acid, and the following formula (9): R 8 COOC k H 2k OH (9)

(式中,k為2~6之整數,且R8為,鏈狀烴) (where k is an integer from 2 to 6, and R 8 is a chain hydrocarbon)

之C2~C6二醇與脂肪酸之單酯。 a monoester of a C 2 ~C 6 diol and a fatty acid.

上述C2~C6二醇與脂肪酸之酯中,作為應酯化之脂肪酸(相當於式(8)及式(9)中,R8COOH及R9COOH),C2~C6二醇與脂肪酸之酯只要滿足上述動力 黏度、抱水率及重量平均分子量之要件即可,並無特別限制,例如,「(a1)鏈狀烴四元醇與至少1個脂肪酸之酯」中所列舉之脂肪酸,亦即,可舉例飽和脂肪酸及不飽和脂肪酸,若考慮氧化等所造成的改質之可能性,飽和脂肪酸較佳。 Among the above esters of C 2 -C 6 diol and fatty acid, as a fatty acid to be esterified (corresponding to R 8 COOH and R 9 COOH in the formulas (8) and (9)), C 2 -C 6 diol The ester with a fatty acid is not particularly limited as long as it satisfies the above-mentioned dynamic viscosity, water retention ratio, and weight average molecular weight, for example, "(a 1 ) chain hydrocarbon tetraol and at least one fatty acid ester" The listed fatty acids, that is, saturated fatty acids and unsaturated fatty acids, are preferred, and saturated fatty acids are preferred in view of the possibility of upgrading due to oxidation or the like.

若以考慮將IOB設成約0.00~約0.60之觀點,在式(8)所示之丁二醇(k=4)與脂肪酸之二酯中,R8C及R9C部分之碳原子數的合計,較佳為約6以上(上述碳原子數之合計為6時,IOB為0.60)。 The carbon number of the R 8 C and R 9 C moieties in the diester of the butanediol (k=4) and the fatty acid represented by the formula (8) from the viewpoint of setting the IOB to about 0.00 to about 0.60. The total amount is preferably about 6 or more (when the total number of carbon atoms is 6, the IOB is 0.60).

若以考慮將IOB設成約0.00~約0.60之觀點,於式(9)所表示之乙二醇(k=2)與脂肪酸之單酯中,R8C部分之碳原子數較佳為約12以上(上述碳原子數為12時,IOB為0.57)。 In view of the fact that the IOB is set to be from about 0.00 to about 0.60, in the monoester of the ethylene glycol (k=2) represented by the formula (9) and the fatty acid, the number of carbon atoms of the R 8 C moiety is preferably about 12 or more (when the number of carbon atoms is 12, the IOB is 0.57).

作為上述C2~C6二醇與脂肪酸之酯,若考慮氧化等所造成的改質之可能性,較佳為來自飽和脂肪酸之C2~C6二醇與脂肪酸之酯,亦即,C2~C6二醇與飽和脂肪酸之酯。 The ester of the C 2 -C 6 diol and the fatty acid is preferably an ester of a C 2 -C 6 diol derived from a saturated fatty acid and a fatty acid, that is, C, in consideration of the possibility of reforming due to oxidation or the like. 2 ~ C 6 diol and ester of saturated fatty acids.

且,作為上述C2~C6二醇與脂肪酸之酯,以將抱水率之值縮小之觀點來看,較佳為來自碳原子數較大之二醇之二醇與脂肪酸之酯,例如,來自丁二醇、戊二醇或己二醇之二醇與脂肪酸之酯。 Further, as the ester of the C 2 -C 6 diol and the fatty acid, from the viewpoint of reducing the value of the water absorbing ratio, it is preferably an ester of a diol derived from a diol having a large carbon number and a fatty acid, for example, An ester of a diol derived from butanediol, pentanediol or hexanediol with a fatty acid.

另外,作為上述C2~C6二醇與脂肪酸之酯,以將抱水率之值縮小之觀點來看,較佳為二酯。 Further, as the ester of the C 2 -C 6 diol and the fatty acid, a diester is preferred from the viewpoint of reducing the value of the water absorbing ratio.

作為上述C2~C6二醇與脂肪酸之酯之市販品,例如, comupoalBL,comupoalBS(以上,日油股份公司製)等。 As a commercial product of the above-mentioned ester of a C 2 -C 6 diol and a fatty acid, for example, comupoal BL, comupoal BS (above, manufactured by Nippon Oil Co., Ltd.) and the like.

[(B)(B1)與(B2)之醚,其中(B1)為具有鏈狀烴部分、與取代上述鏈狀烴部分之氫原子之2~4個羥基之化合物,(B2)為具有鏈狀烴部分、與取代上述鏈狀烴部分之氫原子之1個羥基之化合物] [(B) The ether of (B1) and (B2), wherein (B1) is a compound having a chain hydrocarbon moiety and 2 to 4 hydroxyl groups which replace a hydrogen atom of the above-mentioned chain hydrocarbon moiety, and (B2) has a chain a hydrocarbon moiety and a compound which replaces one hydroxyl group of a hydrogen atom of the above chain hydrocarbon moiety]

(B)(B1)與(B2)之醚,其中(B1)為具有鏈狀烴部分、與取代上述鏈狀烴部分之氫原子之2~4個羥基之化合物,(B2)為具有鏈狀烴部分、與取代上述鏈狀烴部分之氫原子之1個羥基之化合物(以下,亦稱「化合物(B)」)只要具有上述動力黏度、抱水率及重量平均分子量,沒有全部的羥基皆被醚化亦可。 (B) an ether of (B1) and (B2), wherein (B1) is a compound having a chain hydrocarbon moiety and 2 to 4 hydroxyl groups which replace a hydrogen atom of the above chain hydrocarbon moiety, and (B2) has a chain shape The hydrocarbon moiety and the compound which replaces one hydroxyl group of the hydrogen atom of the above-mentioned chain hydrocarbon moiety (hereinafter, also referred to as "compound (B)") have all of the hydroxyl groups as long as they have the above-mentioned dynamic viscosity, water retention ratio and weight average molecular weight. It can also be etherified.

作為(B1)具有鏈狀烴部分、與取代上述鏈狀烴部分之氫原子之2~4個羥基之化合物(以下,亦稱「化合物(B1)」),在「化合物(A)」中作為化合物(A1)被列舉者為例如,季戊四醇、甘油、及二醇。 (B1) a compound having a chain hydrocarbon moiety and 2 to 4 hydroxyl groups which replace the hydrogen atom of the chain hydrocarbon moiety (hereinafter also referred to as "compound (B1)") is used as the "compound (A)" The compound (A1) is exemplified by pentaerythritol, glycerin, and a diol.

作為(B2)具有鏈狀烴部分、與取代上述鏈狀烴部分之氫原子之1個羥基之化合物(以下,亦稱「化合物(B2)」),可舉例如,烴之1個氫原子被1個羥基(-OH)取代之化合物,例如,脂肪族1價醇,例如,飽和脂肪族1價醇及不飽和脂肪族1價醇。 (B2) a compound having a chain hydrocarbon moiety and a hydroxyl group replacing a hydrogen atom of the chain hydrocarbon moiety (hereinafter, also referred to as "compound (B2)"), for example, one hydrogen atom of a hydrocarbon is A compound substituted with a hydroxyl group (-OH), for example, an aliphatic monovalent alcohol, for example, a saturated aliphatic monovalent alcohol and an unsaturated aliphatic monovalent alcohol.

作為上述飽和脂肪族1價醇,例如,C1~C20之飽和脂肪族1價醇,例如,甲基醇(C1)(C1表示碳原 子數,以下相同)、乙基醇(C2)、丙基醇(C3)及其同分異構物,例如,異丙基醇(C3)、丁基醇(C4)及其同分異構物,例如,sec-丁基醇(C4)及tert-丁基醇(C4)、戊基醇(C5)、己基醇(C6)、庚基醇(C7)、辛基醇(C8)及其同分異構物,例如,2-乙基己基醇(C8)、壬基醇(C9)、癸基醇(C10)、十二基醇(C12)、四癸基醇(C14)、六癸基醇(C16)、七癸基醇(C17)、八癸基醇(C18)、及二十醇(C20)、以及沒有被列舉之此等同分異構物。 The saturated aliphatic monovalent alcohol, for example, a C 1 to C 20 saturated aliphatic monovalent alcohol, for example, methyl alcohol (C 1 ) (C 1 represents a carbon number, the same applies hereinafter), ethyl alcohol (C) 2 ), propyl alcohol (C 3 ) and its isomers, for example, isopropyl alcohol (C 3 ), butyl alcohol (C 4 ) and its isomers, for example, sec-butyl Alcohol (C 4 ) and tert-butyl alcohol (C 4 ), pentyl alcohol (C 5 ), hexyl alcohol (C 6 ), heptyl alcohol (C 7 ), octyl alcohol (C 8 ) and their equivalents Isomers, for example, 2-ethylhexyl alcohol (C 8 ), mercapto alcohol (C 9 ), mercapto alcohol (C 10 ), dodecyl alcohol (C 12 ), tetradecyl alcohol (C 14 ) , hexamethylene alcohol (C 16 ), heptadecyl alcohol (C 17 ), octadecyl alcohol (C 18 ), and eicosyl alcohol (C 20 ), and the equivalent isomers not enumerated.

作為上述不飽和脂肪族1價醇,可舉例如將上述飽和脂肪族1價醇之1個C-C單鍵以C=C雙鍵取代者,例如,油醇,例如,新日本理化股份公司所販售之RIKACOL系列及UNJECOL系列之名稱。 As the unsaturated aliphatic monovalent alcohol, for example, one CC single bond of the above saturated aliphatic monovalent alcohol is substituted with a C=C double bond, for example, oleyl alcohol, for example, sold by New Japan Physical and Chemical Co., Ltd. The names of the RIKACOL series and the UNJECOL series are sold.

作為化合物(B),例如,(b1)鏈狀烴四元醇與至少1個脂肪族1價醇之醚,例如,單醚、二醚、三醚及四醚,較佳為二醚、三醚及四醚,更佳為三醚及四醚,且最佳為四醚,(b2)鏈狀烴三元醇與至少1個脂肪族1價醇之醚,例如,單醚、二醚及三醚,較佳為二醚及三醚,且更佳為三醚、以及(b3)鏈狀烴二元醇與至少1個脂肪族1價醇之醚,例如,單醚及二醚,且較佳為二醚。 As the compound (B), for example, an ether of a (b 1 ) chain hydrocarbon tetraol and at least one aliphatic monovalent alcohol, for example, a monoether, a diether, a triether, and a tetraether, preferably a diether, a triether and a tetraether, more preferably a triether and a tetraether, and most preferably a tetraether, (b 2 ) a chain hydrocarbon triol and an ether of at least one aliphatic monovalent alcohol, for example, a monoether, two The ether and the triether, preferably a diether and a triether, and more preferably a triether, and an ether of the (b 3 ) chain hydrocarbon diol and at least one aliphatic monovalent alcohol, for example, a monoether and a second Ether, and preferably diether.

作為上述鏈狀烴四元醇與至少1個脂肪族1價醇之醚,例如,以下之式(10)~(13): As the ether of the above chain hydrocarbon tetraol and at least one aliphatic monovalent alcohol, for example, the following formulas (10) to (13):

(式中,R10~R13分別為鏈狀烴。) (wherein R 10 to R 13 are each a chain hydrocarbon.)

之季戊四醇與脂肪族1價醇之四醚、三醚、二醚及單醚。 The pentaerythritol and the tetraether, triether, diether and monoether of the aliphatic monovalent alcohol.

作為上述鏈狀烴三元醇與至少1個脂肪族1價醇之醚,例如,以下之式(14)~(16): As the ether of the above chain hydrocarbon triol and at least one aliphatic monovalent alcohol, for example, the following formulas (14) to (16):

(式中,R14~R16分別為鏈狀烴。) (wherein R 14 to R 16 are each a chain hydrocarbon.)

之甘油與脂肪族1價醇之三醚、二醚及單醚。 The triglyceride, diether and monoether of glycerol and aliphatic monovalent alcohol.

作為上述鏈狀烴二元醇與至少1個脂肪族1價醇之醚,以下之式(17):R17OCnH2nOR18 (17) As the ether of the above chain hydrocarbon diol and at least one aliphatic monovalent alcohol, the following formula (17): R 17 OC n H 2n OR 18 (17)

(式中,n為2~6之整數,且R17及R18分別為鏈狀烴) (wherein n is an integer from 2 to 6, and R 17 and R 18 are each a chain hydrocarbon)

之C2~C6二醇與脂肪族1價醇之二醚,及以下之式(18):R17OCnH2nOH (18) a diether of a C 2 -C 6 diol and an aliphatic monovalent alcohol, and the following formula (18): R 17 OC n H 2n OH (18)

(式中,n為2~6之整數,且R17為鏈狀烴) (wherein n is an integer from 2 to 6, and R 17 is a chain hydrocarbon)

之C2~C6二醇與脂肪族1價醇之單醚。 a monoether of a C 2 -C 6 diol with an aliphatic monovalent alcohol.

若以考慮將IOB設成約0.00~約0.60之觀 點,於上述季戊四醇與脂肪族1價醇之四醚中,合計構成季戊四醇與脂肪族1價醇之四醚之脂肪族1價醇的碳原子數,亦即,於上述式(10)中,R10、R11、R12及R13部分之碳原子數的合計,較佳為約4以上(上述碳原子數之合計為4時,IOB為0.44)。 In view of the fact that the IOB is set to be from about 0.00 to about 0.60, the carbon atoms of the aliphatic monovalent alcohol constituting the tetraether of the pentaerythritol and the aliphatic monovalent alcohol are added to the tetraether of the pentaerythritol and the aliphatic monovalent alcohol. In the above formula (10), the total number of carbon atoms in the portions R 10 , R 11 , R 12 and R 13 is preferably about 4 or more (when the total number of carbon atoms is 4, IOB) Is 0.44).

若以考慮將IOB設成約0.00~約0.60之觀點,於上述季戊四醇與脂肪族1價醇之三醚中,合計構成季戊四醇與脂肪族1價醇之三醚之脂肪族1價醇的碳原子數,亦即,於上述式(11)中,R10、R11及R12部分之碳原子數的合計,較佳為約9以上(上述碳原子數之合計為9時,IOB為0.57)。 In view of the fact that the IOB is set to be from about 0.00 to about 0.60, the carbon atoms of the aliphatic monovalent alcohol constituting the triether of the pentaerythritol and the aliphatic monovalent alcohol are added to the above-mentioned pentaerythritol and the trivalent ether of the aliphatic monovalent alcohol. In the above formula (11), the total number of carbon atoms in the R 10 , R 11 and R 12 portions is preferably about 9 or more (when the total number of carbon atoms is 9, the IOB is 0.57) .

若以考慮將IOB設成約0.00~約0.60之觀點,於上述季戊四醇與脂肪族1價醇之二醚中,合計構成季戊四醇與脂肪族1價醇之二醚之脂肪族1價醇的碳原子數,亦即,於上述式(12)中,R10及R11部分之碳原子數的合計,較佳為約15以上(上述碳原子數之合計為15時,IOB為0.60)。 In view of the fact that the IOB is set to be from about 0.00 to about 0.60, in the diether of the above pentaerythritol and the aliphatic monovalent alcohol, the carbon atoms of the aliphatic monovalent alcohol constituting the diether of the pentaerythritol and the aliphatic monovalent alcohol are combined. In the above formula (12), the total number of carbon atoms in the R 10 and R 11 portions is preferably about 15 or more (when the total number of carbon atoms is 15, the IOB is 0.60).

若以考慮將IOB設成約0.00~約0.60之觀點,於上述季戊四醇與脂肪族1價醇之單醚中,構成季戊四醇與脂肪族1價醇之單醚之脂肪族1價醇的碳原子數,亦即,於上述式(13)中,R10部分之碳原子數較佳為約22以上(上述碳原子數為22時,IOB為0.59)。 The carbon number of the aliphatic monovalent alcohol constituting the monoether of pentaerythritol and the aliphatic monovalent alcohol in the monoether of the above pentaerythritol and the aliphatic monovalent alcohol from the viewpoint of setting the IOB to about 0.00 to about 0.60. That is, in the above formula (13), the number of carbon atoms in the R 10 portion is preferably about 22 or more (when the number of carbon atoms is 22, IOB is 0.59).

且,若以考慮將IOB設成約0.00~約0.60之觀點,於上述甘油與脂肪族1價醇之三醚中,合計構成甘 油與脂肪族1價醇之三醚之脂肪族1價醇的碳原子數,亦即,於式(14)中,R14,R15及R16部分之碳原子數的合計,較佳為約3以上(上述碳原子數之合計為3時,IOB為0.50)。 Further, in consideration of the fact that the IOB is set to be from about 0.00 to about 0.60, in the triether of the above glycerin and the aliphatic monovalent alcohol, the aliphatic monovalent alcohol constituting the triether of glycerin and the aliphatic monovalent alcohol is added in total. The number of carbon atoms, that is, in the formula (14), the total number of carbon atoms in the R 14 , R 15 and R 16 portions is preferably about 3 or more (when the total number of carbon atoms is 3, the IOB is 0.50) ).

若以考慮將IOB設成約0.00~約0.60之觀點,於上述甘油與脂肪族1價醇之二醚中,合計構成甘油與脂肪族1價醇之二醚之脂肪族1價醇的碳原子數,亦即,於式(15)中,R14及R15部分之碳原子數的合計,較佳為約9以上(上述碳原子數之合計為9時,IOB為0.58)。 In view of the fact that the IOB is set to be from about 0.00 to about 0.60, the carbon atoms of the aliphatic monovalent alcohol constituting the diether of glycerin and the aliphatic monovalent alcohol are added to the diether of the above glycerin and the aliphatic monovalent alcohol. In the formula (15), the total number of carbon atoms in the R 14 and R 15 moieties is preferably about 9 or more (when the total number of carbon atoms is 9, the IOB is 0.58).

若以考慮將IOB設成約0.00~約0.60之觀點,於上述甘油與脂肪族1價醇之單醚中,構成甘油與脂肪族1價醇之單醚之脂肪族1價醇的碳原子數,亦即,於式(16)中,R14部分之碳原子數較佳為約16以上(上述碳原子數為16時,IOB為0.58)。 The carbon number of the aliphatic monovalent alcohol constituting the monoether of glycerin and the aliphatic monovalent alcohol in the monoether of the above glycerin and the aliphatic monovalent alcohol from the viewpoint of setting the IOB to about 0.00 to about 0.60. That is, in the formula (16), the number of carbon atoms in the R 14 moiety is preferably about 16 or more (when the number of carbon atoms is 16, the IOB is 0.58).

若以考慮將IOB設成約0.00~約0.60之觀點,式(17)所表示之丁二醇(n=4)與脂肪族1價醇之二醚中,R17及R18部分之碳原子數的合計,較佳為約2以上(上述碳原子數之合計為2時,IOB為0.33)。 The carbon atom of the R 17 and R 18 moieties in the diether of the butanediol (n=4) represented by the formula (17) and the aliphatic monovalent alcohol, in view of considering the IOB to be from about 0.00 to about 0.60. The total number is preferably about 2 or more (when the total number of carbon atoms is 2, the IOB is 0.33).

且,若以考慮將IOB設成約0.00~約0.60之觀點,式(18)所表示之乙二醇(n=2)與脂肪族1價醇之單醚中,R17部分之碳原子數較佳為約8以上(上述碳原子數為8時,IOB為0.60)。 Further, in consideration of the fact that the IOB is set to be from about 0.00 to about 0.60, the number of carbon atoms of the R 17 moiety in the monoether of the ethylene glycol (n=2) represented by the formula (18) and the aliphatic monovalent alcohol It is preferably about 8 or more (when the number of carbon atoms is 8, the IOB is 0.60).

化合物(B)為藉由,例如,將化合物(B1) 、與化合物(B2)在酸觸媒之存在下,進行脫水縮合所生成。 Compound (B) is by, for example, compound (B1) And the compound (B2) is produced by dehydration condensation in the presence of an acid catalyst.

[(C)(C1)與(C2)之酯,其中(C1)為包含鏈狀烴部分、與取代上述鏈狀烴部分之氫原子之2~4個羧基之羧酸、羥酸、烷氧酸或含氧酸,(C2)為具有鏈狀烴部分、與取代上述鏈狀烴部分之氫原子之1個羥基之化合物] [(C) (C1) and (C2), wherein (C1) is a carboxylic acid, a hydroxy acid, an alkoxy group comprising a chain hydrocarbon moiety and a 2-4 carboxyl group substituted for a hydrogen atom of the above chain hydrocarbon moiety; An acid or an oxo acid, (C2) is a compound having a chain hydrocarbon moiety and a hydroxyl group replacing a hydrogen atom of the above chain hydrocarbon moiety]

(C)(C1)與(C2)之酯,其中(C1)為包含鏈狀烴部分、與取代上述鏈狀烴部分之氫原子之2~4個羧基之羧酸、羥酸、烷氧酸或含氧酸,(C2)為具有鏈狀烴部分、與取代上述鏈狀烴部分之氫原子之1個羥基之化合物(以下,亦稱「化合物(C)」),只要具有上述之動力黏度、抱水率及重量平均分子量,沒有全部的羧基皆被酯化亦可。 (C) an ester of (C1) and (C2), wherein (C1) is a carboxylic acid comprising a chain hydrocarbon moiety and a 2-4 carboxyl group substituted for a hydrogen atom of the above chain hydrocarbon moiety, a hydroxy acid, an alkoxylate Or an oxo acid, (C2) is a compound having a chain hydrocarbon moiety and a hydroxyl group which replaces the hydrogen atom of the chain hydrocarbon moiety (hereinafter, also referred to as "compound (C)"), as long as it has the above-mentioned dynamic viscosity. The water retention ratio and the weight average molecular weight, and not all of the carboxyl groups may be esterified.

作為(C1)之包含鏈狀烴部分、與取代上述鏈狀烴部分之氫原子之2~4個羧基之羧酸、羥酸、烷氧酸或含氧酸(以下,亦稱「化合物(C1)」),例如,具有2~4個羧基之鏈狀烴羧酸,例如,鏈狀烴二羧酸,例如,烷烴二羧酸,例如,乙烷二酸、丙烷二酸、丁烷二酸、戊烷二酸、己烷二酸、庚烷二酸、辛烷二酸、壬烷二酸及癸烷二酸、鏈狀烴三羧酸,例如,烷烴三羧酸,例如,丙烷三酸、丁烷三酸、戊烷三酸、己烷三酸、庚烷三酸、辛烷三酸、壬烷三酸及癸烷三酸、以及鏈狀烴四羧酸,例如,烷烴四羧酸,例如,丁烷四酸、戊烷四酸、己烷四酸、庚 烷四酸、辛烷四酸、壬烷四酸及癸烷四酸。 a carboxylic acid, a hydroxy acid, an alkoxy acid or an oxo acid containing (2) a chain hydrocarbon moiety (C1) and a hydrogen atom replacing the hydrogen atom of the chain hydrocarbon moiety (hereinafter, also referred to as "compound (C1) ")), for example, a chain hydrocarbon carboxylic acid having 2 to 4 carboxyl groups, for example, a chain hydrocarbon dicarboxylic acid, for example, an alkane dicarboxylic acid, for example, ethanedioic acid, propane diacid, butanedioic acid , pentanedioic acid, hexanedioic acid, heptanedioic acid, octanedioic acid, decanedioic acid and decanedioic acid, chain hydrocarbon tricarboxylic acid, for example, alkanetricarboxylic acid, for example, propane tricarboxylic acid Butane tricarboxylic acid, pentane tricarboxylic acid, hexane tricarboxylic acid, heptane triacid, octane tricarboxylic acid, decane tricarboxylic acid and decane tricarboxylic acid, and chain hydrocarbon tetracarboxylic acid, for example, alkane tetracarboxylic acid For example, butane tetraacid, pentane tetracarboxylic acid, hexane tetracarboxylic acid, g Alkanetetracarboxylic acid, octane tetracarboxylic acid, decane tetracarboxylic acid and decane tetracarboxylic acid.

且,化合物(C1)中,包含具有2~4個羧基之鏈狀烴羥酸,例如,蘋果酸、酒石酸、檸檬酸、異檸檬酸等,具有2~4個羧基之鏈狀烴烷氧酸,例如,包含O-乙醯檸檬酸、及具有2~4個羧基之鏈狀烴含氧酸。 Further, the compound (C1) contains a chain hydrocarbon hydroxy acid having 2 to 4 carboxyl groups, for example, malic acid, tartaric acid, citric acid, isocitric acid, etc., and a chain hydrocarbon alkoxylate having 2 to 4 carboxyl groups. For example, it contains O-acetonitrile citric acid, and a chain hydrocarbon oxyacid having 2 to 4 carboxyl groups.

作為(C2)之具有鏈狀烴部分、與取代上述鏈狀烴部分之氫原子之1個羥基之化合物,「化合物(B)」之中所被列舉者例如,脂肪族1價醇。 The compound having a chain hydrocarbon moiety (C2) and a hydroxyl group which replaces the hydrogen atom of the chain hydrocarbon moiety, and the "compound (B)" are, for example, an aliphatic monovalent alcohol.

作為化合物(C),可舉例如(c1)具有4個羧基之鏈狀烴四羧酸、羥酸、烷氧酸或含氧酸、與至少1個脂肪族1價醇之酯,例如,單酯、二酯、三酯及四酯,較佳為二酯、三酯及四酯,更佳為三酯及四酯,且最佳為四酯,(c2)具有3個羧基之鏈狀烴三羧酸、羥酸、烷氧酸或含氧酸、與至少1個脂肪族1價醇之酯,例如,單酯、二酯及三酯,較佳為二酯及三酯,且更佳為三酯、以及(c3)具有2個羧基之鏈狀烴二羧酸、羥酸、烷氧酸或含氧酸、與至少1個脂肪族1價醇之酯,例如,單酯及二酯,較佳為二酯。 The compound (C) may, for example, be (c 1 ) a chain hydrocarbon tetracarboxylic acid having four carboxyl groups, a hydroxy acid, an alkoxy acid or an oxo acid, and an ester of at least one aliphatic monovalent alcohol, for example, Monoesters, diesters, triesters and tetraesters, preferably diesters, triesters and tetraesters, more preferably triesters and triesters, and most preferably tetraesters, (c 2 ) having 3 carboxyl chains An ester of a hydrocarbon tricarboxylic acid, a hydroxy acid, an alkoxy acid or an oxo acid, and at least one aliphatic monovalent alcohol, for example, a monoester, a diester and a triester, preferably a diester and a triester, and More preferably, it is a triester, and (c 3 ) a chain hydrocarbon dicarboxylic acid having two carboxyl groups, a hydroxy acid, an alkoxy acid or an oxo acid, and an ester with at least one aliphatic monovalent alcohol, for example, a monoester And a diester, preferably a diester.

作為化合物(C)之例,可舉例如己二酸二辛基、O-乙醯檸檬酸三丁基等,且被市售。 Examples of the compound (C) include, for example, dioctyl adipate and tributyl ethoxide, O-acetyl citrate, and are commercially available.

[(D)具有鏈狀烴部分、與插入上述鏈狀烴部分之C-C單鍵間之選自醚鍵結(-O-)、羰基鍵結(-CO-),酯鍵結(-COO-)、及碳酸酯鍵結(-OCOO-)所構成之群中之任 一個鍵結之化合物] [(D) having a chain hydrocarbon moiety and an ether bond (-O-), a carbonyl bond (-CO-), an ester bond (-COO-) interposed between the CC single bond inserted into the above-mentioned chain hydrocarbon moiety. And the carbonate bond (-OCOO-) a bonded compound]

作為(D)具有鏈狀烴部分、與插入上述鏈狀烴部分之C-C單鍵間之選自醚鍵結(-O-)、羰基鍵結(-CO-),酯鍵結(-COO-)、及碳酸酯鍵結(-OCOO-)所構成之群中之任一個鍵結之化合物(以下,亦稱「化合物(D)」),可舉例如(d1)脂肪族1價醇與脂肪族1價醇之醚、(d2)二烷基酮、(d3)脂肪酸與脂肪族1價醇之酯、及(d4)二烷基碳酸酯。 As (D) having a chain hydrocarbon moiety and a CC bond inserted into the above-mentioned chain hydrocarbon moiety, it is selected from an ether bond (-O-), a carbonyl bond (-CO-), and an ester bond (-COO-). And a compound (hereinafter, also referred to as "compound (D)") which is bonded to any one of the groups of the carbonate bond (-OCOO-), and examples thereof include (d 1 ) an aliphatic monovalent alcohol and An aliphatic monovalent alcohol ether, (d 2 ) dialkyl ketone, (d 3 ) fatty acid and an aliphatic monovalent alcohol ester, and (d 4 ) dialkyl carbonate.

[(d1)脂肪族1價醇與脂肪族1價醇之醚] [(d 1 ) an ether of an aliphatic monovalent alcohol and an aliphatic monovalent alcohol]

作為上述脂肪族1價醇與脂肪族1價醇之醚,可舉例如具有以下之式(19)之化合物:R19OR20 (19) The ether of the aliphatic monovalent alcohol and the aliphatic monovalent alcohol may, for example, be a compound having the following formula (19): R 19 OR 20 (19)

(式中,R19及R20分別為鏈狀烴)。 (wherein R 19 and R 20 are each a chain hydrocarbon).

作為構成上述醚之脂肪族1價醇(於式(19)中,相當於R19OH及R20OH),上述醚只要具有上述之動力黏度、抱水率及重量平均分子量之要件,並無特別限制,可舉例如,「化合物(B)」之項所列舉之脂肪族1價醇。 The aliphatic monovalent alcohol constituting the ether (corresponding to R 19 OH and R 20 OH in the formula (19)), the ether having no such dynamic viscosity, water retention ratio and weight average molecular weight, The aliphatic monovalent alcohol exemplified in the item "Compound (B)" is exemplified as a specific limitation.

[(d2)二烷基酮] [(d 2 )dialkyl ketone]

作為上述二烷基酮,可舉例如具有以下之式(20)之化合物:R21COR22 (20) The dialkyl ketone may, for example, be a compound having the following formula (20): R 21 COR 22 (20)

(式中,R21及R22分別為烷基)。 (wherein R 21 and R 22 are each an alkyl group).

上述二烷基酮除了市販之外,可藉由習知的方法,例如,將第二級醇以鉻酸等氧化所得。 The above dialkyl ketone can be obtained by oxidizing a second-stage alcohol with chromic acid or the like by a conventional method, in addition to a commercially available product.

[(d3)脂肪酸與脂肪族1價醇之酯] [(d 3 ) ester of fatty acid with aliphatic monovalent alcohol]

作為上述脂肪酸與脂肪族1價醇之酯,例如,具有以下之式(21)之化合物:R23COOR24 (21) As the ester of the above fatty acid and an aliphatic monovalent alcohol, for example, a compound having the following formula (21): R 23 COOR 24 (21)

(式中,R23及R24分別為鏈狀烴)。 (wherein R 23 and R 24 are each a chain hydrocarbon).

作為構成上述酯之脂肪酸(式(21)中,相當於R23COOH),例如,「(a1)鏈狀烴四元醇與脂肪酸之酯」中所列舉之脂肪酸,亦即,飽和脂肪酸或不飽和脂肪酸,若考慮氧化等所造成的改質之可能性,飽和脂肪酸較佳。作為構成上述酯之脂肪族1價醇(式(21)中,相當於R24OH),例如,「化合物(B)」之項所列舉之脂肪族1價醇。 The fatty acid constituting the above-mentioned ester (corresponding to R 23 COOH in the formula (21)), for example, the fatty acid listed in the "(a 1 ) chain hydrocarbon tetraol and fatty acid ester", that is, a saturated fatty acid or For unsaturated fatty acids, saturated fatty acids are preferred in view of the possibility of upgrading due to oxidation or the like. The aliphatic monovalent alcohol constituting the above ester (corresponding to R 24 OH in the formula (21)), for example, the aliphatic monovalent alcohol exemplified in the item "compound (B)".

作為上述脂肪酸與脂肪族1價醇之酯之例,例如,十二酸(C12)、與十二基醇(C12)之酯、十四酸(C14)、與十二基醇(C12)之酯等,作為上述脂肪酸與脂肪族1價醇之酯之市販品,例如,ELECTOLWE20、及ELECTOLWE40(以上,日油股份公司製)。 As an example of the ester of the above fatty acid and an aliphatic monovalent alcohol, for example, dodecanoic acid (C 12 ), ester with dodecyl alcohol (C 12 ), tetradecanoic acid (C 14 ), and dodecyl alcohol ( C 12), etc., esters of monovalent alcohols of the above-described fatty acid as a commercially available product with aliphatic, e.g., ELECTOLWE20, and ELECTOLWE40 (or more shares of NOF Corporation).

[(d4)二烷基碳酸酯] [(d 4 )Dialkyl carbonate]

作為上述二烷基碳酸酯,可舉例如具有以下之式 (22)之化合物:R25OC(=O)OR26 (22) As the above dialkyl carbonate, for example, a compound having the following formula (22): R 25 OC(=O)OR 26 (22)

(式中,R25及R26分別為烷基)。 (wherein R 25 and R 26 are each an alkyl group).

上述二烷基碳酸酯除了市販的之外,可藉由例如,二氯化羰與醇之反應、氯化甲酸酯與醇或醇化物之反應、及碳酸銀與碘化烷基之反應來合成。 The above dialkyl carbonates can be reacted, for example, by the reaction of carbonyl dichloride with an alcohol, the reaction of a chlorinated formate with an alcohol or an alcoholate, and the reaction of silver carbonate with an alkyl iodide, in addition to being commercially available. synthesis.

考慮抱水率、蒸氣壓等之觀點,(d1)脂肪族1價醇與脂肪族1價醇之醚、(d2)二烷基酮、(d3)脂肪酸與脂肪族1價醇之酯、及(d4)二烷基碳酸酯中,重量平均分子量較佳為約100以上,且更佳為約200以上。 Considering the water holding ratio, vapor pressure, and the like, (d 1 ) an aliphatic monovalent alcohol and an aliphatic monovalent alcohol ether, (d 2 ) dialkyl ketone, (d 3 ) fatty acid, and an aliphatic monovalent alcohol The ester and the (d 4 ) dialkyl carbonate preferably have a weight average molecular weight of about 100 or more, and more preferably about 200 or more.

且,(d2)二烷基酮中,上述碳原子數之合計為約8時,例如,5-壬酮之熔點為約-50℃,蒸氣壓在20℃下為約230Pa。 Further, in the (d 2 ) dialkyl ketone, when the total number of carbon atoms is about 8, the melting point of 5-nonanone is, for example, about -50 ° C, and the vapor pressure is about 230 Pa at 20 ° C.

[(E)聚氧C3~C6伸烷基二醇、或其烷基酯或烷基醚] [(E) polyoxy C 3 ~ C 6 alkylene glycol, or alkyl ester or alkyl ether thereof]

作為(E)聚氧C3~C6伸烷基二醇、或其烷基酯或烷基醚(以下,亦稱作化合物(E)),可舉例如(e1)聚氧C3~C6伸烷基二醇、(e2)聚氧C3~C6伸烷基二醇與至少1個脂肪酸之酯、(e3)聚氧C3~C6伸烷基二醇與至少1個脂肪族1價醇之醚。以下,進行說明。 (E) polyoxy C 3 -C 6 alkylene glycol, or an alkyl ester or alkyl ether thereof (hereinafter, also referred to as compound (E)), for example, (e 1 ) polyoxy C 3 ~ C 6 alkylene glycol, (e 2 ) polyoxy C 3 ~ C 6 alkylene glycol and at least one fatty acid ester, (e 3 ) polyoxy C 3 ~ C 6 alkylene glycol and at least An aliphatic monovalent alcohol ether. The following description will be made.

[(e1)聚氧C3~C6伸烷基二醇] [(e 1 ) polyoxy C 3 ~ C 6 alkylene glycol]

上述聚氧C3~C6伸烷基二醇意指,i)氧C3~C6伸烷 基骨架,亦即,具有選自氧丙烯骨架、氧丁烯骨架、氧戊二烯骨架、及氧己烯骨架所構成之群中任一種骨架,且於兩末端具有羥基之同元聚合物,ii)具有選自上述群中之2種以上之骨架,且於兩末端具有羥基之嵌段共聚物,或iii)具有選自上述群中之2種以上之骨架,且於兩末端具有羥基之無規共聚物。 The above polyoxy C 3 -C 6 alkylene glycol means i) an oxygen C 3 -C 6 alkylene skeleton, that is, having an oxypropylene skeleton, an oxybutylene skeleton, an oxopene skeleton, a homopolymer having a skeleton of a group consisting of an oxyhexene skeleton and having a hydroxyl group at both terminals, ii) a block having two or more skeletons selected from the above group and having a hydroxyl group at both terminals The copolymer, or iii) a random copolymer having two or more skeletons selected from the above group and having a hydroxyl group at both terminals.

上述聚氧C3~C6伸烷基二醇以以下之式(23)所表示:HO-(CmH2mO)n-H (23) The above polyoxy C 3 -C 6 alkylene glycol is represented by the following formula (23): HO-(C m H 2m O) n -H (23)

(式中,m為3~6之整數)。 (where m is an integer from 3 to 6).

經本發明者確認後,於聚丙二醇(式(23)中,相當於m=3之同元聚合物)中,重量平均分子量未滿約1,000時,發現並不滿足抱水率之要件。因此,於上述血液滑性賦予劑之範圍中,不包含聚丙二醇之同元聚合物,丙二醇應該作為與其他之二醇之共聚合物或隨機聚合物,包含於(e1)聚氧C3~C6伸烷基二醇中。 After confirming by the inventors, in the case of polypropylene glycol (the homopolymer of m=3 in the formula (23)), when the weight average molecular weight was less than about 1,000, it was found that the water holding ratio was not satisfied. Therefore, in the range of the above-mentioned blood slip imparting agent, a homopolymer of polypropylene glycol is not contained, and propylene glycol should be used as a copolymer or a random polymer with other diols, and is contained in (e 1 ) polyoxy C 3 . ~C 6 alkylene glycol.

另外,經本發明者確認之後,於聚乙二醇(式(23)中,相當於m=2之同元聚合物)中,重量平均分子量未滿1,000時,並無滿足動力黏度及抱水率之要件。 In addition, after confirming by the inventors, in polyethylene glycol (the homopolymer of m=2 in the formula (23)), when the weight average molecular weight is less than 1,000, the dynamic viscosity and the water holding ratio are not satisfied. The essentials.

若以考慮將IOB設成約0.00~約0.60之觀點,例如,式(23)為聚丁二醇(m=4之同元聚合物)時,較佳為n≧約7(n=7時,IOB為0.57)。 When considering the viewpoint of setting IOB to about 0.00 to about 0.60, for example, when formula (23) is polytetramethylene glycol (m=4 isomer), it is preferably n≧ about 7 (n=7) , IOB is 0.57).

作為上述聚C3~C6伸烷基二醇之市販品,例如,uniol(商標)PB-500及PB-700(以上,日油股份公司製)。 As a commercial product of the above-mentioned poly C 3 -C 6 alkylene glycol, for example, uniol (trademark) PB-500 and PB-700 (above, manufactured by Nippon Oil Co., Ltd.).

[(e2)聚氧C3~C6伸烷基二醇與至少1個脂肪酸之酯] [(e 2 ) polyoxy C 3 ~ C 6 alkylene glycol and at least one fatty acid ester]

作為上述聚氧C3~C6伸烷基二醇與至少1個脂肪酸之酯,可舉例如「(e1)聚氧C3~C6伸烷基二醇」中所說明聚氧C3~C6伸烷基二醇之OH末端之一方或兩方藉由脂肪酸所酯化者,亦即,單酯及二酯。 Examples of the polyoxy C 3 ~ C 6 alkylene glycol and at least one of a fatty acid ester includes, for example, "(e 1) polyoxy C 3 ~ C 6 alkylene glycol" as described polyoxy C 3 One or both of the OH ends of the ~C 6 alkylene glycol are esterified by fatty acids, that is, monoesters and diesters.

聚氧C3~C6伸烷基二醇與至少1個脂肪酸之酯中,作為需酯化之脂肪酸,例如,「(a1)鏈狀烴四元醇與至少1個脂肪酸之酯」中所列舉之脂肪酸,亦即,飽和脂肪酸或不飽和脂肪酸,若考慮氧化等所造成的改質之可能性,飽和脂肪酸較佳。 In the ester of polyoxy C 3 ~ C 6 alkylene glycol and at least one fatty acid, as a fatty acid to be esterified, for example, "(a 1 ) chain hydrocarbon tetraol and ester of at least one fatty acid" The fatty acids listed, that is, saturated fatty acids or unsaturated fatty acids, are preferably saturated fatty acids in consideration of the possibility of upgrading due to oxidation or the like.

[(e3)聚氧C3~C6伸烷基二醇與至少1個脂肪族1價醇之醚] [(e 3 ) polyoxy C 3 ~ C 6 alkylene glycol and at least one aliphatic monovalent alcohol ether]

作為上述聚氧C3~C6伸烷基二醇與至少1個脂肪族1價醇之醚,可舉例如「(e1)聚氧C3~C6伸烷基二醇」中所說明之聚氧C3~C6伸烷基二醇之OH末端之一方或兩方,藉由脂肪族1價醇所醚化者,亦即,單醚及二醚。 The ether of the polyoxy C 3 -C 6 alkylene glycol and at least one aliphatic monovalent alcohol may, for example, be described in "(e 1 ) polyoxy C 3 -C 6 alkylene glycol" One or both of the OH ends of the polyoxy C 3 -C 6 alkylene glycol are etherified by an aliphatic monovalent alcohol, that is, a monoether and a diether.

聚氧C3~C6伸烷基二醇與至少1個脂肪族1價醇之醚中,作為應醚化之脂肪族1價醇,可舉例如,「化合物(B)」之項所列舉之脂肪族1價醇。 In the ether of a polyoxy C 3 -C 6 alkylene glycol and at least one aliphatic monovalent alcohol, the aliphatic monovalent alcohol to be etherified may, for example, be listed in the item "Compound (B)" An aliphatic monovalent alcohol.

[(F)鏈狀烴] [(F) chain hydrocarbon]

作為上述鏈狀烴,例如,(f1)鏈狀烷烴,例如,直鏈烷烴及分枝鏈烷烴。直鏈烷烴之熔點為約45℃以下時,碳原子數為約22以下,且蒸氣壓在1氣壓及25℃下為約0.01Pa以下時,碳原子數為約13以上。分枝鏈烷烴比直鏈烷烴,更有在同一碳原子數時熔點較低之傾向。因此,分枝鏈烷烴在熔點為約45℃以下時,亦包含碳原子數為22以上者。 As the above chain hydrocarbon, for example, (f 1 ) chain alkane, for example, a linear alkane and a branched paraffin. When the melting point of the linear alkane is about 45 ° C or lower, the number of carbon atoms is about 22 or less, and when the vapor pressure is about 0.01 Pa or less at 1 atm and 25 ° C, the number of carbon atoms is about 13 or more. Branched paraffins have a tendency to have a lower melting point than the linear alkanes at the same number of carbon atoms. Therefore, when the melting point of the branched paraffin is about 45 ° C or lower, the number of carbon atoms is also 22 or more.

作為上述烴之市販品,可舉例如,Parleam6(日油股份公司)。 As a commercial product of the said hydrocarbon, Parleam6 (Nippon Oil Co., Ltd.) is mentioned, for example.

本發明之實施形態的一個吸收性物品中,含有血液滑性賦予劑之區域包含上述之血液滑性賦予劑。 In an absorbent article according to an embodiment of the present invention, the region containing the blood slip property imparting agent includes the above-described blood slip property imparting agent.

根據本發明之其他實施形態之吸收性物品中,含有血液滑性賦予劑之區域僅由上述之血液滑性賦予劑而成。換言而之,頂部薄片之突狀部中具有僅由血液滑性賦予劑而成之含有血液滑性賦予劑之區域。 In the absorbent article according to another embodiment of the present invention, the region containing the blood slip property imparting agent is formed only by the above-described blood slip property imparting agent. In other words, the protruding portion of the top sheet has a region containing the blood slip imparting agent only composed of the blood slip imparting agent.

根據本發明之其他實施形態之吸收性物品中,含有血液滑性賦予劑之區域是由包含上述之血液滑性賦予劑、與至少1種其他成分之含有血液滑性賦予劑之組成物而成。換而言之,根據本發明之其他實施形態之吸收性物品中,頂部薄片之突狀部中具有由包含血液滑性賦予劑、與至少1種其他成分之含有血液滑性賦予劑之組成物而成之含有血液滑性賦予劑之區域。 In the absorbent article according to another embodiment of the present invention, the region containing the blood slip property imparting agent is a composition comprising the above-described blood slip property imparting agent and at least one other component containing a blood slip property imparting agent. . In other words, in the absorbent article according to another embodiment of the present invention, the protruding portion of the top sheet has a composition containing a blood slip property imparting agent and at least one other component containing a blood slip imparting agent. The area containing the blood slip imparting agent.

以下,針對含有血液滑性賦予劑之組成物進行說明。 Hereinafter, the composition containing the blood slip imparting agent will be described.

[含有血液滑性賦予劑之組成物] [Composition containing a blood slip imparting agent]

含有血液滑性賦予劑之組成物,其包含上述之血液滑性賦予劑、與至少1種其他成分。作為上述之至少1種其他成分,只要是不阻害本發明之效果者,並無特別限制,可舉例如同業界中之吸收性物品,特別是習慣地適用於頂部薄片者。 A composition containing a blood slip property-imparting agent comprising the above-described blood slip property-imparting agent and at least one other component. The at least one other component described above is not particularly limited as long as it does not impair the effects of the present invention, and examples thereof include absorbent articles in the industry, and particularly those which are customarily applied to the top sheet.

作為上述之至少1種其他成分,可舉例如,矽油、矽、矽系乙烯系樹脂等。 Examples of the at least one other component described above include eucalyptus oil, hydrazine, and fluorene-based vinyl resin.

作為上述之至少1種其他成分,可舉例如,抗氧化劑,例如,BHT(2,6-二-t-丁基-p-甲酚)、BHA(丁基化氫氧苯甲醚)、沒食子酸丙酯等。 The at least one other component mentioned above may, for example, be an antioxidant, for example, BHT (2,6-di-t-butyl-p-cresol), BHA (butylated hydroxyanisole), or Propionate and the like.

作為上述之至少1種其他成分,例如,維他命,例如,天然維他命或合成維他命。作為上述維他命,例如,水溶性維他命,例如,維他命B群,例如,維他命B1、維他命B2、維他命B3、維他命B5、維他命B6、維他命B7、維他命B9、維他命B12等、維他命C。 As at least one other component mentioned above, for example, a vitamin, for example, a natural vitamin or a synthetic vitamin. As the above vitamins, for example, water-soluble vitamins, for example, vitamin B group, for example, vitamin B 1 , vitamin B 2 , vitamin B 3 , vitamin B 5 , vitamin B 6 , vitamin B 7 , vitamin B 9 , vitamin B 12 , etc. , vitamin C.

作為上述維他命,例如,脂溶性維他命,例如,維他命A群、維他命D群、維他命E群、及維他命K群等。 As the above-mentioned vitamin, for example, a fat-soluble vitamin, for example, a vitamin A group, a vitamin D group, a vitamin E group, and a vitamin K group.

上述維他命中又包含此等之衍生物。 These vitamins also contain such derivatives.

作為上述之至少1種其他成分,例如,胺基酸,可舉例如,丙氨酸、精氨酸、離胺酸、組氨酸、脯氨酸、羥脯胺酸等、以及胜肽。 Examples of the at least one other component described above include, for example, alanine, arginine, lysine, histidine, proline, hydroxyproline, and the like.

作為上述之至少1種其他成分,可舉例如, 沸石,例如,天然沸石,例如,方沸石、菱沸石、輝沸石、鈉沸石、束沸石、及硫銻錳銀礦、以及合成沸石。 As at least one of the other components described above, for example, Zeolites, for example, natural zeolites, for example, analcime, chabazite, stilbite, sodium zeolite, bundled zeolite, and samarium manganese silver ore, and synthetic zeolites.

作為上述之至少1種其他成分,可舉例如,膽固醇、玻尿酸、卵燐脂、神經醯胺等。 The at least one other component mentioned above may, for example, be cholesterol, hyaluronic acid, egg yolk, or ceramide.

且,作為上述之至少1種其他成分,例如,藥劑,可舉例如,皮膚收斂劑、抗青春痘劑、抗皺劑、抗皮下脂肪劑、美白劑、抗菌劑、抗霉劑等。 Further, examples of the at least one other component mentioned above include a skin astringent, an anti-acne agent, an anti-wrinkle agent, an anti-subcutaneous fat agent, a whitening agent, an antibacterial agent, and an antifungal agent.

作為上述皮膚收斂劑,可舉例如,氧化鋅、硫酸鋁、單寧酸等,油溶性皮膚收斂劑,例如,油溶性聚酚。作為上述油溶性聚酚,天然之油溶性聚酚,可舉例如,黃檗樹皮萃取物、金絲桃萃取物、短柄野芝麻萃取物、洋甘菊萃取物、牛蒡萃取物、鼠尾草萃取物、菩提樹萃取物、西方椴樹萃取物、樺樹萃取物、木賊草萃取物、鼠尾草萃取物、鼠尾草葉萃取物、胡桃木萃取物、木槿萃取物、枇杷葉萃取物、椴樹萃取物、蛇麻草萃取物、甜栗萃取物、薏苡籽萃取物等。 Examples of the skin astringent agent include zinc oxide, aluminum sulfate, tannic acid, and the like, and oil-soluble skin astringents, for example, oil-soluble polyphenols. As the oil-soluble polyphenol, the natural oil-soluble polyphenol may, for example, be a barley bark extract, a hypericum extract, a stalk extract, a chamomile extract, an burdock extract, a sage extract, Linden extract, western eucalyptus extract, birch extract, Equisetum extract, sage extract, sage leaf extract, walnut extract, hibiscus extract, eucalyptus extract, eucalyptus extract , hop extract, sweet chestnut extract, eucalyptus seed extract, etc.

作為上述抗青春痘劑,可舉例如,水楊酸、過氧化苯甲醯、間苯二酚、硫、紅黴素、鋅等。 Examples of the anti-acne agent include salicylic acid, benzammonium peroxide, resorcinol, sulfur, erythromycin, zinc, and the like.

作為上述抗皺劑,可舉例如,乳酸、水楊酸、水楊酸衍生物、乙二醇酸、六磷酸肌醇、硫辛酸、磷脂酸。 Examples of the anti-wrinkle agent include lactic acid, salicylic acid, a salicylic acid derivative, glycolic acid, inositol hexaphosphate, lipoic acid, and phosphatidic acid.

作為上述抗皮下脂肪劑,可舉例如,二氧嘌呤化合物,例如,胺非林、咖啡因、茶鹼、可可素等。 The anti-subcutaneous fat agent may, for example, be a dioxin compound, for example, an amine, a caffeine, a theophylline, a cocoa, or the like.

作為上述美白劑,可舉例如,菸鹼、鞠酸、熊果素、殼胺糖及衍生物、植物固醇衍生物、抗壞血酸及其衍生 物、以及桑樹抽出物及胎盤抽出物。 As the above whitening agent, for example, nicotine, citric acid, arbutin, chitosan and derivatives, phytosterol derivatives, ascorbic acid and derivatives thereof may be mentioned. Objects, as well as mulberry extracts and placenta extracts.

且,作為上述之至少1種其他成分,例如,抗炎症成分、pH調整劑、抗菌劑、保濕劑、香料、色素、染料、顏料、植物抽出萃取物等。作為上述抗炎症成分,可舉例如,天然的抗炎症劑,例如,牡丹、黃苓、金絲桃、洋甘菊、甘草、桃花、洋艾草、紫蘇萃取物等,合成抗炎症劑,例如,乙內醯脲、二鉀甘草酸苷等。 Further, as at least one of the other components described above, for example, an anti-inflammatory component, a pH adjuster, an antibacterial agent, a moisturizer, a fragrance, a coloring matter, a dye, a pigment, a plant extract, and the like. Examples of the anti-inflammatory component include natural anti-inflammatory agents such as peony, scutellaria, hypericum, chamomile, licorice, peach blossom, wormwood, perilla extract, and the like, and synthetic anti-inflammatory agents, for example, B. Internal carbamide, potassium dihydroglycyrrhizin and the like.

作為上述pH調整劑,為將皮膚保持在弱酸性者,例如,蘋果酸、琥珀酸、檸檬酸、酒石酸、乳酸等。 As the pH adjuster, in order to keep the skin weakly acidic, for example, malic acid, succinic acid, citric acid, tartaric acid, lactic acid or the like.

作為上述顏料,可舉例如,二氧化鈦。 As the pigment, for example, titanium dioxide can be mentioned.

上述含有血液滑性賦予劑之組成物含有血液滑性賦予劑及至少1種其他成分,其分別較佳為約50~約99質量%及約1~約50質量%,更佳為約60~約99質量%及約1~約40質量%,最佳為約70~約99質量%及約1~約30質量%,更較佳為約80~約99質量%及約1~約20質量%,更較佳為約90~99質量%及約1~約10質量%,且更較佳為約95~99質量%及約1~約5質量%是從本發明之效果之觀點來看。 The composition containing the blood-slipness-imparting agent contains a blood-slipness-imparting agent and at least one other component, and each of them is preferably from about 50 to about 99% by mass and from about 1 to about 50% by mass, more preferably about 60%. About 99% by mass and about 1 to about 40% by mass, most preferably from about 70 to about 99% by mass and from about 1 to about 30% by mass, more preferably from about 80 to about 99% by mass and from about 1 to about 20% by mass %, more preferably from about 90 to 99% by mass and from about 1 to about 10% by mass, and still more preferably from about 95 to 99% by mass and from about 1 to about 5% by mass, from the viewpoint of the effect of the present invention .

上述含有血液滑性賦予劑之組成物含有界面活性劑為來自頂部薄片或第2薄片之親水化處理之量以下較佳。更具體來說,上述含有血液滑性賦予劑之組成物含有界面活性劑,並較佳為含有約0.0~約1.0g/m2,更佳為約0.0~約0.8g/m2,最佳為約0.1~約0.5g/m2,且更較佳為約0.1~約0.3g/m2之基重之範圍。 It is preferable that the composition containing the blood-slipness-imparting agent contains a surfactant in an amount of less than the amount of the hydrophilization treatment from the top sheet or the second sheet. More specifically, the composition containing the blood slip imparting agent contains a surfactant, and preferably contains from about 0.0 to about 1.0 g/m 2 , more preferably from about 0.0 to about 0.8 g/m 2 , most preferably It is in the range of from about 0.1 to about 0.5 g/m 2 , and more preferably from about 0.1 to about 0.3 g/m 2 .

是因為若界面活性劑的量增加,會有經血容易殘存在頂部薄片上之傾向。且,界面活性劑不存在抱水率之值。是因為由於要與水混和,故應測定之物質之層不存在。 This is because if the amount of the surfactant increases, there is a tendency that menstrual blood tends to remain on the top sheet. Moreover, the surfactant does not have a value of water retention. This is because the layer of the substance to be measured does not exist because it is mixed with water.

上述含有血液滑性賦予劑之組成物含有水,較佳為含有約0.0~約1.0g/m2,更佳為約0.0~約0.8g/m2,最佳為約0.1~約0.5g/m2,且更較佳為約0.1~約0.3g/m2之基重之範圍。 The composition containing the blood slip imparting agent contains water, preferably from about 0.0 to about 1.0 g/m 2 , more preferably from about 0.0 to about 0.8 g/m 2 , most preferably from about 0.1 to about 0.5 g/ m 2 , and more preferably in the range of from about 0.1 to about 0.3 g/m 2 basis weight.

由於要將吸收性物品之吸收性能降低,水較少較佳。 Water is less preferred because of the reduced absorption properties of the absorbent article.

上述含有血液滑性賦予劑之組成物與血液滑性賦予劑相同,作為組成物,在40℃下,較佳為具有約0~約80mm2/s之動力黏度,更佳為具有約1~約70mm2/s之動力黏度,最佳為具有約3~約60mm2/s之動力黏度,極佳為具有約5~約50mm2/s之動力黏度,且超佳為具有約7~約45mm2/s之動力黏度。 The composition containing the blood-slipness-imparting agent is the same as the blood-slipness-imparting agent, and preferably has a dynamic viscosity of about 0 to about 80 mm 2 /s at 40 ° C, more preferably about 1 to 1 as a composition. The dynamic viscosity of about 70 mm 2 /s, preferably having a dynamic viscosity of about 3 to about 60 mm 2 /s, preferably having a dynamic viscosity of about 5 to about 50 mm 2 /s, and preferably having a viscosity of about 7 to about Dynamic viscosity of 45mm 2 /s.

上述含有血液滑性賦予劑之組成物之動力黏度若超過約80mm2/s,有黏性變高,且到達頂部薄片之接觸肌膚面之經血與血液滑性賦予劑組成物較難滑落至吸收性物品之內部之傾向。 When the dynamic viscosity of the composition containing the blood-slipness-imparting agent exceeds about 80 mm 2 /s, the viscosity becomes high, and the composition of the menstrual blood and blood-slip-forming agent which reaches the top surface of the sheet is difficult to slide down to absorb. The tendency of the inside of sexual goods.

上述含有血液滑性賦予劑之組成物含有作為上述之至少1種其他成份之與上述血液滑性賦予劑混和之成分時,其他成分,較佳為具有未滿約1,000之重量平均分子量,且更佳為具有小於約900之重量平均分子量。是因為若上述重量平均分子量為約1,000以上,會有含有血液滑性賦予劑之組成物本身黏性產生,給著用者不快感之 傾向。且,若重量平均分子量變高,由於會有含有血液滑性賦予劑之組成物之黏度變高之傾向,故難以加溫,將血液滑性賦予劑組成物之黏度,下降至適合於塗布之黏度,其結果,即產生不得不將血液滑性賦予劑以溶媒稀釋之狀況。 When the composition containing the blood-slipness-imparting agent contains a component which is mixed with the blood-slipness-imparting agent as at least one of the other components described above, the other component preferably has a weight average molecular weight of less than about 1,000, and more preferably Preferably, it has a weight average molecular weight of less than about 900. This is because if the weight average molecular weight is about 1,000 or more, the composition containing the blood slip imparting agent itself is sticky, giving the user an unpleasant feeling. tendency. In addition, when the weight average molecular weight is high, the viscosity of the composition containing the blood slip imparting agent tends to be high, so that it is difficult to increase the temperature, and the viscosity of the blood slip imparting agent composition is lowered to be suitable for coating. The viscosity, as a result, is a condition in which the blood slip imparting agent has to be diluted with a solvent.

上述含有血液滑性賦予劑之組成物是作為組成物,且具有約0.01~約4.0質量%之抱水率,較佳為具有約0.02~約3.5質量%之抱水率,更佳為具有約0.03~約3.0質量%之抱水率,最佳為具有約0.04~約2.5質量%之抱水率,且極佳為具有約0.05~約2.0質量%之抱水率。 The composition containing the blood slip imparting agent is a composition and has a water holding ratio of about 0.01 to about 4.0% by mass, preferably a water holding ratio of about 0.02 to about 3.5% by mass, more preferably about The water holding ratio of 0.03 to about 3.0% by mass is preferably a water holding ratio of from about 0.04 to about 2.5% by mass, and is preferably a water holding ratio of from about 0.05 to about 2.0% by mass.

若上述抱水率變低,血液滑性賦予劑組成物與經血之親和性低下,到達頂部薄片之接觸肌膚面之經血會有難以滑落至吸收性物品之內部的傾向。 When the water absorbing rate is lowered, the affinity of the blood slidability imparting agent composition to menstrual blood is low, and the menstrual blood that reaches the skin surface of the top sheet tends to be difficult to slip into the interior of the absorbent article.

且,上述含有血液滑性賦予劑之組成物含有固形物時,在動力黏度及抱水率之測定時,此等較佳以濾過來去除。 Further, when the composition containing the blood slip property imparting agent contains a solid matter, it is preferably removed by filtration when measuring the dynamic viscosity and the water holding ratio.

上述血液滑性賦予劑或含有血液滑性賦予劑之組成物能夠因應所望作為揮發性溶媒,例如,含有醇系溶媒、酯系溶媒、芳香族系溶媒等之塗布液來塗布。上述塗布液藉由含有揮發性溶媒,使含有上述血液滑性賦予劑或含有血液滑性賦予劑之組成物之塗布液的黏度下降,能夠使塗布變得容易,且達成不需要塗裝時的加溫等之塗布工程的簡易化。 The blood slip property-imparting agent or the composition containing the blood-slipness-imparting agent can be applied as a volatile solvent, for example, a coating liquid containing an alcohol-based solvent, an ester-based solvent, or an aromatic solvent. When the coating liquid contains a volatile solvent, the viscosity of the coating liquid containing the composition of the blood slip property imparting agent or the composition containing the blood slip property imparting agent is lowered, and the coating can be easily performed, and the coating is not required. The simplification of the coating process such as heating.

[吸收性物品之製造方法] [Manufacturing method of absorbent article]

突狀部具有特定角度θ之頂部薄片,可藉由例如,同技術領域中周知的方法來製造。例如,根據日本特開2008-25080號記載之方法,製造本發明之吸收性物品中之頂部薄片。且,藉由單獨將頂部薄片與吸收體一起、或與第2薄片及吸收體一起擠壓並形成壓印,能夠形成突狀部具有特定角度θ之頂部薄片。 The top sheet having the protrusions at a particular angle θ can be fabricated, for example, by methods well known in the art. For example, the top sheet in the absorbent article of the present invention is produced according to the method described in JP-A-2008-25080. Further, by separately pressing the top sheet together with the absorbent body or the second sheet and the absorbent body to form an embossing, it is possible to form the top sheet having the projections having a specific angle θ.

上述血液滑性賦予劑或含有血液滑性賦予劑之組成物、或含有此等之塗布液的塗布方法,並無特別限制,能夠應必要將上述血液滑性賦予劑或含有血液滑性賦予劑之組成物、或含有此等之塗布液加熱,例如,非接觸式之塗布機,例如,使用螺旋塗布機、布幕塗布機、噴霧塗布機、浸液塗布機等、接觸式之塗布機等塗布裝置,能夠塗布上述血液滑性賦予劑或含有血液滑性賦予劑之組成物、或含有此等之塗布液。作為上述塗布裝置,由液滴狀或粒子狀之改質劑能夠全體均一地分散之點、及不對資材產生損害之觀點來看,非接觸式之塗布機較佳。 The blood slip property-imparting agent or the composition containing the blood-slipness-imparting agent or the coating method containing the coating liquid is not particularly limited, and the blood-slip property-imparting agent or the blood-slip imparting agent may be necessary. The composition or the coating liquid containing the same is heated, for example, a non-contact type coating machine, for example, a spiral coater, a curtain coater, a spray coater, a immersion coater, or the like, a contact coater, or the like. The coating device can apply the above-described blood slip imparting agent or a composition containing a blood slip imparting agent, or a coating liquid containing the same. As the coating apparatus, a non-contact type coating machine is preferable from the viewpoint that the droplet-shaped or particulate-shaped modifier can be uniformly dispersed in the entirety and the material is not damaged.

且,上述血液滑性賦予劑或含有血液滑性賦予劑之組成物、或含有此等之塗布液,能夠在室溫為液體之原狀態,或為了降低黏度進行加熱,且在室溫為固體時加熱使之液化,並從控制接縫HMA(Hot Melt Adhesive)噴槍進行塗布。藉由將控制接縫HMA噴槍之空氣壓力提高,能夠塗布微粒子狀之血液滑性賦予劑或含有血液滑性賦予劑之組成物。 Further, the blood slip imparting agent or the composition containing the blood slip imparting agent or the coating liquid containing the same can be heated at room temperature in the original state of the liquid or in order to lower the viscosity, and is solid at room temperature. It was heated to liquefy and coated from a HM (Hot Melt Adhesive) spray gun. By increasing the air pressure of the control joint HMA spray gun, it is possible to apply a fine particle-shaped blood slip imparting agent or a composition containing a blood slip imparting agent.

且,血液改質賦予劑或含有血液滑性賦予劑之組成物之塗布量,例如,能夠控制由控制接縫HMA噴槍之塗出量來調節。 Further, the coating amount of the blood reforming agent or the composition containing the blood slip imparting agent can be adjusted, for example, by controlling the amount of coating of the control seam HMA spray gun.

作為上述液體可透性之頂部薄片,只要滿足上述之要件,能夠採用同技術領域所通用者,並無特別限制,例如,具有透過液體之構造之薄片狀材料,可舉例如,薄膜、織布、不織布等。作為構成上述織布及不織布之纖維,可舉例如天然纖維及化學纖維,作為天然纖維,可舉例如,短纖漿、棉等纖維素,作為化學纖維,可舉例如,人造絲、小纖維人造絲等之再生纖維素、乙酸酯、三乙酸酯等半合成纖維素、熱可塑性疏水性化學纖維、以及實施親水化處理之熱可塑性疏水性化學纖維。 The above-mentioned liquid permeable top sheet can be used in the technical field as long as it satisfies the above requirements, and is not particularly limited. For example, a sheet-like material having a liquid-permeable structure, for example, a film or a woven fabric , not weaving, etc. Examples of the fibers constituting the woven fabric and the non-woven fabric include natural fibers and chemical fibers. Examples of the natural fibers include cellulose such as fluff pulp and cotton. Examples of the chemical fibers include rayon and small fiber artificial. Semi-synthetic cellulose such as regenerated cellulose, acetate, or triacetate such as silk, thermoplastic hydrophobic chemical fiber, and thermoplastic thermoplastic chemical fiber subjected to hydrophilization treatment.

作為上述熱可塑性疏水性化學纖維,可舉例如,由聚乙烯(PE)、聚丙烯(PP)、聚乙烯對苯二甲酸酯(PET)等單纖維、PE及PP之接枝聚合物所構成之纖維。 Examples of the thermoplastic hydrophobic chemical fiber include a single fiber such as polyethylene (PE), polypropylene (PP), or polyethylene terephthalate (PET), and a graft polymer of PE and PP. The fibers that make up.

作為上述不織布之例,可舉例如,透氣不織布、紡絲黏合不織布、點接合不織布、水流絡合不織布、針軋不織布、熔噴不織布、及此等之組合(例如,SMS等)等。 Examples of the nonwoven fabric include a breathable nonwoven fabric, a spunbonded nonwoven fabric, a point bonded nonwoven fabric, a water flow non-woven fabric, a needle-punched nonwoven fabric, a melt blown nonwoven fabric, and the like (for example, SMS or the like).

作為上述液體不可透性之後部薄片,可為接合含有PE、PP等薄膜、具有通氣性之樹脂薄膜、紡絲黏合或水流絡合等之不織布上具有通氣性之樹脂薄膜者、SMS等之複層不織布等。若考慮吸收性物品之柔軟性,例如,較佳為基重約15~約30g/m2之低密度聚乙烯 (LDPE)薄膜。 The liquid-impermeable back sheet may be a resin film containing a film having a film such as PE or PP, a resin film having air permeability, a nonwoven fabric such as a spun bond or a water flow, or the like, and a resin film or the like. The layer is not woven, etc. In view of the flexibility of the absorbent article, for example, a low density polyethylene (LDPE) film having a basis weight of from about 15 to about 30 g/m 2 is preferred.

依照本發明之一實施形態之吸收性物品在液體可透性之頂部薄片、與吸收體之間,包含第2薄片。作為上述第2薄片,可舉例與液體可透性之頂部薄片相同之例。 An absorbent article according to an embodiment of the present invention comprises a second sheet between a liquid permeable top sheet and an absorbent body. The second sheet may be exemplified by the same example as the liquid permeable top sheet.

作為上述吸收體之第1例,可舉例如吸收芯部以芯部包覆材料包覆者。 As a first example of the above-mentioned absorber, for example, the absorbent core is covered with a core covering material.

作為上述吸收芯部之構成要素,可舉例如,親水性纖維,例如,短纖漿、棉等纖維素、人造絲、小纖維人造絲等再生纖維素、乙酸酯、三乙酸酯等半合成纖維素、粒子狀聚合物、纖維狀聚合物、熱可塑性疏水性化學纖維、及經親水化處理之熱可塑性疏水性化學纖維、以及此等之組合等。且,作為上述吸收芯部之構成要素,高吸收性聚合物,可舉例如,丙烯酸鈉共聚合物等粒狀物。 Examples of the constituent elements of the absorbent core include hydrophilic fibers such as fluff pulp, cotton such as cotton, rayon, and rayon rayon, such as regenerated cellulose, acetate, and triacetate. Synthetic cellulose, particulate polymer, fibrous polymer, thermoplastic hydrophobic chemical fiber, and hydrophilized hydrophobic thermoplastic fiber treated with hydrophilization, and combinations thereof. Further, as a constituent element of the above-mentioned absorbent core, a superabsorbent polymer may, for example, be a granular material such as a sodium acrylate copolymer.

作為上述芯部包覆材料,只要是液體可透性,且具有高分子吸收體不會透過之阻隔性之物即可,並無特別限制,例如,織布、不織布等。作為上述織布及不織布,可舉例如天然纖維、化學纖維、紙巾等。 The core coating material is not particularly limited as long as it is liquid-permeable and has a barrier property that the polymer absorber does not permeate, and is, for example, a woven fabric or a nonwoven fabric. Examples of the woven fabric and the nonwoven fabric include natural fibers, chemical fibers, and paper towels.

作為上述吸收體之第2例,可舉例如由吸收薄片或聚合物薄片所形成者,其厚度較佳為約0.3~約5.0mm。作為上述吸收薄片及聚合物薄片,通常,只要是用於生理用衛生棉等之吸收性物品者即可使用,並無特別限制。 The second example of the absorbent body is, for example, an absorbent sheet or a polymer sheet, and the thickness thereof is preferably from about 0.3 to about 5.0 mm. The absorbent sheet and the polymer sheet are generally used as long as they are used for absorbent articles such as sanitary napkins, and are not particularly limited.

作為上述側邊薄片,可舉例如與液體可透性 之頂部薄片相同之例。 As the side sheet, for example, liquid permeability is exemplified. The top sheet is the same.

上述側翼能夠由側邊薄片、與液體不可透性之後部薄片所形成,根據所求,可具有補強薄片,例如,於此等之間具有紙。 The side flaps may be formed of a side sheet and a liquid impermeable back sheet, and may have a reinforcing sheet as desired, for example, having paper therebetween.

且,液體可透性之頂部薄片是由不織布或織布所形成時,上述血液滑性賦予劑或含有血液滑性賦予劑之組成物,較佳為不阻塞不織布或織布之纖維間的空隙,上述血液滑性賦予劑或含有血液滑性賦予劑之組成物,可例如,於不織布或織布之纖維之表面上以液滴狀或粒子狀附著、或包覆纖維之表面。 Further, when the liquid permeable top sheet is formed of a non-woven fabric or a woven fabric, the blood slip imparting agent or the composition containing the blood slip imparting agent is preferably a gap between fibers not blocking the nonwoven fabric or the woven fabric. The blood slip imparting agent or the composition containing the blood slip imparting agent may be attached to the surface of the fiber, for example, in the form of droplets or particles on the surface of the fiber of the nonwoven fabric or the woven fabric.

另一方面,液體可透性之頂部薄片為由孔洞薄膜所形成時,上述血液滑性賦予劑或含有血液滑性賦予劑之組成物以不阻塞孔洞薄膜之開孔為佳,上述血液滑性賦予劑或含有血液滑性賦予劑之組成物,可例如,於孔洞薄膜之表面上以液滴狀或粒子狀附著、或以不阻塞開孔之情況下包覆薄膜之表面。是因為若上述血液滑性賦予劑或含有血液滑性賦予劑之組成物阻塞孔洞薄膜之開孔,會阻害吸收後之液體之往吸收體之移行。 On the other hand, when the liquid permeable top sheet is formed of a hole film, the blood slip imparting agent or the composition containing the blood slip imparting agent is preferably an opening which does not block the film of the hole, and the above-mentioned blood slip property is preferable. The imparting agent or the composition containing the blood slip imparting agent may, for example, be attached to the surface of the film by droplets or particles on the surface of the pore film or without blocking the opening. This is because if the blood slip imparting agent or the composition containing the blood slip imparting agent blocks the opening of the pore film, the migration of the absorbed liquid to the absorber is prevented.

且,上述血液滑性賦予劑或含有血液滑性賦予劑之組成物,為了與吸收之經血一起滑落,其表面積大較佳,以液滴狀或粒子狀存在之血液滑性賦予劑或含有血液滑性賦予劑之組成物,粒徑小較佳。 Further, the blood slip property-imparting agent or the composition containing the blood-slipness-imparting agent has a large surface area for slipping off with the absorbed menstrual blood, and is a blood-slipness-imparting agent or a blood-containing substance which is present in the form of droplets or particles. The composition of the slip imparting agent is preferably small in particle diameter.

經血液滑性賦予劑或含有血液滑性賦予劑之組成物塗布之資材,例如,頂部薄片為由合成樹脂所形成 之不織布或織布、孔洞薄膜等時,此等以親水化處理較佳。作為上述親水化處理,可舉例如將親水劑包覆於不織布或織布之纖維的表面、或孔洞薄膜的表面上、與將親水劑混合於不織布或織布、孔洞薄膜等原料之合成樹脂中。 A material coated with a blood slip imparting agent or a composition containing a blood slip imparting agent, for example, the top sheet is formed of a synthetic resin When it is not woven or woven, a film of a hole, or the like, these are preferably hydrophilized. The hydrophilization treatment may be, for example, a method in which a hydrophilic agent is coated on a surface of a fiber of a nonwoven fabric or a woven fabric, or a surface of a pore film, and a synthetic resin in which a hydrophilic agent is mixed with a raw material such as a nonwoven fabric, a woven fabric, or a pore film. .

塗布血液滑性賦予劑或含有血液滑性賦予劑之組成物之前的資材藉由具有親水性,在頂部薄片上,來自血液滑性賦予劑之親油性區域、與來自親水劑之親水性區域會稀疏地共存,並使血液滑性賦予劑或含有血液滑性賦予劑之組成物發揮滑落性能,且容易將經血迅速地移行至吸收體。 The material before the application of the blood slip imparting agent or the composition containing the blood slip imparting agent is hydrophilic, on the top sheet, the lipophilic region derived from the blood slip imparting agent, and the hydrophilic region derived from the hydrophilic agent The mixture is sparsely coherent, and the blood slip imparting agent or the composition containing the blood slip imparting agent exhibits a sliding property, and the menstrual blood is easily transferred to the absorbent body.

上述血液滑性賦予劑或含有血液滑性賦予劑之組成物也有具有潤滑劑之作用。因此,頂部薄片為不織布或織布時,血液滑性賦予劑或含有血液滑性賦予劑之組成物會減少纖維的互相摩擦,並提升柔軟度。且,頂部薄片為樹脂薄膜時,血液滑性賦予劑或含有血液滑性賦予劑之組成物會減少頂部薄片與肌膚的摩擦。 The blood slip imparting agent or the composition containing the blood slip imparting agent also has a function as a lubricant. Therefore, when the top sheet is a non-woven fabric or a woven fabric, the blood slip imparting agent or the composition containing the blood slip imparting agent reduces the mutual friction of the fibers and enhances the softness. Further, when the top sheet is a resin film, the blood slip imparting agent or the composition containing the blood slip imparting agent reduces the friction between the top sheet and the skin.

根據本發明較佳之實施形態之吸收性物品為,以吸收血液作為目的者,例如,生理用衛生棉、內褲護墊等。 The absorbent article according to a preferred embodiment of the present invention is intended to absorb blood, for example, a sanitary napkin, a panty liner, or the like.

且,本發明之吸收性物品與,含有周知之護膚組成物、乳液組成物等之吸收性物品相異,不需要柔軟劑、固定化劑等成分,依照本發明之一實施形態之吸收性物品為不包含柔軟劑及/或固定化劑。 Further, the absorbent article of the present invention is different from the absorbent article containing a well-known skin care composition, an emulsion composition, and the like, and does not require a component such as a softening agent or an immobilizing agent, and the absorbent article according to an embodiment of the present invention It does not contain a softener and/or an immobilizing agent.

[實施例] [Examples]

以下,雖然列舉出事例來說明本發明,但本發明並不限定於此等例。 Hereinafter, the present invention will be described by way of examples, but the present invention is not limited to these examples.

[例1] [example 1]

根據日本特開2008-2034號記載之方法,準備具有脊溝構造之頂部薄片No.1-1。以高精度2次元雷射變位計LJ-G030、及電子顯微鏡測定後,頂部薄片No.1-1具有1049μm之脊部高度H、與約1577μm之脊部之1/2寬度,且於溝部形成開孔率約15%之開孔部。 The top sheet No. 1-1 having a ridge structure was prepared in accordance with the method described in JP-A-2008-2034. After measuring with a high-precision two-dimensional laser displacement meter LJ-G030 and an electron microscope, the top sheet No. 1-1 has a ridge height H of 1049 μm and a width of 1/2 of a ridge of about 1577 μm, and is in the groove portion. An opening portion having an opening ratio of about 15% is formed.

將頂部薄片No.1-1進行加熱處理,使其高度變化,準備已將脊部之高度H及1/2寬度變化之頂部薄片No.1-2~No.1-4。頂部薄片No.1-2~No.1-4之脊部之高度H、脊部之1/2寬度W表示於下述表2。 The top sheet No. 1-1 was heat-treated to change its height, and the top sheets No. 1-2 to No. 1-4 in which the height H and the 1/2 width of the ridges were changed were prepared. The height H of the ridge portion of the top sheet No. 1-2 to No. 1-4 and the width W of the 1/2 portion of the ridge portion are shown in Table 2 below.

分別將頂部薄片No.1-1~No.1-4以高精度2次元雷射變位計LJ-G030、及電子顯微鏡,測定脊部之高度H、與脊部之1/2寬度,接著,求出角度θ。 The top sheets No. 1-1 to No. 1-4 were respectively measured by a high-precision two-dimensional laser displacement meter LJ-G030 and an electron microscope, and the height H of the ridge and the 1/2 width of the ridge were measured. Find the angle θ.

接著,於頂部薄片No.1-1~No.1-4上,使用控制接縫HMA噴槍,將Panacet810s(日油股份公司製)塗布於頂部薄片之接觸肌膚面上,使基重成為約10g/m2,分別準備頂部薄片No.1-5~No.1-8。 Next, on the top sheets No. 1-1 to No. 1-4, Panacet 810s (manufactured by Nippon Oil Co., Ltd.) was applied to the contact surface of the top sheet with a control joint HMA spray gun to make the basis weight about 10 g. /m 2 , Prepare the top sheets No. 1-5 to No. 1-8, respectively.

作為生理用衛生棉,準備Unicharm股份有限公司製,蘇菲Hadaomoi(量多日用~普通,沒有翼部,21cm),從此等中將頂部薄片取出,頂部薄片被取出之蘇 菲衛生棉上,放置上述之頂部薄片(No.1-1~No.1-8中之任一者,已測定質量),準備生理用衛生棉No.1-1~1-8。 As a sanitary napkin, it is prepared by Unicharm Co., Ltd., Sufi Hadaomoi (available for many days ~ normal, no wings, 21cm), from which the top sheet is taken out, and the top sheet is taken out. On the Phillips sanitary napkin, the above top sheet (No. 1-1 to No. 1-8, the mass has been measured) was placed, and the sanitary napkin No. 1-1 to 1-8 was prepared.

對此等之生理用衛生棉,評估頂部薄片移行速度(T/S移行速度)、吸收體移行速度、及頂部薄片經血殘存量(T/S經血殘存量)。 For the physiological sanitary napkins of this type, the top sheet moving speed (T/S moving speed), the moving body migration speed, and the top sheet menstrual blood residual amount (T/S menstrual blood residual amount) were evaluated.

[試驗方法] [experiment method]

於頂部薄片上,放置開有孔洞之壓克力板(200mm×100mm,125g,中央開有40mm×10mm之孔洞),從上述孔洞,使用吸量管將4.0g之37±1℃之馬EDTA血(馬的血液中,為了防止凝結,添加乙烯二胺四乙酸(以下,稱作「EDTA」))(第1次)滴下。 On the top sheet, place an acrylic plate with a hole (200 mm × 100 mm, 125 g, and a hole of 40 mm × 10 mm in the center). From the above hole, use a pipette to place 4.0 g of 37 ± 1 ° C horse EDTA. Blood (in the blood of the horse, in order to prevent coagulation, ethylene diaminetetraacetic acid (hereinafter referred to as "EDTA")) (first time) is added.

在滴下馬EDTA血的同時開始測量,測定馬EDTA血從滴下開始到移行至頂部薄片為止的時間「頂部薄片移行速度」(第1次)。上述T/S移行速度意指,從壓克力板之孔洞將馬EDTA血滴下開始,至壓克力板之孔洞中游離之馬EDTA血消失為止的時間。 The measurement was started while dropping the horse EDTA blood, and the time "top sheet moving speed" (first time) from the start of the dropping of the horse EDTA blood to the top sheet was measured. The above T/S transition speed means the time from the drop of the horse EDTA blood from the hole of the acrylic plate to the disappearance of the free horse EDTA blood in the hole of the acrylic plate.

接著,測定馬EDTA血從滴下開始至移行至吸收體之時間之「吸收體移行速度」(第1次)。上述吸收體移行速度意指,從壓克力板之孔洞將馬EDTA血滴下開始,至壓克力板之孔洞中游離之馬EDTA血消失且頂部薄片之表面及內部馬EDTA血的紅色看不見為止之時間。 Next, the "absorbent migration speed" (first time) of the time when the horse EDTA blood was dropped from the time of dropping to the time of migration to the absorbent body was measured. The above-mentioned absorption speed of the absorbent body means that the blood of the horse EDTA is dripped from the hole of the acrylic plate, and the free EDTA blood disappears in the hole of the acrylic plate, and the surface of the top sheet and the red color of the horse EDTA blood are invisible. The time until then.

從第一次滴下開始3分鐘後,從壓克力板之孔洞使用吸量管將4.0g之37±1℃之馬EDTA血(第2 次)滴下,同樣地,測量T/S移行速度(第2次)及吸收體移行速度(第2次)。 3 minutes after the first drip, 4.0g of 37±1°C horse EDTA blood was used from the hole of the acrylic plate using a pipette (2nd) In the same manner, the T/S transition speed (second time) and the absorber migration speed (second time) were measured.

從第2次滴下開始3分鐘後,將頂部薄片取出,測定其質量,由與試驗前之質量的差,測定出頂部薄片經血殘留量。 Three minutes after the second drip, the top sheet was taken out, the mass was measured, and the amount of residual blood in the top sheet was measured from the difference from the mass before the test.

重複上述試驗10次,採用其平均。結果表示於表2。 The above test was repeated 10 times, using the average. The results are shown in Table 2.

從表2可以了解,生理用衛生棉No.1-7及No.1-8,2次的實驗中,往頂部薄片之移行、及往吸收體之移行快速,且往頂部薄片之馬EDTA血的殘存量少。 As can be seen from Table 2, physiological cotton No. 1-7 and No. 1-8, in two experiments, the migration to the top sheet, and the migration to the absorbent body, and the EDTA blood to the top sheet The residual amount is small.

[例2] [Example 2] [再濕率及吸收體移行速度之評價] [Evaluation of Rewetting Rate and Absorbing Body Migration Speed]

準備如圖1所表示之形狀之市販生理用衛生棉(沒有塗布血液滑性賦予劑)。該生理用衛生棉示為以下所構成:由經親水劑處理之透氣不織布(由聚酯及聚乙烯對苯二甲酸酯所成之複合纖維,基重:35g/m2)形成之頂部薄片、與由透氣不織布(由聚酯及聚乙烯對苯二甲酸酯所成之複合纖維,基重:30g/m2)形成之第2薄片、與包含木漿(基重:150~450g/m2,愈靠近中央部愈多)、丙烯酸系高吸收聚合物(基重:15g/m2)及作為芯部包覆材料之薄紙之吸收體、與經撥水劑處理之側邊薄片、與聚乙烯薄膜所成之後部薄片。 A commercially available sanitary napkin (not coated with a blood slip imparting agent) having a shape as shown in Fig. 1 was prepared. The sanitary tampon is shown as follows: a top sheet formed of a permeable woven fabric treated with a hydrophilic agent (composite fiber composed of polyester and polyethylene terephthalate, basis weight: 35 g/m 2 ) And a second sheet formed of a gas permeable non-woven fabric (composite fiber made of polyester and polyethylene terephthalate, basis weight: 30 g/m 2 ), and wood pulp (basis weight: 150-450 g/ m 2 , the closer to the central portion, the acrylic high-absorbent polymer (basis weight: 15 g/m 2 ), and the absorbent body of the tissue as the core coating material, and the side sheet treated with the water repellent agent, The rear sheet is formed with a polyethylene film.

以下,列舉出使用於實驗之血液滑性賦予劑。 Hereinafter, the blood slip property imparting agent used in the experiment will be listed.

[(a1)鏈狀烴四元醇與至少1個脂肪酸之酯] [(a 1 ) an ester of a chain hydrocarbon tetraol with at least one fatty acid] .Unister H-408BRS,日油股份公司製 . Unister H-408BRS, manufactured by Nippon Oil Co., Ltd.

四2-乙基己酸季戊四醇,重量平均分子量:約640 Pentaerythritol tetraethyl 2-hexanoate, weight average molecular weight: about 640

.Unister H-2408BRS-22,日油股份公司製 . Unister H-2408BRS-22, manufactured by Nippon Oil Co., Ltd.

四2-乙基己酸季戊四醇、與二2-乙基己酸新戊基乙二醇之混合物(58:42,重量比),重量平均分子量:約 520 Mixture of tetrakis-2-ethylhexanoic acid pentaerythritol and di-2-ethylhexanoic acid neopentyl glycol (58:42, weight ratio), weight average molecular weight: about 520

[(a2)鏈狀烴三元醇與至少1個脂肪酸之酯] [(a 2 ) an ester of a chain hydrocarbon triol with at least one fatty acid] .Cetiol SB45DEO,BASF Japan股份有限公司製 . Cetiol SB45DEO, manufactured by BASF Japan

脂肪酸為十八烯酸或硬脂醯酸,為甘油與脂肪酸之三酯 The fatty acid is oleic acid or stearic acid, which is a triglyceride of glycerol and fatty acid.

.SOY42,日油股份公司製 . SOY42, made by Nippon Oil Co., Ltd.

C14之脂肪酸:C16之脂肪酸:C18之脂肪酸:C20之脂肪酸(包含飽和脂肪酸及不飽和脂肪酸之兩者)約以0.2:11:88:0.8之質量比含有,甘油與脂肪酸之三酯,重量平均分子量:880 C 14 fatty acids: C 16 fatty acids: C 18 fatty acids: C 20 fatty acids (including both saturated and unsaturated fatty acids) are contained in a mass ratio of 0.2:11:88:0.8, glycerol and fatty acid Ester, weight average molecular weight: 880

.三C2L油脂肪酸甘油酯,日油股份公司製 . Three C2L oil fatty acid glycerides, manufactured by Nippon Oil Co., Ltd.

C8之脂肪酸:C10之脂肪酸:C12之脂肪酸大約以37:7:56之重量比含有之甘油與脂肪酸之三酯,重量平均分子量:約570 Fatty acid of C 8 : fatty acid of C 10 : fatty acid of C 12 containing triglyceride of glycerol and fatty acid in a weight ratio of 37:7:56, weight average molecular weight: about 570

.三CL油脂肪酸甘油酯,日油股份公司製 . Tri-CL oil fatty acid glyceride, manufactured by Nippon Oil Co., Ltd.

C8之脂肪酸:C12之脂肪酸大約以44:56之重量比含有之甘油與脂肪酸之三酯,重量平均分子量:約570 C 8 fatty acid: C 12 fatty acid contains about glycerol and fatty acid triester in a weight ratio of 44:56, weight average molecular weight: about 570

.Panacet810s,日油股份公司製 . Panacet810s, manufactured by Nippon Oil Co., Ltd.

C8之脂肪酸:C10之脂肪酸大約以85:15之重量比含有之甘油與脂肪酸之三酯,重量平均分子量:約480 Fatty acid of C 8 : C 10 fatty acid containing triglyceride of glycerol and fatty acid in a weight ratio of 85:15, weight average molecular weight: about 480

.Panacet800,日油股份公司製 . Panacet800, manufactured by Nippon Oil Co., Ltd.

脂肪酸全部為辛酸(C8)之甘油與脂肪酸之三酯,重量平均分子量:約470 The fatty acids are all octanoic acid (C 8 ) glycerol and fatty acid triester, weight average molecular weight: about 470

.Panacet800B,日油股份公司製 . Panacet800B, manufactured by Nippon Oil Co., Ltd.

脂肪酸全部為2-乙基己酸(C8)之甘油與脂肪酸之三酯,重量平均分子量:約470 The fatty acids are all 2-ethylhexanoic acid (C 8 ) glycerol and fatty acid triester, weight average molecular weight: about 470

.NA36,日油股份公司製 . NA36, manufactured by Nippon Oil Co., Ltd.

C16之脂肪酸:C18之脂肪酸:C20之脂肪酸(包含飽和脂肪酸及不飽和脂肪酸之兩者)為約以5:92:3之重量比含有之甘油與脂肪酸之三酯,重量平均分子量:約880 C 16 fatty acid: C 18 fatty acid: C 20 fatty acid (including both saturated fatty acids and unsaturated fatty acids) is a triglyceride containing glycerol and fatty acid in a weight ratio of about 5:92:3, weight average molecular weight: About 880

.三椰子油脂肪酸甘油酯,日油股份公司製 . Three coconut oil fatty acid glyceride, manufactured by Nippon Oil Co., Ltd.

C8之脂肪酸:C10之脂肪酸:C12之脂肪酸:C14之脂肪酸:C16之脂肪酸(包含飽和脂肪酸及不飽和脂肪酸之兩者)為以約4:8:60:25:3之重量比含有之甘油與脂肪酸之三酯,重量平均分子量:670 C 8 fatty acids: C 10 fatty acids: C 12 fatty acids: C 14 fatty acids: C 16 fatty acids (including both saturated and unsaturated fatty acids) are about 4:8:60:25:3 by weight Than the glycerol and fatty acid triester, weight average molecular weight: 670

.辛酸二甘油酯,日油股份公司製 . Dioctyl octanoate, manufactured by Nippon Oil Co., Ltd.

脂肪酸為辛酸之甘油與脂肪酸之二酯,重量平均分子量:340 Fatty acid is a diester of glycerin and fatty acid of octanoic acid, weight average molecular weight: 340

[(a3)鏈狀烴二元醇與至少1個脂肪酸之酯] [(a 3 ) an ester of a chain hydrocarbon diol with at least one fatty acid] .Unister H-208BRS,日油股份公司製 . Unister H-208BRS, manufactured by Nippon Oil Co., Ltd.

二2-乙基己酸新戊基乙二醇,重量平均分子量:約 360 Diethyl 2-ethylhexanoate neopentyl glycol, weight average molecular weight: about 360

.comupoalBL,日油股份公司製 . comupoalBL, made by Nippon Oil Co., Ltd.

丁二醇之十二酸(C12)單酯,重量平均分子量:約270 Butanediol dodecanoic acid (C 12 ) monoester, weight average molecular weight: about 270

.comupoalBS,日油股份公司製 . comupoalBS, manufactured by Nippon Oil Co., Ltd.

丁二醇之十八酸(C18)單酯,重量平均分子量:約350 Butyl diol octadecanoic acid (C 18 ) monoester, weight average molecular weight: about 350

[(c2)具有3個羧基之鏈狀烴三羧酸、羥酸、烷氧酸或含氧酸、與至少1個脂肪族1價醇之酯] [(c 2 ) a chain hydrocarbon tricarboxylic acid having three carboxyl groups, a hydroxy acid, an alkoxy acid or an oxo acid, and an ester of at least one aliphatic monovalent alcohol] .O-乙醯檸檬酸三丁基,東京化成工業股份有限公司製 . O-acetonitrile tributyl citrate, manufactured by Tokyo Chemical Industry Co., Ltd.

重量平均分子量:約400 Weight average molecular weight: about 400

.檸檬酸三丁基,東京化成工業股份有限公司製 . Tributyl citrate, manufactured by Tokyo Chemical Industry Co., Ltd.

重量平均分子量:約360 Weight average molecular weight: about 360

[(c3)具有2個羧基之鏈狀烴二羧酸、羥酸、烷氧酸或含氧酸、與至少1個脂肪族1價醇之酯] [(c 3 ) a chain hydrocarbon dicarboxylic acid having two carboxyl groups, a hydroxy acid, an alkoxy acid or an oxo acid, and an ester of at least one aliphatic monovalent alcohol] .己二酸二辛基,和光純藥工業製 . Dioctyl adipate, manufactured by Wako Pure Chemical Industries

重量平均分子量:約380 Weight average molecular weight: about 380

[(d3)脂肪酸與脂肪族1價醇之酯] [(d 3 ) ester of fatty acid with aliphatic monovalent alcohol] .ELECTOLWE20,日油股份公司製 . ELECTOLWE20, manufactured by Nippon Oil Co., Ltd.

十二酸(C12)、與十二基醇(C12)之酯,重量平均分子量:約360 Dodecanoic acid (C 12 ), ester with dodecyl alcohol (C 12 ), weight average molecular weight: about 360

.ELECTOLWE40,日油股份公司製 . ELECTOLWE40, manufactured by Nippon Oil Co., Ltd.

十四酸(C14)、與十二基醇(C12)之酯,重量平均 分子量:約390 Ammonic acid (C 14 ), ester with dodecyl alcohol (C 12 ), weight average molecular weight: about 390

[(e1)聚氧C3~C6伸烷基二醇] [(e 1 ) polyoxy C 3 ~ C 6 alkylene glycol] .uniolPB500,日油股份公司製 . uniolPB500, made by Nippon Oil Co., Ltd.

聚丁二醇,重量平均分子量:約500 Polytetramethylene glycol, weight average molecular weight: about 500

.uniolPB700,日油股份公司製 . uniolPB700, manufactured by Nippon Oil Co., Ltd.

聚氧丁烯聚氧丙二醇,重量平均分子量:約700 Polyoxybutylene polyoxypropylene glycol, weight average molecular weight: about 700

[(f1)鏈狀烷烴] [(f 1 )chain alkane] .Parleam6,日油股份公司製 . Parleam6, manufactured by Nippon Oil Co., Ltd.

藉由共聚合流動異石臘、異丁烯及n-丁烯,接著附加氫原子所生成之分枝鏈烴,聚合度:約5~約10,重量平均分子量:約330 By branching a mixture of isoparaffin, isobutylene and n-butene, followed by addition of a hydrogen atom to form a branched chain hydrocarbon, the degree of polymerization is from about 5 to about 10, and the weight average molecular weight is about 330.

[其他材料] [other materials] .NA50,日油股份公司製 . NA50, manufactured by Nippon Oil Co., Ltd.

於NA36上附加氫原子,並將原料之來自不飽和脂肪酸之雙鍵之比率下降之甘油與脂肪酸之三酯,重量平均分子量:約880 A glycerol and a fatty acid triester having a hydrogen atom added to the NA36 and a ratio of a double bond derived from an unsaturated fatty acid of the raw material, weight average molecular weight: about 880

.(辛酸/癸酸)單甘油酯,日油股份公司製 . (octanoic acid/capric acid) monoglyceride, manufactured by Nippon Oil Co., Ltd.

辛酸(C8)及癸酸(C10)大約以85:15之重量比含有之甘油與脂肪酸之單酯,重量平均分子量:約220 Octanoic acid (C 8 ) and citric acid (C 10 ) contain a monoester of glycerol and fatty acid in a weight ratio of about 85:15, weight average molecular weight: about 220

.Monomuls 90-L2十二酸單甘油酯,BASF Japan股份有限公司製 . Monomuls 90-L2 dodecanoic acid monoglyceride, manufactured by BASF Japan .檸檬酸異丙基,東京化成工業股份有限公司製 . Isopropyl citrate, manufactured by Tokyo Chemical Industry Co., Ltd.

重量平均分子量:約230 Weight average molecular weight: about 230

.蘋果酸二異硬脂醯 . Diisostearate

重量平均分子量:約640 Weight average molecular weight: about 640

.uniolPB1000R,日油股份公司製 . uniolPB1000R, made by Nippon Oil Co., Ltd.

聚丁二醇,重量平均分子量:約1,000 Polytetramethylene glycol, weight average molecular weight: about 1,000

.uniolD-250,日油股份公司製 . uniolD-250, manufactured by Nippon Oil Co., Ltd.

聚丙二醇,重量平均分子量:約250 Polypropylene glycol, weight average molecular weight: about 250

.uniolD-400,日油股份公司製 . uniolD-400, manufactured by Nippon Oil Co., Ltd.

聚丙二醇,重量平均分子量:約400 Polypropylene glycol, weight average molecular weight: about 400

.uniolD-700,日油股份公司製 . uniolD-700, manufactured by Nippon Oil Co., Ltd.

聚丙二醇,重量平均分子量:約700 Polypropylene glycol, weight average molecular weight: about 700

.uniolD-1000,日油股份公司製 . uniolD-1000, made by Nippon Oil Co., Ltd.

聚丙二醇,重量平均分子量:約1,000 Polypropylene glycol, weight average molecular weight: about 1,000

.uniolD-1200,日油股份公司製 . uniolD-1200, manufactured by Nippon Oil Co., Ltd.

聚丙二醇,重量平均分子量:約1,160 Polypropylene glycol, weight average molecular weight: about 1,160

.uniolD-2000,日油股份公司製 . uniolD-2000, made by Nippon Oil Co., Ltd.

聚丙二醇,重量平均分子量:約2,030 Polypropylene glycol, weight average molecular weight: about 2,030

.uniolD-3000,日油股份公司製 . uniolD-3000, made by Nippon Oil Co., Ltd.

聚丙二醇,重量平均分子量:約3,000 Polypropylene glycol, weight average molecular weight: about 3,000

.uniolD-4000,日油股份公司製 . uniolD-4000, manufactured by Nippon Oil Co., Ltd.

聚丙二醇,重量平均分子量:約4,000 Polypropylene glycol, weight average molecular weight: about 4,000

.PEG1500,日油股份公司製 . PEG1500, made by Nippon Oil Co., Ltd.

聚乙二醇,重量平均分子量:約1,500~約1,600 Polyethylene glycol, weight average molecular weight: about 1,500 ~ about 1,600

.WilBridecp9,日油股份公司製 . WilBridecp9, made by Nippon Oil Co., Ltd.

聚丁二醇之兩末端之OH基為經十六酸(C16)酯化之化合物,重量平均分子量:約1,150 The OH group at both ends of the polytetramethylene glycol is a compound esterified with hexadecanoic acid (C 16 ), and the weight average molecular weight is about 1,150.

.unilubMS-70K,日油股份公司製 . unilubMS-70K, manufactured by Nippon Oil Co., Ltd.

聚丙二醇之硬脂醯醚為約15個重複單位,重量平均分子量:約1,140 The stearyl ether of polypropylene glycol is about 15 repeating units, and the weight average molecular weight is about 1,140.

.非離子界面活性劑S-6,日油股份公司製 . Non-ionic surfactant S-6, manufactured by Nippon Oil Co., Ltd.

聚氧乙烯單硬脂酸脂,約7個重複單位,重量平均分子量:約880 Polyoxyethylene monostearate, about 7 repeating units, weight average molecular weight: about 880

.unilub5TP-300KB . unilub5TP-300KB

在季戊四醇1莫耳中,藉由附加氧化乙烯5莫耳、與氧化丙烯65莫耳所生成之聚氧乙烯聚氧丙烯五丁四醇醚,重量平均分子量:4,130 In the pentaerythritol 1 molar, polyoxyethylene polyoxypropylene pentabutanol ether formed by adding ethylene oxide 5 moles and propylene oxide 65 moles, weight average molecular weight: 4,130

.WilBrides753,日油股份公司製 . WilBrides 753, manufactured by Nippon Oil Co., Ltd.

聚氧乙烯聚氧丙烯聚氧丁烯甘油,重量平均分子量:約960 Polyoxyethylene polyoxypropylene polyoxybutylene glycerol, weight average molecular weight: about 960

.uniol TG-330,日油股份公司製 . Uniol TG-330, manufactured by Nippon Oil Co., Ltd.

聚丙二醇之甘油基醚,約6個重複單位,重量平均分 子量:約330 Glyceryl ether of polypropylene glycol, about 6 repeating units, weight average Sub-quantity: about 330

.uniol TG-1000,日油股份公司製 . Uniol TG-1000, manufactured by Nippon Oil Co., Ltd.

聚丙二醇之甘油基醚,約16個重複單位,重量平均分子量:約1,000 Glyceryl ether of polypropylene glycol, about 16 repeating units, weight average molecular weight: about 1,000

.uniol TG-3000,日油股份公司製 . Uniol TG-3000, manufactured by Nippon Oil Co., Ltd.

聚丙二醇之甘油基醚,約16個重複單位,重量平均分子量:約3,000 Glyceryl ether of polypropylene glycol, about 16 repeating units, weight average molecular weight: about 3,000

.uniol TG-4000,日油股份公司製 . Uniol TG-4000, manufactured by Nippon Oil Co., Ltd.

聚丙二醇之甘油基醚,約16個重複單位,重量平均分子量:約4,000 Glyceryl ether of polypropylene glycol, about 16 repeating units, weight average molecular weight: about 4,000

.unilub DGP-700,日油股份公司製 . Unilub DGP-700, manufactured by Nippon Oil Co., Ltd.

聚丙二醇之二甘油基醚,約9個重複單位,重量平均分子量:約700 Diglyceryl ether of polypropylene glycol, about 9 repeating units, weight average molecular weight: about 700

.UnioxHC60,日油股份公司製 . UnioxHC60, manufactured by Nippon Oil Co., Ltd.

聚氧乙烯硬化菎麻油,重量平均分子量:約3,570 Polyoxyethylene hardened castor oil, weight average molecular weight: about 3,570

.凡士林,BASF Japan股份有限公司製 . Vaseline, made by BASF Japan Co., Ltd.

來自石油之烴,半固相 Hydrocarbon from petroleum, semi-solid phase

將上述試料之動力黏度、抱水率、重量平均分子量、IOB及熔點表示於下述表3中。 The dynamic viscosity, water retention ratio, weight average molecular weight, IOB and melting point of the above samples are shown in Table 3 below.

且,關於熔點,「<45」意指熔點小於45℃之意思。 Further, regarding the melting point, "<45" means that the melting point is less than 45 °C.

將上述血液滑性賦予劑塗布於上述生理用衛生棉之頂部薄片之接觸肌膚面之幾乎全體上。血液滑性賦 予劑於室溫下為液體之狀態時以原狀態,或血液滑性賦予劑於室溫下為固體之狀態時,加熱至熔點+20℃之溫度,接著,使用控制接縫HMA噴槍,將各血液滑性賦予劑微粒化,並於頂部薄片之接觸肌膚面,塗布各血液滑性賦予劑至基重成為約5g/m2The blood slip property-imparting agent is applied to almost the entire skin contact surface of the top sheet of the sanitary napkin. When the blood slip property imparting agent is in a state of being in a liquid state at room temperature, or when the blood slip property imparting agent is in a solid state at room temperature, it is heated to a temperature of a melting point of +20 ° C, and then a control joint HMA is used. In the spray gun, each blood slip property imparting agent was atomized, and the top sheet contacted the skin surface, and each blood slip property imparting agent was applied until the basis weight became about 5 g/m 2 .

圖4為頂部薄片包含三C2L油脂肪酸甘油酯之生理用衛生棉(No.2-5)中頂部薄片之接觸肌膚面之電子顯微鏡照片。圖4明顯得知,三C2L油脂肪酸甘油酯以微粒子狀存在於纖維之表面。 Fig. 4 is an electron micrograph of the skin contact surface of the top sheet in the sanitary napkin (No. 2-5) of the top sheet containing the three C2L oil fatty acid glycerides. As is apparent from Fig. 4, the tri-C2L oil fatty acid glyceride is present in the form of fine particles on the surface of the fiber.

[試驗方法] [experiment method]

於包含各血液滑性賦予劑之頂部薄片上,放置開有孔洞之壓克力板(200mm×100mm,125g,中央開有40mm×10mm之孔洞),從上述孔洞,使用吸量管,將37±1℃之馬EDTA血(馬之血液中,為了防止凝結,添加有乙烯二胺四乙酸(以下,亦稱「EDTA」))3.0g滴下(第1次),1分鐘後,將37±1℃之馬EDTA血3.0g從壓克力板之孔洞,以吸量管再度滴下(第2次)。 On the top sheet containing each blood slip imparting agent, an acrylic plate (200 mm × 100 mm, 125 g, a hole of 40 mm × 10 mm in the center) with a hole was placed, and a suction tube was used from the above hole, 37 EDTA blood of ±1 °C (in the blood of horses, in order to prevent coagulation, 3.0 g of ethylenediaminetetraacetic acid (hereinafter also referred to as "EDTA")) was added (first time), and after 1 minute, 37 ± 3.0 g of horse EDTA blood at 1 ° C was dropped from the pores of the acrylic plate and again with a pipette (second time).

在第2次血液滴下後,直接將上述壓克力板取出,在血液滴之處,放置濾紙(Advantech東洋股份有限公司定性濾紙No.2,50mm×35mm)10枚(濾紙10枚之總質量:FW0(g)),從其上方,放置秤砣使壓力成為30g/cm2。1分後,將上述濾紙取出,測定試驗後濾紙10枚之總質量FW1(g),根據以下之式,算出「再濕 率」。 After the second blood drop, the acrylic plate was taken out directly, and 10 pieces of filter paper (Advantech Toyo Co., Ltd. qualitative filter paper No. 2, 50 mm × 35 mm) were placed at the place where the blood was dropped (the total mass of 10 pieces of filter paper) : FW 0 (g)), from above, the scale was placed so that the pressure became 30 g/cm 2 . After 1 minute, the filter paper was taken out, and the total mass FW 1 (g) of 10 pieces of filter paper after the test was measured, and the "re-humidification rate" was calculated according to the following formula.

再濕率(質量%)=100×[FW1(g)-FW0(g)]/6.0(g) Rewetting rate (% by mass) = 100 × [FW 1 (g) - FW 0 (g)] / 6.0 (g)

且,再濕率之評價之外,第2次血液滴下後,測定血液從頂部薄片移行至吸收體的時間「吸收體移行速度」。上述吸收體移行速度意指,從將血液投入頂部薄片開始,到頂部薄片之表面及內部上,血液之紅色消失為止之時間。 Further, in addition to the evaluation of the rewet rate, after the second blood drop, the time "absorbent migration speed" at which the blood migrated from the top sheet to the absorber was measured. The above-described absorption speed of the absorbent body means the time from when the blood is introduced into the top sheet to the surface and inside of the top sheet, and the red color of the blood disappears.

再濕率、與吸收體移行速度之結果表示於下述表3。 The results of the rewetting rate and the speed of migration of the absorbent body are shown in Table 3 below.

且,將吸收體移行速度之試驗後的頂部薄片(T/S)之接觸肌膚面之白色度,根據以下之基準,以目視評估。 Further, the whiteness of the contact sheet of the top sheet (T/S) after the test of the speed of the absorbent body was visually evaluated based on the following criteria.

◎:血液的紅色幾乎不殘留,且沒有血液存在之處、與不存在之處之區別 ◎: The red color of the blood hardly remains, and there is no difference between the place where the blood exists and the place where it does not exist.

○:雖然血液的紅色些許殘留,但是難以區別血液存在之處、與不存在之處 ○: Although the red color of the blood remains, it is difficult to distinguish where the blood exists and where it does not exist.

△:血液之紅色些許殘存,但血液存在之處明顯 △: The red color of the blood remains, but the blood is obvious.

×:血液之紅色殘留於原處 ×: The red color of the blood remains in place

且,根據以下之基準於35℃下測定頂部薄片之接觸肌膚面之黏性。 Further, the adhesion of the top sheet to the skin surface was measured at 35 ° C according to the following criteria.

○:沒有黏性 ○: no stickiness

△:有些許黏性 △: Some stickiness

×:有黏性 ×: Viscous

將結果合併表示於下述表3。 The results are combined and shown in Table 3 below.

雖然在沒有血液滑性賦予劑時,再濕率為22.7%,且吸收體移行速度超過60秒,但由於甘油與脂肪酸之三酯其再濕率皆為7.0%以下,且吸收體移行速度皆為8秒以下,故吸收性能大幅地改善。 Although there is no blood slip property imparting agent, the rewetting rate is 22.7%, and the absorption speed of the absorber exceeds 60 seconds, but since the glycerin and the fatty acid triester have a rewetting rate of 7.0% or less, and the absorption speed of the absorbent body is It is 8 seconds or less, so the absorption performance is greatly improved.

相同地,具有40℃下為約0.01~80mm2/s之動力黏度、與約0.01~約4.0質量%之抱水率、與未滿約1,000之重量平均分子量之血液滑性賦予劑,其吸收性能大幅地改善。 Similarly, the blood slip property imparting agent having a dynamic viscosity of about 0.01 to 80 mm 2 /s at 40 ° C, a water absorbing ratio of about 0.01 to about 4.0% by mass, and a weight average molecular weight of less than about 1,000 is absorbed. The performance has been greatly improved.

接著,讓複數之自願被驗者著用No.2-1~2-51之生理用衛生棉後,得到的回答是:含有No.2-1~2-23之血液滑性賦予劑之生理用衛生棉,即使在吸收經血後,在頂部薄片無沾黏感,且頂部薄片有乾爽感。 Then, after the medicinal cotton of No. 2-1 to 2-51 was used by the volunteers, the answer was: Physiology of the blood-slipness-imparting agent containing No. 2-1 to 2-23. With sanitary napkins, even after absorbing menstrual blood, there is no stickiness on the top sheet, and the top sheet has a dry feel.

且,含有No.2-11、13、16、18~20及23之血液滑性賦予劑之生理用衛生棉,得到的回答是:吸收經血後,其頂部薄片之接觸肌膚面並沒有被血液染紅,且不快感較少。 Further, the physiological sanitary napkin containing the blood slip property imparting agents of No. 2-11, 13, 16, 18 to 20, and 23 was obtained as follows: after absorbing menstrual blood, the top sheet contacted the skin surface without being affected by blood. Reddish and less unpleasant.

[例3] [Example 3] [具有脊溝構造之頂部薄片中經血之表面殘留率] [Residual rate of menstrual blood in the top sheet with a ridge structure]

評估具有脊溝構造之頂部薄片中經血之表面殘留率。 The surface residual rate of menstrual blood in the top sheet having the ridge structure was evaluated.

準備由經親水劑處理之透氣不織布(由聚酯及聚乙烯對苯二甲酸酯而成之複合纖維,基重:35g/m2)所形成之頂部薄片、與由透氣不織布(由聚酯及聚乙烯對苯二甲酸酯而成之複合纖維,基重:30g/m2)所形成之第2薄片、 與包含木漿(基重:150~450g/m2,愈靠近中央部愈多)、與丙烯酸系高吸收聚合物(基重:15g/m2)及作為芯部包覆材料之薄紙之吸收體、與經撥水劑處理之側邊薄片、與由聚乙烯薄膜而成之後部薄片。 Prepare a top sheet formed from a hydrophilic agent-treated breathable nonwoven fabric (composite fiber made of polyester and polyethylene terephthalate, basis weight: 35 g/m 2 ), and a non-woven fabric (by polyester) And polyethylene terephthalate composite fiber, basis weight: 30g / m 2 ) formed by the second sheet, and containing wood pulp (basis weight: 150 ~ 450g / m 2 , the closer to the central part Many), an acrylic-based superabsorbent polymer (basis weight: 15 g/m 2 ), and an absorbent body of a thin paper as a core coating material, a side sheet treated with a water repellent agent, and a polyethylene film After the sheet.

上述頂部薄片為依據日本特開2008-2034號記載之方法製造之具有脊溝構造之頂部薄片,脊部之厚度為約1.5mm,且溝部的厚度為約0.4mm,脊溝構造之間距(脊部之寬度+溝部之寬度)為約4mm,且溝部上有形成開孔率約15%之開孔部。 The top sheet is a top sheet having a ridge groove structure manufactured according to the method described in JP-A-2008-2034, the thickness of the ridge portion is about 1.5 mm, and the thickness of the groove portion is about 0.4 mm, and the distance between the ridge grooves is (ridge). The width of the portion + the width of the groove portion is about 4 mm, and the groove portion has an opening portion having an opening ratio of about 15%.

作為血液滑性賦予劑,可選擇Unister H-408BRS(日油股份公司製,季戊四醇與脂肪酸之四酯),於室溫下,由控制接縫HMA噴槍,於上述頂部薄片之接觸肌膚面(脊溝面)上,以5.0g/m2之基重進行塗布。經電子顯微鏡確認後,H-408BRS是以微粒子狀附著於纖維之表面。 As a blood slip imparting agent, Unister H-408BRS (manufactured by Nippon Oil Co., Ltd., pentaerythritol and tetraester of fatty acid) can be selected at room temperature by a controlled seam HMA spray gun to contact the skin surface of the top sheet (ridge On the groove surface, the coating was carried out at a basis weight of 5.0 g/m 2 . After confirmation by an electron microscope, H-408BRS was attached to the surface of the fiber in the form of fine particles.

接著,藉由將後部薄片、吸收體、第2薄片、及脊溝面向上之頂部薄片依順重疊,形成生理用衛生棉No.3-1。 Next, the sanitary napkin No. 3-1 was formed by gradually overlapping the rear sheet, the absorbent body, the second sheet, and the top sheet having the ridge groove facing upward.

將血液滑性賦予劑,從Unister H-408BRS變更成下述表4所表示者,製造生理用衛生棉No.3-2~No.3-40。且,血液滑性賦予劑在室溫下為液體時,以原狀態,且血液滑性賦予劑在室溫為固體時,加熱至熔點+20℃之溫度,接著,使用控制接縫HMA噴槍,將血液滑性賦予劑微粒化,於頂部薄片之接觸肌膚面塗布至基重約成為5g/m2The blood slip property-imparting agent was changed from Unister H-408BRS to the one shown in the following Table 4 to produce sanitary napkins No. 3-2 to No. 3-40. Further, when the blood-slip property-imparting agent is liquid at room temperature, it is in the original state, and when the blood-slipness-imparting agent is solid at room temperature, it is heated to a temperature of +20 ° C, and then a control joint HMA spray gun is used. The blood slip imparting agent was micronized, and applied to the skin contact surface of the top sheet to a basis weight of about 5 g/m 2 .

且,血液滑性賦予劑約塗布於頂部薄片之接觸肌膚面之幾乎全面,且脊部及溝部之兩方亦有塗布。 Further, the blood-slip property-imparting agent is applied to almost the entire surface of the top sheet which is in contact with the skin, and both the ridge portion and the groove portion are coated.

[試驗方法] [experiment method]

測定頂部薄片之質量:W2(g)(試驗前頂部薄片之質量)後,於吸收性物品之縱向及寬方向的中央部且頂部薄片之上方,放置開有孔洞之壓克力板(200mm×100mm,125g,中央開有40mm×10mm之孔洞),從上述孔洞,使用吸量管滴下4.0g之37±1℃之馬EDTA血(馬血液中,為了防止凝結,有添加乙烯二胺四乙酸(以下,亦稱「EDTA」))。 After measuring the quality of the top sheet: W 2 (g) (the mass of the top sheet before the test), an acrylic sheet with holes was placed in the center portion of the longitudinal direction and the width direction of the absorbent article and above the top sheet (200 mm) ×100mm, 125g, 40mm × 10mm hole in the center), from the above hole, use a pipette to drip 4.0g of 37±1°C horse EDTA blood (in horse blood, in order to prevent condensation, there is ethylene diamine added) Acetic acid (hereinafter also referred to as "EDTA")).

馬EDTA血滴下後,直接取出上述壓克力板,並取出頂部薄片,測定其質量:W3(g)(試驗後之頂部薄片之質量),根據以下之式,算出「表面殘留率(質量%)」。 After the horse EDTA blood was dropped, the above acrylic plate was directly taken out, and the top sheet was taken out, and the mass thereof was measured: W 3 (g) (the mass of the top sheet after the test), and the "surface residual ratio (quality) was calculated according to the following formula %)".

表面殘留率(質量%)=100×[W3(g)-W2(g)]/4.0(g) Surface residual ratio (% by mass) = 100 × [W 3 (g) - W 2 (g)] / 4.0 (g)

將結果表示於下述表4。 The results are shown in Table 4 below.

在不具有血液滑性賦予劑之生理用衛生棉No.3-40中,雖然表面殘留率為7.5質量%,但是在動力黏度及抱水率於特定範圍內之生理用衛生棉No.3-1~No.3-16中,其表面殘留率為2.5質量%以下。 In the sanitary napkin No. 3-40 which does not have a blood-slipness-imparting agent, although the surface residual ratio is 7.5% by mass, the sanitary napkin No. 3- in the dynamic range of the dynamic viscosity and the water holding ratio is within a specific range. In 1 to No. 3-16, the surface residual ratio is 2.5% by mass or less.

生理用衛生棉No.3-1~No.3-16中,從頂部薄片之脊部滴下之馬EDTA血會由脊部滑落至溝部,觀察從溝部迅速地吸收至吸收體內部的樣子。另一方面,不具有 血液滑性賦予劑之生理用衛生棉No.3-40中,滴下的馬EDTA血不會滑落至溝部,會緩緩地垂落在溝部上,較多殘留在頂部薄片之脊部上。且,抱水率高的吸收性物品,例如,No.3-25中,從頂部薄片之脊部滴下的馬EDTA血不會滑落至溝部,且一部分殘留在頂部薄片上緩慢地垂落,且一部分殘留在脊部上。 In the sanitary napkin No. 3-1 to No. 3-16, the horse EDTA blood dropped from the ridge of the top sheet slipped from the ridge to the groove portion, and the state in which it was quickly absorbed from the groove portion into the inside of the absorbent body was observed. On the other hand, does not have In the sanitary napkin No. 3-40 of the blood slip imparting agent, the dropped horse EDTA blood does not slide down to the groove portion, and gradually falls on the groove portion, and remains on the ridge portion of the top sheet. Further, in the absorbent article having a high water holding ratio, for example, in No. 3-25, the horse EDTA blood dropped from the ridge of the top sheet does not slip to the groove portion, and a part remains on the top sheet and slowly falls, and a part thereof Remains on the ridge.

為了確認血液滑性賦予劑之作用,更進行以下之實驗。 In order to confirm the action of the blood slip imparting agent, the following experiment was carried out.

[例4] [Example 4] [含有血液滑性賦予劑之血液黏性] [Blood viscosity containing blood slip imparting agent]

含有血液滑性賦予劑之血液黏性以使用Rheometric Expansion System ARES(Rheometric Scientific,Inc)測定。於馬脫纖維血中,添加2質量%之Panacet810s,輕輕攪拌並形成試料,於直徑50mm之平行板上承載試料,形成100μm之孔隙,在37±0.5℃下測定黏度。由於是平行板,試料並不需均一之剪力速度,但機器上所表示之平均剪力速度為10s-1The blood viscosity of the blood slip imparting agent was measured using a Rheometric Expansion System ARES (Rheometric Scientific, Inc). To the horse's fiber, 2% by mass of Panacet 810s was added, and the sample was gently stirred to form a sample, and the sample was placed on a parallel plate having a diameter of 50 mm to form a pore of 100 μm, and the viscosity was measured at 37 ± 0.5 °C. Since it is a parallel plate, the sample does not require a uniform shear velocity, but the average shear velocity expressed on the machine is 10 s -1 .

含有2質量%之Panacet810s之馬脫纖維血的黏度為,5.9mPa.s,另一方面,不包含血液滑性賦予劑之馬脫纖維血之黏度為50.4mPa.s。因此,包含2質量%之Panacet810s之馬脫纖維血,相較於不包含血液滑性賦予劑時,能夠降低約90%之黏度。 The viscosity of the horse-defibrinated blood containing 2% by mass of Panacet 810s is 5.9 mPa. s, on the other hand, the viscosity of the horse hair fiber without the blood slip imparting agent is 50.4 mPa. s. Therefore, the horse defibrinated blood containing 2% by mass of Panacet 810s can reduce the viscosity by about 90% as compared with the case where the blood slip imparting agent is not contained.

雖然已知血液含有血球等成分,且具有觸變 性之性質,但本發明之血液滑性賦予劑具有低黏度域,且將經血等之血液黏度下降之作用。藉由降低血液之黏度,吸收之經血容易迅速地從頂部薄片移行至吸收體。 Although blood is known to contain blood cells and other components, and has thixotropic The nature of the sex, but the blood slip imparting agent of the present invention has a low viscosity domain and has a function of lowering the blood viscosity of menstrual blood or the like. By lowering the viscosity of the blood, the absorbed menstrual blood easily migrates from the top sheet to the absorber.

[例5] [Example 5] [包含血液滑性賦予劑之血液的顯微鏡照片] [Micrograph of blood containing blood slip agent]

將健康之自願者的經血,採取至食品保護用保鮮薄膜上,於其一部份中添加分散於10倍質量之磷酸緩衝生理食鹽水中之Panacet810s,至Panacet810s之濃度成為1質量%為止。將經血,放置於玻璃薄片,蓋上蓋玻片,於光學顯微鏡下,觀察紅血球之狀態。不包含血液滑性賦予劑之經血之顯微鏡照片表示於圖5(a),且包含Panacet810s之經血之顯微鏡照片顯表示於圖5(b)。 The menstrual blood of the healthy volunteers was applied to a preservative film for food protection, and Panacet 810s dispersed in 10 times by mass of phosphate buffered physiological saline was added to a part thereof until the concentration of Panacet 810s became 1% by mass. The menstrual blood was placed on a glass slide, covered with a cover glass, and the state of the red blood cells was observed under an optical microscope. The photomicrograph of the menstrual blood containing no blood slip imparting agent is shown in Fig. 5(a), and the photomicrograph of the menstrual blood containing Panacet 810s is shown in Fig. 5(b).

由圖5可知,雖然不包含血液滑性賦予劑之經血,紅血球會形成鏈球狀等凝集塊,但包含Panacet810s之經血,其紅血球會各自且安定地分散。因此,血液滑性賦予劑在血液中具有使紅血球安定化之作用。 As is clear from Fig. 5, although the menstrual blood containing the blood slip imparting agent is not contained, the red blood cells form agglomerates such as a chain shape, but the menstrual blood containing Panacet 810s is stably dispersed in the red blood cells. Therefore, the blood slip imparting agent has an effect of stabilizing the red blood cells in the blood.

[例6] [Example 6] [包含血液滑性賦予劑之血液表面張力] [The surface tension of blood containing a blood slip imparting agent]

將包含血液滑性賦予劑之血液表面張力使用協和界面科學社製接觸角計Drop Master500,以懸垂液滴法測定。表面張力為,於羊的脫纖維血中,添加特定量之血液滑性賦予劑,充分震盪後進行測定。 The blood surface tension including the blood slip imparting agent was measured by a drape drop method using a contact angle meter Drop Master 500 manufactured by Kyowa Interface Science Co., Ltd. The surface tension is determined by adding a specific amount of a blood slip property-imparting agent to the defibrinated blood of the sheep, and sufficiently measuring the vibration.

測定是機器會自動進行,表面張力γ是以以下之式求出(參照圖6)。 The measurement is performed automatically by the machine, and the surface tension γ is obtained by the following equation (see Fig. 6).

γ=g×ρ×(de)2×1/H γ =g× ρ ×(de) 2 ×1/H

g:重力係數 g: gravity coefficient

1/H:由ds/de求出之補正項 1/H: Correction term determined by ds/de

ρ:密度 ρ: density

de:最大直径 De: maximum diameter

ds:從滴下端僅有de上升之位置的直徑 Ds: diameter from the position where the drop end is only de rising

密度ρ是以JIS K 2249-1995之「密度試驗方法及密度.質量.容量換算表」之5.振動式密度試驗方法為根據,並以下述表5所表示之溫度測定。 The density ρ is based on the vibration density test method of the "density test method and density, mass and capacity conversion table" of JIS K 2249-1995, and is measured at the temperatures shown in Table 5 below.

測定中是使用京都電子工業股份有限公司之DA-505。 In the measurement, DA-505 of Kyoto Electronics Industry Co., Ltd. was used.

將結果表示於下述表5。 The results are shown in Table 5 below.

由表5可知,血液滑性賦予劑具有降低血液 之表面張力之作用。 As can be seen from Table 5, the blood slip imparting agent has a blood lowering The role of surface tension.

藉由降低血液之表面張力,吸收之血液不會停留在頂部薄片之纖維間,並會迅速地移行至吸收體中。 By lowering the surface tension of the blood, the absorbed blood does not stay between the fibers of the top sheet and will rapidly migrate into the absorbent body.

本發明為關於以下之J1~J10。 The present invention relates to the following J1 to J10.

[J1] [J1]

一種吸收性物品,其係具有液體可透性之頂部薄片、與液體不可透性之後部薄片、與上述頂部薄片及後部薄片之間之吸收體之吸收性物品,其特徵為:上述液體可透性之頂部薄片在排泄口接觸區域具有複數之突狀部,上述突狀部相對於上述吸收性物品之平面方向,具有36~80°之角度,且上述液體可透性之頂部薄片在排泄口接觸區域之至少上述突狀部中,具有血液滑性賦予劑之區域,其血液滑性賦予劑之區域包含於40℃下為0.01~80mm2/s之動力黏度、0.01~4.0質量%之抱水率、與未滿1,000之重量平均分子量之血液滑性賦予劑。 An absorbent article comprising: a liquid permeable top sheet, a liquid impermeable back sheet, and an absorbent article between the top sheet and the back sheet, wherein the liquid is permeable The top sheet has a plurality of protrusions in the discharge port contact area, the protrusion has an angle of 36 to 80° with respect to the plane direction of the absorbent article, and the liquid permeable top sheet is at the drain At least the above-mentioned protruding portion of the contact region has a region of a blood slip imparting agent, and the region of the blood slip imparting agent includes a dynamic viscosity of 0.01 to 80 mm 2 /s at 40 ° C, and a holding of 0.01 to 4.0% by mass. A water-slip imparting agent having a water rate and a weight average molecular weight of less than 1,000.

[J2] [J2]

如J1之吸收性物品,其中上述血液滑性賦予劑更具有0.00~0.60之IOB。 An absorbent article according to J1, wherein the blood slip imparting agent further has an IOB of 0.00 to 0.60.

[J3] [J3]

如J1或J2之吸收性物品,其中上述頂部薄片在突狀部之頂部處,具有0.2~15.0mm之厚度。 An absorbent article according to J1 or J2, wherein said top sheet has a thickness of 0.2 to 15.0 mm at the top of the projection.

[J4] [J4]

如J1~J3中任一項之吸收性物品,其中上述頂部薄片,在上述含有血液滑性賦予劑之區域中,具有1~30g/m2基重之上述血液滑性賦予劑。 In the above-mentioned top sheet, the above-mentioned top sheet has the above-mentioned blood slip property imparting agent having a basis weight of 1 to 30 g/m 2 in the region containing the blood slip property imparting agent.

[J5] [J5]

如J1~J4中任一項之吸收性物品,其中上述複數之突狀部,其係複數之脊部。 An absorbent article according to any one of J1 to J4, wherein the plurality of ridges are plural ridges.

[J6] [J6]

如J1~J5中任一項之吸收性物品,其中上述血液滑性賦予劑為,選自以下之(i)~(iii)以及此等之任意組合所構成之群,(i)烴、(ii)具有(ii-1)烴部分、與(ii-2)一個或複數之相同或相異之插入上述烴部分之C-C單鍵間之選自羰基(-CO-)及氧基(-O-)所構成之群之基之化合物,及(iii)具有(iii-1)烴部分、與(iii-2)一個或複數之相同或相異之插入上述烴部分之C-C單鍵間之選自羰基(-CO-)及氧基(-O-)所構成之群之基、與(iii-3)一個或複數之相同或相異之選自取代上述烴部分之氫原子之選自羧基(-COOH)及羥基(-OH)所構成之群之基之化合物,於此,(ii)或(iii)之化合物中,插入2個以上之 氧基時,各氧基不相鄰接。 The absorbent article according to any one of the above items, wherein the blood slip imparting agent is a group consisting of (i) to (iii) and any combination of the following, (i) a hydrocarbon, ( Ii) a carbonyl group (-CO-) and an oxy group (-O) having (ii-1) a hydrocarbon moiety, the same or different from (ii-2) one or more of the CC single bonds inserted into the hydrocarbon moiety -) the compound of the group consisting of, and (iii) the choice between the CC single bond having the (iii-1) hydrocarbon moiety, the same or different from (iii-2) one or more of the hydrocarbon moiety inserted into the hydrocarbon moiety a group selected from the group consisting of a carbonyl group (-CO-) and an oxy group (-O-), which is the same as or different from (iii-3) one or a plurality of hydrogen atoms selected from the above hydrocarbon moiety; a compound of a group consisting of (-COOH) and a hydroxyl group (-OH), wherein two or more of the compounds of (ii) or (iii) are inserted. In the case of an oxy group, each oxy group is not adjacent.

[J7] [J7]

如J1~J6中任一項之吸收性物品,其中上述血液滑性賦予劑為選自以下之(i’)~(iii’)以及此等之任意組合所構成之群,(i’)烴、(ii’)具有(ii’-1)烴部分、與(ii’-2)一個或複數之相同或相異之插入上述烴部分之C-C單鍵間之選自羰基鍵結(-CO-)、酯鍵結(-COO-)、碳酸酯鍵結(-OCOO-)、及醚鍵結(-O-)所構成之群之鍵結之化合物,及(iii’)具有(iii’-1)烴部分、與(iii’-2)一個或複數之相同或相異之插入上述烴部分之C-C單鍵間之選自羰基鍵結(-CO-)、酯鍵結(-COO-)、碳酸酯鍵結(-OCOO-)、及醚鍵結(-O-)所構成之群之鍵結、與(iii’-3)一個或複數之相同或相異之取代上述烴部分之氫原子之選自羧基(-COOH)及羥基(-OH)所構成之群之基之化合物,於此,(ii’)或(iii’)之化合物中,插入2個以上相同或相異之鍵結時,各鍵結不相鄰接。 The absorbent article according to any one of J1 to J6, wherein the blood slip imparting agent is a group consisting of (i') to (iii') and any combination of the following, (i') hydrocarbon And (ii') a carbonyl bond (-CO-) having a (ii'-1) hydrocarbon moiety, which is the same or different from (ii'-2) one or more of the CC single bonds inserted into the hydrocarbon moiety. a compound bonded to a group consisting of an ester bond (-COO-), a carbonate bond (-OCOO-), and an ether bond (-O-), and (iii') has (iii'- 1) a hydrocarbon moiety, which is the same as or different from (iii'-2) one or more of the CC single bonds inserted into the hydrocarbon moiety selected from the group consisting of a carbonyl bond (-CO-) and an ester bond (-COO-) a bond of a group consisting of a carbonate bond (-OCOO-) and an ether bond (-O-), and a hydrogen of the same or different ones as the (iii'-3) one or more plural a compound in which the atom is selected from the group consisting of a carboxyl group (-COOH) and a hydroxyl group (-OH), wherein two or more identical or different bonds are inserted into the compound of (ii') or (iii'). At the time of knotting, the bonds are not adjacent.

[J8] [J8]

如J1~J7中任一項之吸收性物品,其中上述血液滑性賦予劑為以下之(A)~(F), (A)(A1)與(A2)之酯,其中(A1)為具有鏈狀烴部分、與取代上述鏈狀烴部分之氫原子之2~4個羥基之化合物,(A2)為具有鏈狀烴部分、與取代上述鏈狀烴部分之氫原子之1個羧基之化合物,(B)(B1)與(B2)之醚,其中(B1)為具有鏈狀烴部分、與取代上述鏈狀烴部分之氫原子之2~4個羥基之化合物,(B2)為具有鏈狀烴部分、與取代上述鏈狀烴部分之氫原子之1個羥基之化合物,(C)(C1)與(C2)之酯,其中(C1)為包含鏈狀烴部分、與取代上述鏈狀烴部分之氫原子之2~4個羧基之羧酸、羥酸、烷氧酸或含氧酸,(C2)為具有鏈狀烴部分、與取代上述鏈狀烴部分之氫原子之1個羥基之化合物,(D)具有鏈狀烴部分、與插入上述鏈狀烴部分之C-C單鍵間之選自醚鍵結(-O-)、羰基鍵結(-CO-),酯鍵結(-COO-)、及碳酸酯鍵結(-OCOO-)所構成之群中之任一個鍵結之化合物,(E)聚氧C3~C6伸烷基二醇、或其烷基酯或烷基醚,及(F)鏈狀烴,以及選自此等之任意組合所構成之群。 The absorbent article according to any one of J1 to J7, wherein the blood slip imparting agent is an ester of (A) to (F), (A) (A1) and (A2), wherein (A1) has a chain hydrocarbon portion, a compound having 2 to 4 hydroxyl groups substituted for a hydrogen atom of the above chain hydrocarbon portion, and (A2) a compound having a chain hydrocarbon portion and a carboxyl group replacing a hydrogen atom of the chain hydrocarbon portion (B) (B1) and (B2) an ether, wherein (B1) is a compound having a chain hydrocarbon moiety and 2 to 4 hydroxyl groups which replace a hydrogen atom of the above chain hydrocarbon moiety, and (B2) has a chain a hydrocarbon-like moiety, a compound substituted with one hydroxyl group of a hydrogen atom of the above-mentioned chain hydrocarbon moiety, (C) an ester of (C1) and (C2), wherein (C1) is a chain hydrocarbon-containing moiety and a substituted chain a carboxylic acid, a hydroxy acid, an alkoxy acid or an oxo acid of 2 to 4 carboxyl groups of a hydrogen atom of a hydrocarbon moiety, (C2) being a hydroxyl group having a chain hydrocarbon moiety and a hydrogen atom replacing the above chain hydrocarbon moiety a compound having (D) having a chain hydrocarbon moiety and an ether bond (-O-), a carbonyl bond (-CO-), and an ester bond (- between the CC single bond inserted into the chain hydrocarbon moiety) COO-), and carbonate bond (-OCOO-) Any of a group bonded to the compound, (E) polyoxy C 3 ~ C 6 alkylene glycol, or alkyl ester or alkyl ether, and (F) a chain hydrocarbon, and the selected such A group consisting of any combination.

[J9] [J9]

如J1~J8中任一項之吸收性物品,其中上述血液滑性 賦予劑為選自(a1)鏈狀烴四元醇與至少1個脂肪酸之酯、(a2)鏈狀烴三元醇與至少1個脂肪酸之酯、(a3)鏈狀烴二元醇與至少1個脂肪酸之酯、(b1)鏈狀烴四元醇與至少1個脂肪族1價醇之醚、(b2)鏈狀烴三元醇與至少1個脂肪族1價醇之醚、(b3)鏈狀烴二元醇與至少1個脂肪族1價醇之醚、(c1)具有4個羧基之鏈狀烴四羧酸、羥酸、烷氧酸或含氧酸、與至少1個脂肪族1價醇之酯、(c2)具有3個羧基之鏈狀烴三羧酸、羥酸、烷氧酸或含氧酸、與至少1個脂肪族1價醇之酯、(c3)具有2個羧基之鏈狀烴二羧酸、羥酸、烷氧酸或含氧酸、與至少1個脂肪族1價醇之酯、(d1)脂肪族1價醇與脂肪族1價醇之醚、(d2)二烷基酮、(d3)脂肪酸與脂肪族1價醇之酯,(d4)二烷基碳酸酯、(e1)聚氧C3~C6伸烷基二醇、(e2)聚氧C3~C6伸烷基二醇與至少1個脂肪酸之酯、(e3)聚氧C3~C6伸烷基二醇與至少1個脂肪族1價醇之醚、及(f1)鏈狀烷烴,以及此等之任意組合所構成之群。 The absorbent article of any one of J1 ~ J8, the slipperiness of the blood wherein imparting agent (a 1) tetrahydric alcohol chain hydrocarbon with at least one of the fatty acid ester is selected from, (a 2) a chain hydrocarbon three yuan An ester of an alcohol with at least one fatty acid, an ester of (a 3 ) a chain hydrocarbon diol with at least one fatty acid, (b 1 ) a chain hydrocarbon tetraol, and an ether of at least one aliphatic monovalent alcohol, ( b 2 ) an ether of a chain hydrocarbon triol and at least one aliphatic monovalent alcohol, (b 3 ) a chain hydrocarbon diol and at least one ether of an aliphatic monovalent alcohol, and (c 1 ) having 4 a chain hydrocarbon tetracarboxylic acid of a carboxyl group, a hydroxy acid, an alkoxy acid or an oxo acid, an ester with at least one aliphatic monovalent alcohol, (c 2 ) a chain hydrocarbon tricarboxylic acid having three carboxyl groups, a hydroxy acid And an alkoxylic acid or an oxo acid, an ester with at least one aliphatic monovalent alcohol, (c 3 ) a chain hydrocarbon dicarboxylic acid having two carboxyl groups, a hydroxy acid, an alkoxy acid or an oxyacid, and at least An ester of an aliphatic monovalent alcohol, (d 1 ) an aliphatic monovalent alcohol and an aliphatic monovalent alcohol ether, (d 2 ) dialkyl ketone, (d 3 ) fatty acid and an aliphatic monovalent alcohol ester , (d 4) a dialkyl carbonate, (e 1) polyoxy C 3 ~ C 6 alkylene glycol, (e 2) polyoxy C 3 ~ C 6 alkylene glycol Of at least one fatty acid esters, (e 3) polyoxy C 3 ~ C 6 alkylene glycol and at least one aliphatic ethers of monovalent alcohols, and (F 1) alkane, and any combination of these The group formed.

[J10] [J10]

如J1~J9中任一項之吸收性物品,其中上述頂部薄片為選自不織布、織布及孔洞薄膜所構成之群,上述血液滑性賦予劑在上述不織布或織布纖維的表面、或上述孔洞薄膜的表面上,以液滴狀或粒子狀附著。 The absorbent article according to any one of the above items, wherein the top sheet is a group selected from the group consisting of a nonwoven fabric, a woven fabric, and a film of a hole, and the blood slip imparting agent is on the surface of the nonwoven fabric or the woven fabric, or The surface of the pore film is attached in the form of droplets or particles.

[J11] [J11]

如J1~J10中任一項之吸收性物品,其係生理用衛生棉或內褲護墊。 An absorbent article according to any one of J1 to J10, which is a sanitary napkin or a panty liner.

1‧‧‧吸收性物品 1‧‧‧Absorbables

2‧‧‧頂部薄片 2‧‧‧Top sheet

3‧‧‧吸收體 3‧‧‧ absorber

4‧‧‧側翼 4‧‧‧Flanking

5‧‧‧側邊薄片 5‧‧‧Side sheet

6、6’‧‧‧壓印 6, 6' ‧ ‧ embossing

7‧‧‧含有血液滑性賦予劑之區域 7‧‧‧A zone containing a blood slip agent

Claims (13)

一種吸收性物品,其係具有液體可透性之頂部薄片、液體不可透性之後部薄片、以及前述頂部薄片及後部薄片之間之吸收體之吸收性物品,其特徵為前述液體可透性之頂部薄片於排泄口接觸區域具有複數之突狀部,前述突狀部相對於前述吸收性物品之平面方向,具有38~60°之角度,且前述液體可透性之頂部薄片至少於排泄口接觸區域之前述突狀部上,具有含有血液滑性賦予劑區域,該含有血液滑性賦予劑區域包含具有於40℃下0.01~80mm2/s之動力黏度、0.01~4.0質量%之抱水率、未滿1,000之重量平均分子量之血液滑性賦予劑。 An absorbent article comprising a liquid permeable top sheet, a liquid impermeable back sheet, and an absorbent article of the absorbent body between the top sheet and the back sheet, characterized by the liquid permeable property The top sheet has a plurality of protrusions in the discharge port contact area, the protrusion has an angle of 38 to 60° with respect to the plane direction of the absorbent article, and the liquid permeable top sheet contacts at least the drain opening The region of the protruding portion of the region has a blood-slip imparting agent region containing a dynamic viscosity of 0.01 to 80 mm 2 /s at 40 ° C and a water holding ratio of 0.01 to 4.0% by mass. A blood slip property imparting agent having a weight average molecular weight of less than 1,000. 如請求項1之吸收性物品,其中前述血液滑性賦予劑更具有0.00~0.60之IOB(無機有機平衡)。 The absorbent article of claim 1, wherein the blood slip imparting agent further has an IOB (inorganic organic balance) of 0.00 to 0.60. 如請求項1之吸收性物品,其中前述頂部薄片在突狀部的頂部之處具有0.2~15.0mm之厚度。 The absorbent article of claim 1, wherein the top sheet has a thickness of 0.2 to 15.0 mm at the top of the projection. 如請求項1之吸收性物品,其中前述複數之突狀部分別具有0.1mm以上且未滿15.0mm之高度。 The absorbent article of claim 1, wherein the plurality of protrusions have a height of 0.1 mm or more and less than 15.0 mm, respectively. 如請求項1之吸收性物品,其中於前述頂部薄片之前述含有血液滑性賦予劑之區域中,具有1~30g/m2基重之前述血液滑性賦予劑。 The absorbent article according to claim 1, wherein the blood slip imparting agent having a basis weight of 1 to 30 g/m 2 is contained in the region containing the blood slip property imparting agent in the top sheet. 如請求項1之吸收性物品,其中前述頂部薄片具備:作為前述複數之突狀部之複數之脊部、與複數之溝部且分 別配置在鄰接兩個前述脊部之間者。 The absorbent article of claim 1, wherein the top sheet has a plurality of ridges as the plurality of ridges and a plurality of ridges Do not be placed between adjacent two aforementioned ridges. 如請求項1之吸收性物品,其中前述頂部薄片由不織布所構成。 The absorbent article of claim 1, wherein the aforementioned top sheet is composed of a non-woven fabric. 如請求項1~7中任一項之吸收性物品,其中前述血液滑性賦予劑為,選自以下之(i)~(iii)以及此等之任意組合所成之群,(i)烴、(ii)具有(ii-1)烴部分、與(ii-2)一個或複數之相同或相異之插入前述烴部分之C-C單鍵間之選自羰基(-CO-)及氧基(-O-)所構成之群之基之化合物、及(iii)具有(iii-1)烴部分、(iii-2)一個或複數之相同或相異之插入前述烴部分之C-C單鍵間之選自羰基(-CO-)及氧基(-O-)所構成之群之基、與(iii-3)一個或複數之相同或相異之取代前述烴部分之氫原子之選自羧基(-COOH)及羥基(-OH)所構成之群之基之化合物,於此,(ii)或(iii)之化合物中,插入2個以上之氧基時,各氧基不相鄰接。 The absorbent article according to any one of claims 1 to 7, wherein the blood slip imparting agent is a group selected from the group consisting of (i) to (iii) and any combination of the following, (i) a hydrocarbon And (ii) having a (ii-1) hydrocarbon moiety, which is the same or different from (ii-2) one or more of the CC single bonds inserted into the hydrocarbon moiety, selected from the group consisting of a carbonyl group (-CO-) and an oxy group ( -O-) a compound of the group consisting of, and (iii) having a (iii-1) hydrocarbon moiety, (iii-2) one or a plurality of the same or different intervening CC single bonds inserted into the hydrocarbon moiety a group selected from the group consisting of a carbonyl group (-CO-) and an oxy group (-O-), which is the same as or different from (iii-3) one or a plurality of hydrogen atoms substituted for the aforementioned hydrocarbon moiety, selected from a carboxyl group ( -COOH) and a compound of a group consisting of a hydroxyl group (-OH). In the compound of (ii) or (iii), when two or more oxy groups are inserted, each oxy group is not adjacent. 如請求項1~7中任一項之吸收性物品,其中前述血液滑性賦予劑為選自以下(i’)~(iii’)以及此等之任意組合所構成之群,(i’)烴、(ii’)具有(ii’-1)烴部分、與(ii’-2)一個或複數之相同或相異之插入前述烴部分之C-C單鍵間之選自羰基 鍵結(-CO-)、酯鍵結(-COO-)、碳酸酯鍵結(-OCOO-)、及醚鍵結(-O-)所構成之群之鍵結之化合物、及(iii’)具有(iii’-1)烴部分、(iii’-2)一個或複數之相同或相異之插入前述烴部分之C-C單鍵間之選自羰基鍵結(-CO-)、酯鍵結(-COO-)、碳酸酯鍵結(-OCOO-)、及醚鍵結(-O-)所構成之群之鍵結、與(iii’-3)具有一個或複數之相同或相異之取代前述烴部分之氫原子之選自羧基(-COOH)及羥基(-OH)所構成之群之基之化合物,於此,於(ii’)或(iii’)之化合物中,插入2個以上之相同或相異之鍵結時,各鍵結不相鄰接。 The absorbent article according to any one of claims 1 to 7, wherein the blood slip imparting agent is a group selected from the following (i') to (iii') and any combination thereof, (i') a hydrocarbon, (ii') having a (ii'-1) hydrocarbon moiety, which is the same or different from (ii'-2) one or more of a plurality of CC single bonds inserted into the hydrocarbon moiety, selected from a carbonyl group a compound of a bond formed by a bond (-CO-), an ester bond (-COO-), a carbonate bond (-OCOO-), and an ether bond (-O-), and (iii' a carbonyl bond (-CO-), ester bond having a (iii'-1) hydrocarbon moiety, (iii'-2) one or a plurality of identical or different CC single bonds inserted into the hydrocarbon moiety The bond of the group consisting of (-COO-), carbonate bond (-OCOO-), and ether bond (-O-), and (iii'-3) have one or plural identical or different a compound in which a hydrogen atom of the hydrocarbon moiety is selected from the group consisting of a carboxyl group (-COOH) and a hydroxyl group (-OH), and in the compound of (ii') or (iii'), two are inserted. When the above identical or different bonding is performed, the bonding is not adjacent. 如請求項1~7中任一項之吸收性物品,其中前述血液滑性賦予劑為選自以下(A)~(F)以及此等之任意組合所構成之群,(A)(A1)與(A2)之酯,其中(A1)為具有鏈狀烴部分、與取代前述鏈狀烴部分之氫原子之2~4個羥基之化合物,(A2)為具有鏈狀烴部分、與取代前述鏈狀烴部分之氫原子之1個羧基之化合物,(B)(B1)與(B2)之醚,其中(B1)為具有鏈狀烴部分、與取代前述鏈狀烴部分之氫原子之2~4個羥基之化合物,(B2)為具有鏈狀烴部分、與取代前述鏈狀烴部分之氫原子之1個羥基之化合物,(C)(C1)與(C2)之酯,其中(C1)為包含鏈狀烴部分、與取代前述鏈狀烴部分之氫原子之2~4個羧基之 羧酸、羥酸、烷氧酸或含氧酸,(C2)為具有鏈狀烴部分、與取代前述鏈狀烴部分之氫原子之1個羥基之化合物,(D)具有鏈狀烴部分、與插入前述鏈狀烴部分之C-C單鍵間之選自醚鍵結(-O-)、羰基鍵結(-CO-)、酯鍵結(-COO-)、及碳酸酯鍵結(-OCOO-)所構成之群中之任1個鍵結之化合物,(E)聚氧C3~C6伸烷基二醇、或其烷基酯或烷基醚、及(F)鏈狀烴。 The absorbent article according to any one of claims 1 to 7, wherein the blood slip imparting agent is a group selected from the following (A) to (F) and any combination thereof, (A) (A1) And (A1) is a compound having a chain hydrocarbon moiety and 2 to 4 hydroxyl groups which replace a hydrogen atom of the chain hydrocarbon moiety, and (A2) has a chain hydrocarbon moiety and a substituted a compound of one carboxyl group of a hydrogen atom of a chain hydrocarbon moiety, (B) an ether of (B1) and (B2), wherein (B1) is a hydrogen atom having a chain hydrocarbon moiety and a part of the above-mentioned chain hydrocarbon moiety; a compound of ~4 hydroxyl groups, (B2) is a compound having a chain hydrocarbon moiety and a hydroxyl group substituted for a hydrogen atom of the aforementioned chain hydrocarbon moiety, (C) an ester of (C1) and (C2), wherein (C1) Is a carboxylic acid, a hydroxy acid, an alkoxy acid or an oxo acid containing a chain hydrocarbon moiety and a 2-4 carboxyl group which replaces the hydrogen atom of the aforementioned chain hydrocarbon moiety, and (C2) has a chain hydrocarbon moiety, and a compound which replaces one hydroxyl group of a hydrogen atom of the aforementioned chain hydrocarbon moiety, (D) has a chain hydrocarbon moiety, and is selected from an ether bond (-O-), a carbonyl group, and a CC single bond inserted into the chain hydrocarbon moiety. Bond (-CO-), ester Junction (-COO-), a carbonate bond and bonded to any group consisting of compounds of the knot (-OCOO-), (E) polyoxy C 3 ~ C 6 alkylene glycol, or an alkoxy a base or alkyl ether, and (F) a chain hydrocarbon. 如請求項1~7中任一項之吸收性物品,其中前述血液滑性賦予劑為選自(a1)鏈狀烴四元醇與至少1個脂肪酸之酯,(a2)鏈狀烴三元醇與至少1個脂肪酸之酯,(a3)鏈狀烴二元醇與至少1個脂肪酸之酯,(b1)鏈狀烴四元醇與至少1個脂肪族1價醇之醚,(b2)鏈狀烴三元醇與至少1個脂肪族1價醇之醚,(b3)鏈狀烴二元醇與至少1個脂肪族1價醇之醚,(c1)具有4個羧基之鏈狀烴四羧酸、羥酸、烷氧酸或含氧酸、與至少1個脂肪族1價醇之酯,(c2)具有3個羧基之鏈狀烴三羧酸、羥酸、烷氧酸或含氧酸、與至少1個脂肪族1價醇之酯,(c3)具有2個羧基之鏈狀烴二羧酸、羥酸、烷氧酸或含氧酸、與至少1個脂肪族1價醇之酯,(d1)脂肪族1價醇與脂肪族1價醇之醚,(d2)二烷基酮,(d3)脂肪酸與脂肪族1價醇之酯,(d4)二烷基碳酸酯,(e1)聚氧 C3~C6伸烷基二醇,(e2)聚氧C3~C6伸烷基二醇與至少1個脂肪酸之酯,(e3)聚氧C3~C6伸烷基二醇與至少1個脂肪族1價醇之醚,及(f1)鏈狀烷烴,以及此等之任意組合所構成之群。 The absorbent article according to any one of claims 1 to 7, wherein the blood slip imparting agent is an ester selected from the group consisting of (a 1 ) chain hydrocarbon tetraol and at least one fatty acid, (a 2 ) chain hydrocarbon An ester of a triol with at least one fatty acid, an ester of (a 3 ) a chain hydrocarbon diol with at least one fatty acid, (b 1 ) a chain hydrocarbon tetraol and an ether of at least one aliphatic monovalent alcohol (b 2 ) an ether of a chain hydrocarbon triol with at least one aliphatic monovalent alcohol, (b 3 ) a chain hydrocarbon diol and an ether of at least one aliphatic monovalent alcohol, (c 1 ) a chain of four carboxyl-chain hydrocarbon tetracarboxylic acids, a hydroxy acid, an alkoxy acid or an oxo acid, and an ester of at least one aliphatic monovalent alcohol, (c 2 ) a chain hydrocarbon tricarboxylic acid having three carboxyl groups, a hydroxy acid, an alkoxy acid or an oxo acid, an ester with at least one aliphatic monovalent alcohol, (c 3 ) a chain hydrocarbon dicarboxylic acid having two carboxyl groups, a hydroxy acid, an alkoxy acid or an oxo acid, An ester with at least one aliphatic monovalent alcohol, (d 1 ) an aliphatic monovalent alcohol and an aliphatic monovalent alcohol ether, (d 2 ) dialkyl ketone, (d 3 ) fatty acid and an aliphatic monovalent alcohol Ester, (d 4 ) dialkyl carbonate, (e 1 ) polyoxy C 3 ~ C 6 alkylene glycol, (e 2 ) polyoxy C 3 ~ C 6 alkyl An ester of a diol with at least one fatty acid, (e 3 ) a polyoxy C 3 -C 6 alkylene glycol and an ether of at least one aliphatic monovalent alcohol, and (f 1 ) a chain alkane, and such A group consisting of any combination. 如請求項1~7中任一項之吸收性物品,其中前述頂部薄片為選自不織布、織布及孔洞薄膜所構成之群,前述血液滑性賦予劑為,以液滴狀或粒子狀附著於前述不織布或織布之纖維表面,或前述孔洞薄膜之表面。 The absorbent article according to any one of claims 1 to 7, wherein the top sheet is a group selected from the group consisting of a nonwoven fabric, a woven fabric, and a pore film, and the blood slip imparting agent is attached in a droplet shape or a particle shape. The surface of the fiber of the aforementioned non-woven fabric or woven fabric, or the surface of the aforementioned aperture film. 如請求項1~7中任一項之吸收性物品,其係生理用衛生棉或內褲護墊。 The absorbent article according to any one of claims 1 to 7, which is a sanitary napkin or a panty liner.
TW102135077A 2012-09-28 2013-09-27 Absorbent article TWI594739B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012218769A JP6104551B2 (en) 2012-09-28 2012-09-28 Absorbent articles

Publications (2)

Publication Number Publication Date
TW201436776A TW201436776A (en) 2014-10-01
TWI594739B true TWI594739B (en) 2017-08-11

Family

ID=50388010

Family Applications (1)

Application Number Title Priority Date Filing Date
TW102135077A TWI594739B (en) 2012-09-28 2013-09-27 Absorbent article

Country Status (3)

Country Link
JP (1) JP6104551B2 (en)
TW (1) TWI594739B (en)
WO (1) WO2014050603A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6021565B2 (en) 2012-09-28 2016-11-09 ユニ・チャーム株式会社 Absorbent articles

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1077109A (en) * 1991-11-11 1993-10-13 普罗格特-甘布尔公司 Have comfortable and absorbing articles rapid acquisition topsheet
JP2002172130A (en) * 2000-09-28 2002-06-18 Uni Charm Corp Adsorptive article and barrier agent for adsorptive article
CN1380824A (en) * 1999-10-01 2002-11-20 宝洁公司 Absorbent article having barrier sheet against migration of skin care composition
JP2012143543A (en) * 2010-12-20 2012-08-02 Kao Corp Absorbent article

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK24893D0 (en) * 1993-03-05 1993-03-05 Danaklon As FIBERS AND MANUFACTURING THEREOF
US5643588A (en) * 1994-11-28 1997-07-01 The Procter & Gamble Company Diaper having a lotioned topsheet
JP4342434B2 (en) * 2004-12-27 2009-10-14 花王株式会社 Fiber sheet
US20090030391A1 (en) * 2007-07-25 2009-01-29 John Lee Hammons Absorbent article
JP5268416B2 (en) * 2008-05-01 2013-08-21 大王製紙株式会社 Method for manufacturing absorbent article
JP2011110122A (en) * 2009-11-24 2011-06-09 Kao Corp Absorbent article
JP2011131044A (en) * 2009-11-24 2011-07-07 Kao Corp Absorbent article
JP5548554B2 (en) * 2010-08-17 2014-07-16 モレックス インコーポレイテド Speaker device
JP6021565B2 (en) * 2012-09-28 2016-11-09 ユニ・チャーム株式会社 Absorbent articles

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1077109A (en) * 1991-11-11 1993-10-13 普罗格特-甘布尔公司 Have comfortable and absorbing articles rapid acquisition topsheet
CN1380824A (en) * 1999-10-01 2002-11-20 宝洁公司 Absorbent article having barrier sheet against migration of skin care composition
JP2002172130A (en) * 2000-09-28 2002-06-18 Uni Charm Corp Adsorptive article and barrier agent for adsorptive article
JP2012143543A (en) * 2010-12-20 2012-08-02 Kao Corp Absorbent article

Also Published As

Publication number Publication date
TW201436776A (en) 2014-10-01
JP6104551B2 (en) 2017-03-29
WO2014050603A1 (en) 2014-04-03
JP2014068926A (en) 2014-04-21

Similar Documents

Publication Publication Date Title
TWI580409B (en) Non-woven and absorbent articles
TWI600413B (en) Absorbent article
TWI577352B (en) Absorbent items
JP5122007B1 (en) Absorbent articles
TWI573577B (en) Absorbent items
TWI551273B (en) Absorbent items
JP6116179B2 (en) Absorbent articles
JP6116177B2 (en) Absorbent articles
TWI577359B (en) Absorbent items
KR101914810B1 (en) Absorbent article
TW201424703A (en) Absorbent article
KR101953427B1 (en) Method for producing absorbent article
JP6012380B2 (en) Nonwoven fabric and absorbent article
JP5988810B2 (en) Absorbent articles
TWI594739B (en) Absorbent article
TWI573576B (en) Absorbent items

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees